Loading organization details...
Loading organization details...
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$92.8M
VA/DoD Award Count
17
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding (partial)
$1.5B
Awards Found
200+
Additional awards may exist. View all on USAspending.gov →
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | CANCER CENTER SUPPORT GRANT | $52.9M | FY1997 | Sep 1997 – Jan 2027 |
| Department of Health and Human Services | MULTIMODAL DEVELOPMENTAL NEUROGENETICS OF FEMALES WITH ASD | $35.3M | FY2012 | Sep 2012 – Jun 2027 |
| Department of Education | CARES ACT HIGHER ED EMERGENCY RELIEF FUND PART 2 FOR THE UNIVERSITY OF VIRGINIA | $32M | FY2020 | May 2020 – Feb 2022 |
| Department of Education | CARES ACT GRANT US DEPT OF EDUCATION FOR THE UNIVERSITY OF VIRGINIA | $26.9M | FY2020 | Apr 2020 – Dec 2023 |
| Department of Health and Human Services | PANNEXIN CHANNELS IN VASCULAR PHYSIOLOGY & INFLAMMATION | $24M | FY2014 | Aug 2014 – May 2025 |
| Department of Health and Human Services | DOPAMINE/ANGIOSTENSIN RECEPTORS IN GENETIC HYPERTENSION | $23.9M | FY2004 | Apr 2004 – May 2022 |
| Department of Health and Human Services | THE STROKE HYPERGLYCEMIA INSULIN NETWORK EFFORT (SHINE) TRIAL | $22.6M | FY2011 | Aug 2011 – Jul 2020 |
| Department of Education | CARES ACT - RADFORD UNIVERSITY | $21.3M | FY2020 | Apr 2020 – Dec 2023 |
| Department of Health and Human Services | CELL MIGRATION CONSORTIUM | $20.6M | FY2001 | Sep 2001 – Jul 2011 |
| Department of Health and Human Services | PROVISION OF CLINICAL DATA TO SUPPORT A NATIONWIDE COVID-19 COHORT COLLABORATIVE | $20.3M | FY2020 | Aug 2020 – Sep 2025 |
| Environmental Protection Agency | DESCRIPTION:THIS AGREEMENT PROVIDES FUNDING UNDER THE INFLATION REDUCTION ACT (IRA) TO THE UNIVERSITY OF VIRGINIA. SPECIFICALLY, THE PROJECT WILL ALLOW THE UNIVERSITY OF VIRGINIA, WORKING IN UTQIAGVIK, AK, TO IMPROVE STORM- AND MELT-WATER INFRASTRUCTURE AND MANAGEMENT; PRESERVE INUPIAT TRADITIONS AND CULTURAL SITES; ENHANCE BARROW LOCAL UTILITIES' READINESS AND PREPAREDNESS, AND STRENGTHEN LOCAL CAPACITY; IMPROVE RESIDENTIAL SANITATION BY CONNECTING UNSERVICED HOMES TO MODERN WATER/SEWER SYSTEMS; AND PROTECT THE COMMUNITY'S DRINKING WATER LAGOON. ACTIVITIES:THE ACTIVITIES INCLUDE A COMPREHENSIVE DRAINAGE STUDY OF THE CITY TO INFORM INFRASTRUCTURE UPGRADES AND SUSTAINABLE WATER, SNOW AND PERMAFROST MANAGEMENT, AND IMPLEMENTING IDENTIFIED UPGRADES TO BETTER RESPOND TO INCREASED PRECIPITATION, FLOODING AND ASSOCIATED PERMAFROST DEGRADATION; INSTALLING THERMOSIPHONS IN TRADITIONAL ICE CELLARS WITH UPGRADED DRILLING EQUIPMENT, AND INSTALLING AND IMPROVING DRAINAGE AND RESTORING DISTURBED TUNDRA VEGETATION TO REDUCE FLOODING AT THE COMMUNITY'S CEMETERY; UPGRADING OR EXPANDING CRITICAL HEAVY-DUTY MAINTENANCE VEHICLES THAT ARE BETTER EQUIPPED FOR THE ARCTIC CONDITIONS TO ENHANCE THE LOCAL UTILITY'S READINESS AND PREPAREDNESS, AND STRENGTHENING LOCAL WORKFORCE CAPACITY WHILE REDUCING GREENHOUSE GAS EMISSIONS AND OCCUPATIONAL HAZARDS, AND CREATING AND EXPANDING PROGRAMS THAT BUILD KNOWLEDGE AND JOBS IN SUSTAINABLE WATER, SNOW AND PERMAFROST MANAGEMENT; CONNECTING UNSERVICED HOMES TO MODERN WATER/SEWER SYSTEMS, ELIMINATING OR REDUCING THE USE OF HONEY BUCKETS, HUMAN WASTE SPILLAGE, AND ASSOCIATED ENVIRONMENTAL AND HUMAN HEALTH RISKS; AND PROTECTING THE COMMUNITY'S DRINKING WATER LAGOON BY CONDUCTING COMPREHENSIVE FEASIBILITY STUDIES FOR PER-AND POLYFLUOROALKYL (PFAS) SUBSTANCES REMEDIATION/REMOVAL AND ALGAE BLOOM MITIGATION. SUBRECIPIENT:THE SUBAWARD WITH BARROW UTILITIES AND ELECTRIC COOPERATIVE, INC. (BUECI) WILL COVER WATER AND SEWER CONNECTIONS FOR UNSERVICED HOMES, UPGRADE OF HEAVY-DUTY VEHICLES TO IMPROVE READINESS AND REDUCE GREENHOUSE GAS EMISSIONS AND OCCUPATIONAL HAZARDS, FEASIBILITY STUDIES FOR PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND ALGAL GROWTH MITIGATION IN THE COMMUNITY DRINKING WATER LAGOON, MATERIAL COSTS TO STABILIZE SUBSIDING BUECI STRUCTURES DUE TO PERMAFROST DEGRADATION, AND CONTINUING EDUCATION FOR BUECI LEADERSHIP AND MEMBERS. THE SUBAWARD WITH NORTH SLOPE BOROUGH (NSB) WILL COVER IMPROVEMENTS TO DRAINAGE INFRASTRUCTURE AND COVER MATERIALS, AND CIVIL WORKS TO STABILIZE PERMAFROST AND REDUCE MELTWATER FLOODING, IMPROVE PUMPING OPERATION OF NEWLY ADDED SEWER TANKS, CONDUCT A COMMUNITY-WIDE DRAINAGE ASSESSMENT AND PRODUCE AN ACTION PLAN FOR STORMWATER/MELTWATER MANAGEMENT, CONTINUING EDUCATION FOR NSB LEADERSHIP AND PUBLIC WORKS OPERATORS, AND INTERNSHIPS / APPRENTICESHIPS BETWEEN DEPARTMENT OF PUBLIC WORKS AND I#7735;ISA#289;VIK COLLEGE'S WORKFORCE DEVELOPMENT PROGRAM. THE SUBAWARD WITH THE CITY OF UTQIA#289;IVK (COU) WILL ALLOW FOR IMPROVEMENTS TO THE CULTURAL SITE OF IMAIQSAUN CEMETERY AND COVER DRAINAGE DESIGN, DRAINAGE INSTALLATION AND EXPANSION, IMPROVED SNOW AND MELTWATER MANAGEMENT, GRAVESITE REVEGETATION, AND REPATRIATION OF GRAVESITES INCLUDING NEW COFFINS AND CULTURAL RE-BURIAL CEREMONY. THE SUBAWARD WITH THE INUPIAT COMMUNITY OF ARCTIC SLOPE (ICAS) WILL COVER THE PURCHASE AND SHIPPING OF THERMOSIPHONS AND AN AUGER DRILL TO BE USED FOR THEIR ICE CELLAR PRESERVATION PROJECT. THE SUBAWARD WITH THE ARCTIC INFRASTRUCTURE DEVELOPMENT CENTER AT THE UNIVERSITY OF ALASKA FAIRBANKS WILL ALLOW THE AIDC TO PROVIDE ON-SITE ASSESSMENTS, AND REVIEW AND CONSULTATION ON FEASIBILITY STUDIES AND ICE CELLAR PRESERVATION. OUTCOMES:THE ANTICIPATED DELIVERABLES INCLUDE INCLUDE A STORM(MELT)WATER INFRASTRUCTURE AND MANAGEMENT STUDY/ACTION PLAN, AND IMPLEMENTATION OF THE RECOMMENDATIONS IDENTIFIED IN THE PLAN; ACQUISITION OF THERMOSIPHON INSTALLATION EQUIPMENT AND INSTALLATION OF THERMOSIP | $20M | FY2025 | May 2025 – May 2025 |
| Department of Health and Human Services | TARGETED SPHINGOLIPID METABOLISM FOR TREATMENT OF AML | $19.9M | FY2013 | Sep 2013 – May 2026 |
| Environmental Protection Agency | DESCRIPTION:THIS AGREEMENT PROVIDES FUNDING UNDER THE INFLATION REDUCTION ACT (IRA) TO RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA (UVA). SPECIFICALLY, THE PROJECT WILL IMPLEMENT CLIMATE RESILIENCE PLANNING IN TEN COMMUNITIES THROUGH SOUTHWEST (APPALACHIAN) VIRGINIA AND ADVANCE PROJECTS THAT REDUCE POLLUTION AND CARBON EMISSIONS WHILE SIMULTANEOUSLY ADVANCING CRITICAL COMMUNITY NEEDS: CLIMATE-RESILIENT AFFORDABLE HOUSING, ENERGY-EFFICIENT AND CARBON-NEUTRAL CHILDCARE AND WORKFORCE TRAINING, AND CLIMATE-RESILIENT GATHERING SPACES THAT DOUBLE AS COMMUNITY CAPACITY BUILDING SPACES AND HEALTHCARE ACCESS POINTS. ACTIVITIES:THE ACTIVITIES INCLUDE 1) PARTNER WITH UNITED WAY OF SOUTHWEST VIRGINIA/ENDLESS OPPORTUNITIES (UW/EO), BUCHANAN COUNTY, AND DICKENSON COUNTY TO SUPPORT ELECTRIC VEHICLE TRANSPORTATION OPTIONS AS WELL AS EV CHARGING UNITS; 2) PARTNER WITH BUCHANAN COUNTY AND THE SOUTHERN GAP DEVELOPMENT AREA TO BUILD ENERGY-EFFICIENT, HEALTHY AND CLIMATE-RESILIENT WORKFORCE HOUSING; 3) PARTNER WITH UW/EO TO INCREASE THE ENERGY EFFICIENCIES OF THEIR WORKFORCE AND CHILDCARE CENTERS; 4) PARTNER WITH THE UW/EO TO SUPPORT THE INSTALLATION OF COMMUNITY SOLAR ON THEIR AFFILIATED WORKFORCE DEVELOPMENT AND CHILDCARE CENTERS; 5) PARTNER WITH DICKENSON COUNTY AND THE TOWN OF HAYSI TO DEVELOP A COMMUNITY RESILIENCE HUB THAT CAN ALSO BE A CENTER FOR COMMUNITY ENGAGEMENT AND CAPACITY; 6) PARTNER WITH HEALTHY APPALACHIA INSTITUTE TO RENOVATE 10 LOCATIONS TO DOUBLE AS COMMUNITY RESILIENCE HUBS AND HEALTHCARE OUTPOSTS; 7) CONDUCT FEASIBILITY STUDIES OF ADVANCING MIXED RENEWABLE ENERGY DEVELOPMENTS ON BROWNFIELD SITES IN BUCHANAN AND DICKENSON COUNTIES; AND 8) PARTNER WITH JAMES MADISON UNIVERSITY'S CENTER FOR THE ADVANCEMENT OF SUSTAINABLE ENERGY AND THE NETWORK OF LOCAL COMMUNITY COLLEGES TO ADVANCE CLEAN ENERGY CAREER DEVELOPMENT. SUBRECIPIENT:SUBAWARD OF $4,594,245 TO UNITED WAY (FORMERLY EO) FOR THE DECARBONIZATION AND CARBON MITIGATION OF CHILDCARE CENTERS. THIS PROJECT INCLUDES SOLAR INSTALLATION AND ENERGY EFFICIENCY UPGRADES TO CHILDCARE FACILITIES, OUTDOOR CLASSROOMS, AND BUILDING OUT PROGRAMMING FOR THE RENEWABLE ENERGY SECTOR WORKFORCE. SUBAWARD OF $1,757,708 TO DICKENSON COUNTY FOR BUILDING A CLIMATE RESILIENCE HUB IN THE TOWN OF HAYSI OUTSIDE OF THE FLOODPLAIN. THIS PROJECT INCLUDES ENGINEERING AND ARCHITECTURAL DESIGN AND PERMITS, CONSTRUCTION OF THE FACILITY, AND INSTALLATION OF EV FAST CHARGER. SUBAWARD OF $4,847,841 TO BUCHANAN COUNTY FOR THE BUILDING OF CLIMATE RESILIENT HOUSING IN SOUTHERN GAP OUTSIDE OF THE FLOODPLAIN. THIS PROJECT INCLUDES CONSTRUCTION EXTENSION OF INFRASTRUCTURE (WATER, SEWER, POWER AND TELCOM) TO SUBDIVISION LOTS, CONSTRUCTION OF INTERIOR ROADWAYS AND WALKWAYS, CONSTRUCTION OF TWO SINGLE FAMILY DWELLING UNITS, CONSTRUCTION OF MULTI-FAMILY TOWN HOUSE RENTAL UNITS, AND AN EV CHARGING STATION AT THE REGIONAL OFFICE PARK OFFICE BUILDING. SUBAWARD OF $132,000 TO VIRGINIA TECH FOR A COMMUNITY ENGAGEMENT PROJECT ON CLIMATE RESILIENCE STRATEGIC PLANNING. THIS COMMUNITY-BASED CLIMATE RESILIENCE PLANNING PROCESS INVOLVES THE RAFT (RESILIENCE ADAPTATION FEASIBILITY TOOL). SUBAWARD OF $1,973,797 TO JAMES MADISON UNIVERSITY (JMU) CENTER FOR THE ADVANCEMENT OF SUSTAINABLE ENERGY FOR DEVELOPING CLEAN ENERGY CAREERS. THIS PROJECT INCLUDES BUILDING OR EXPANDING A REGIONAL ENERGY WORKFORCE HUB IN ABINGDON IN PARTNERSHIP WITH VIRGINIA HIGHLANDS COMMUNITY COLLEGE (VHCC) AND NEW RIVER COMMUNITY COLLEGE (NRCC) TO DEVELOP GREEN JOBS PIPELINE, FROM ENTRY LEVEL INSTALLATION, TO PROJECT MANAGEMENT, TO ADVANCED MANAGERIAL AND LEADERSHIP IN RENEWABLE ENERGY CAREERS. PROGRAMS SUPPORTED AT THE REGIONAL HUB WILL ADDRESS RENEWABLE ENERGY SKILL DEVELOPMENT FOR K-12 STUDENTS, TEACHER TRAININGS FOR K-12 FACULTY, RENEWABLE ENERGY KIT AND CURRICULUM DISTRIBUTION, SUMMER CAMPS, AND SUPPORT FOR KIDWIND CHALLENGE TEAMS. OUTCOMES:THE ANTICIPATED DELIVERABLES INCLUDE SOLAR INSTALLATION, ENERGY EFFICIENCY UPGRADES, | $19.9M | FY2025 | Feb 2025 – May 2025 |
| Department of Energy | NEW: CENTER FOR CATALYTIC HYDROCARBON FUNCTIONALIZATION -- EFRC; PI - BRENT GUNNOE | $17.6M | FY2009 | Jul 2009 – Jul 2015 |
| Department of Health and Human Services | ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (ESETT) | $15.4M | FY2014 | Sep 2014 – Feb 2020 |
| Department of Health and Human Services | STRUCTURAL DYNAMICS OF PRESYNAPTIC MEMBRANE FUSION | $14.6M | FY2005 | Apr 2005 – Jun 2024 |
| Department of Health and Human Services | HCMR NOVEL MARKERS OF PROGNOSIS IN HYPERTROPHIC CARDIOMYOPATHY | $14.5M | FY2013 | Jul 2013 – Apr 2021 |
| Department of Health and Human Services | GENERAL CLINICAL RESEARCH CENTER | $14.3M | FY1997 | May 1997 – Feb 2011 |
| Department of Health and Human Services | BASIC CARDIOVASCULAR RESEARCH TRAINING GRANT | $14M | FY1977 | Jul 1977 – Jun 2027 |
| Department of Education | APPALACHIAN SUPPORT FOR SPECIALIZED EDUCATION TRAINING (ASSET) | $13.8M | FY2018 | Oct 2017 – Sep 2021 |
| Department of Energy | ELECTRON INTERACTIONS WITH NUCLEI | $13.3M | FY1996 | Dec 1995 – Nov 2025 |
| Department of Health and Human Services | CLINICAL ACCEPTANCE OF THE ARTIFICIAL PANCREAS: THE INTERNATIONAL DIABETES CLOSED LOOP (IDCL) TRIAL | $12.6M | FY2016 | Jan 2016 – Aug 2021 |
| Department of Health and Human Services | SIGNALING AND PROGRESSION IN PROSTATE CANCER | $12.5M | FY2005 | Aug 2005 – Aug 2017 |
| Department of Health and Human Services | IMMUNOBIOLOGY OF TRANSFUSION | $12.2M | FY2017 | Sep 2017 – Jun 2023 |
| Department of Health and Human Services | KIDNEY DEVELOPMENT CELL FATE AND PRECURSORS OF DISEASE IN THE YOUNG AND ADULT | $12M | FY2012 | Sep 2012 – Aug 2027 |
| Department of Health and Human Services | PROTEIN SEQUENCING BY TANDEM MASS SPECTROMETRY | $11.6M | FY1987 | Jan 1987 – May 2025 |
| Department of Health and Human Services | INFECTIOUS DISEASES TRAINING PROGRAM | $10.8M | FY1977 | Jul 1977 – Jun 2027 |
| Department of Health and Human Services | EPIDEMIOLOGY OF OVARIAN CANCER IN AFRICAN-AMERICAN WOMEN | $10.6M | FY2010 | Jun 2010 – Apr 2017 |
| National Endowment for the Humanities | CELEBRATING THE 250TH ANNIVERSARY OF THE UNITED STATES OF AMERICA: CREATING AND SUSTAINING ACCESS TO FOUNDING ERA / EARLY REP [THE COLLABORATIVE PROJECT, CELEBRATING THE 250TH ANNIVERSARY OF THE UNITED STATES OF AMERICA: CREATING AND SUSTAINING ACCESS TO FOUNDING ERA / EARLY REPUBLIC PRIMARY SOURCES, REPRESENTS A TIMELY AND TRANSFORMATIVE INVESTMENT IN RESEARCHING, EDITING, PUBLISHING, AND PROMOTING THE DOCUMENTARY HERITAGE OF THE FOUNDING ERA AND EARLY REPUBLIC. WITH SUPPORT FROM THIS GRANT, THE UNIVERSITY OF VIRGINIA AND ITS PARTNERS WILL ACHIEVE FOUR CRITICAL OUTCOMES: INCREASING OUR UNDERSTANDING OF THE FOUNDING ERA AND EARLY REPUBLIC; REFINING AND STRENGTHENING THE TECHNICAL AND INSTITUTIONAL INFRASTRUCTURE; CREATING A DYNAMIC, FREELY-ACCESSIBLE WEBSITE; AND PROVIDING HANDS-ON TRAINING AND KNOWLEDGE-SHARING OPPORTUNITIES. BY UNITING EDITORIAL EXPERTISE, TECHNOLOGICAL INNOVATION, AND PUBLIC OUTREACH, THIS INITIATIVE ENSURES THAT THE IDEAS, VOICES, AND EXPERIENCES THAT SHAPED THE FOUNDING OF THE UNITED STATES OF AMERICA REMAIN AVAILABLE, UNDERSTANDABLE, AND ENDURING FOR FUTURE GENERATIONS.] | $10M | FY2026 | Jan 2026 – Dec 2030 |
| Department of Health and Human Services | MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES | $9.8M | FY2009 | Sep 2009 – Mar 2025 |
| Department of Health and Human Services | MEDICAL SCIENTIST TRAINING PROGRAM | $9.8M | FY1977 | Jul 1977 – Jun 2025 |
| Department of Health and Human Services | CANCER RESEARCH TRAINING IN MOLECULAR BIOLOGY | $9.3M | FY1976 | Jul 1976 – Jun 2027 |
| Department of Health and Human Services | KETAMINE ADD-ON FOR ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (KESETT) - THE KETAMINE ADD-ON THERAPY FOR ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (KESETT) IS A PHASE III RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL TO TEST WHETHER KETAMINE (KET) (1 OR 3 MG/KG) ADDED TO THE STANDARD THERAPY, LEVETIRACETAM (LEV), IS MORE EFFECTIVE THAN LEVETIRACETAM (60 MG/KG) ALONE IN TREATING STATUS EPILEPTICUS AFTER BENZODIAZEPINES HAVE FAILED. GENERALIZED CONVULSIVE STATUS EPILEPTICUS (SE) IS A DANGEROUS BUT COMMON NEUROLOGIC EMERGENCY; IT CAN CAUSE RESPIRATORY DEPRESSION AND PERMANENT BRAIN DAMAGE. BENZODIAZEPINES ARE AN EFFECTIVE FIRST-LINE THERAPY, BUT APPROXIMATELY ONE-THIRD OF CHILDREN AND 40% OF ADULTS DO NOT RESPOND. PATIENTS WHO FAIL BENZODIAZEPINES ARE IN ESTABLISHED STATUS EPILEPTICUS. THEY ARE TREATED WITH SECOND-LINE AGENTS SUCH AS LEVETIRACETAM, WHICH SUCCESSFULLY TERMINATES STATUS EPILEPTICUS IN ONLY 47% OF SUBJECTS. WE PROPOSE THAT ADDING KETAMINE TO LEVETIRACETAM WILL INCREASE EFFICACY TO 62%. PRECLINICAL AND CLINICAL EVIDENCE SUPPORTS THIS TRIAL. KETAMINE, AN NMDA RECEPTOR ANTAGONIST, TERMINATES BENZODIAZEPINE REFRACTORY SE IN EXPERIMENTAL ANIMALS. NMDA RECEPTOR ACTIVATION TRIGGERS SELF-REINFORCING SEIZURE MECHANISMS UNDERLYING SE. IT ABROGATES INHIBITORY PLASTICITY, PREVENTS EXCITOTOXICITY AND NEURONAL DEATH, AND PREVENTS EPILEPTOGENESIS ACCOMPANYING SE IN EXPERIMENTAL ANIMALS. RECENT CLINICAL STUDIES IN CHILDREN AND ADULTS SHOWED THAT KETAMINE TERMINATED ESTABLISHED STATUS EPILEPTICUS IN 23 OF 24 SUBJECTS. KETAMINE IS USED EXTENSIVELY IN EMERGENCY SETTINGS FOR SEDATION, INTUBATION, AGITATION, AND PAIN MANAGEMENT; IT IS ON THE WHO ESSENTIAL MEDICATIONS LIST BECAUSE IT IS SAFELY USED EXTENSIVELY. CLINICIANS USE IT EFFECTIVELY TO TREAT REFRACTORY AND SUPER-REFRACTORY SE, AND MANY EXPERTS RECOMMEND IT. ED PHYSICIANS HAVE USED IT FOR DECADES FOR PROCEDURAL SEDATION. WE PROPOSE TO TEST 1 AND 3 MG/KG KETAMINE DOSES BASED ON RECENT HUMAN STUDIES, EXTENSIVE PHARMACOKINETIC MODELING, ANIMAL-TO-HUMAN DOSE CONVERSION AS SUGGESTED BY THE FDA, AND DATA ON THE SAFETY OF KETAMINE. OUR OVERALL HYPOTHESIS IS THAT KETAMINE ADDED TO LEV WILL IMPROVE THE OUTCOME OF ESTABLISHED STATUS EPILEPTICUS COMPARED TO TREATMENT WITH LEVETIRACETAM ALONE BY CLINICALLY MEANINGFUL 15%. WE WILL TEST THIS HYPOTHESIS BY ACCOMPLISHING THE FOLLOWING SPECIFIC AIMS IN A BAYESIAN-ADAPTIVE RANDOMIZED CLINICAL TRIAL: AIM 1: DETERMINE WHETHER PARTICIPANTS RANDOMIZED TO LEVETIRACETAM +3 MG/KG KETAMINE OR LEVETIRACETAM +1 MG/KG KETAMINE WILL HAVE MORE DESIRABLE OUTCOMES THAN THOSE RECEIVING LEVETIRACETAM +PLACEBO. WE RANK THE OUTCOMES ON A SCALE RANGING FROM 1 TO 5. AIM 2: TO ENSURE THAT THE TRIAL IS INFORMATIVE FOR TREATING ESTABLISHED STATUS EPILEPTICUS IN CHILDREN BY DESCRIBING THE EFFECTIVENESS AND RATE OF ADVERSE REACTIONS OF THESE DRUGS. AIM 3: MEASURE DIFFERENCES BETWEEN TREATMENT ARMS IN SECONDARY OUTCOMES. THIS TRIAL CAN CHANGE THE TREATMENT PARADIGM FOR SE BY SUPPLEMENTING CURRENT SECOND-LINE AGENTS WITH KETAMINE TO IMPROVE THE TIMELINESS OF SEIZURE TERMINATION. | $9.3M | FY2025 | Jan 2025 – Dec 2026 |
| Department of Health and Human Services | SYSTEMS ANALYSIS OF STRESS-ADAPTED CANCER ORGANELLES (SASCO) CENTER - PROJECT SUMMARY/ABSTRACT ONCOGENE ACTIVATION IS MODULATED BY NORMAL SUBCELLULAR COMPARTMENTS THAT EXECUTE SPECIALIZED FUNCTIONS RELATED TO HALLMARK CANCER PHENOTYPES. THESE ORGANELLES MUST ADAPT TO ONCOGENIC STRESS IN ORDER FOR TUMORS TO INITIATE AND PROGRESS, BUT THERE IS LITTLE TO NO SYSTEMS-LEVEL UNDERSTANDING OF HOW SUCH ADAPTATIONS OCCUR AND WHAT VULNERABILITIES MIGHT BE CREATED. THE SYSTEMS ANALYSIS OF STRESS-ADAPTED CANCER ORGANELLES (SASCO) CENTER AT THE UNIVERSITY OF VIRGINIA WILL ADDRESS THIS CHALLENGE BY MECHANISTIC MODELING OF ORGANELLAR PROCESSES THAT ITERATES WITH QUANTITATIVE EXPERIMENTS IN DISEASE-RELEVANT CELL CULTURES AND PRIMARY TUMORS. THE WORKING SASCO CENTER HYPOTHESIS IS THAT ORGANELLE-SPECIFIC ADAPTATION TO ONCOGENIC STRESS OCCURS THROUGH A FEW CRITICAL BOTTLENECKS, WHICH BECOME IDENTIFIABLE ONCE THE RELEVANT SIGNALING, METABOLIC, AND TRANSPORT PATHWAYS HAVE BEEN PROPERLY INTEGRATED. THE CENTER BRINGS TOGETHER 14 INVESTIGATORS WITH PRIMARY AND COLLABORATIVE TRACK RECORDS IN CANCER BIOLOGY, SYSTEMS BIOLOGY, GENETICALLY ENGINEERED MOUSE MODELS OF CANCER, AND CLINICAL PRACTICE. THREE RESEARCH PROJECTS AND ONE SHARED RESEARCH CORE WILL PURSUE A COMMON RESEARCH STRATEGY, WHICH LEVERAGES MECHANISTIC MODELS TO TEST COMPETING ALTERNATIVE HYPOTHESES ABOUT HOW ORGANELLES ADAPT TO STRESSES FROM PROXIMAL ONCOGENES THAT DRIVE SPECIFIC TYPES OF CANCER. THE PROJECTS ARE ORGANIZED HIERARCHICALLY AS ORGANELLE STRESSES DOWNSTREAM OF PROLIFERATION-INDUCING ONCOGENES. PROJECT 1 WILL EXAMINE THE CHROMOSOME PASSENGER COMPLEX AND ITS REGULATED PHASE SEPARATION DURING METAPHASE AS AN ORGANELLE THAT SENSES AND REPAIRS SPINDLE DEFECTS TO SUPPRESS BREAST CANCER ANEUPLOIDY DRIVEN BY MITOTIC TRANSCRIPTION FACTORS. PROJECT 2 WILL EVALUATE THE METABOLIC CONSEQUENCES OF CHRONIC MITOCHONDRIAL FRAGMENTATION CAUSED BY MUTANT KRAS IN PRIMARY COLORECTAL CANCERS AND SECONDARY LIVER METASTASES. PROJECT 3 WILL INVESTIGATE LOCALIZED SIGNAL-TRANSDUCTION REBALANCING AS A MECHANISM FOR ALLEVIATING PLASMA-MEMBRANE STRESS CAUSED BY EGFR AMPLIFICATION IN GLIOBLASTOMA. ALL RESEARCH PROJECTS WILL RELY ON THE HIGH-CONTENT IMAGING & ANALYSIS CORE TO OBTAIN ITERATIVE MULTICHANNEL IMMUNOFLUORESCENCE DATA WITH ORGANELLE-LEVEL RESOLUTION AND QUANTIFICATION. THE SASCO OUTREACH CORE AMPLIFIES ONGOING PROGRAMS AT THE UNIVERSITY OF VIRGINIA TO PROVIDE SUMMER RESEARCH EXPERIENCES FOR UNDERGRADUATES AND FACULTY SCHOLARS FROM HISTORICALLY UNDERREPRESENTED BACKGROUNDS AS WELL AS INTRODUCTORY SYSTEMS BIOLOGY MODELING MATERIALS FOR CLINICIANS ACROSS THE COMMONWEALTH OF VIRGINIA. THE SASCO CENTER WILL THUS CREATE A NATIONAL HEADQUARTERS FOR SUBCELLULAR CANCER SYSTEMS BIOLOGY WITHIN THE BROADER CANCER SYSTEMS BIOLOGY CONSORTIUM. | $8.9M | FY2022 | Sep 2022 – Aug 2027 |
| Department of Energy | THE UNIVERSITY OF VIRGINIA EXPERIMENTAL HIGH ENERGY PHYSICS AT THE ENERGY FRONTIER | $8.9M | FY2012 | May 2012 – Mar 2027 |
| Department of Health and Human Services | CLINICAL AND BASIC STUDIES IN POLYCYSTIC OVARIAN SYNDROME | $8.6M | FY1997 | Apr 1997 – Mar 2020 |
| Department of Health and Human Services | CLINICAL & BASIC STUDIES IN POLYCYSTIC OVARIAN SYNDROME | $8.5M | FY2003 | Apr 2003 – Mar 2019 |
| VA/DoDDepartment of Defense | "CENTER FOR HYPERSONIC COMBINED CYCLE FLOW PHYSICS" | $8.4M | FY2009 | Aug 2009 – Jul 2014 |
| Department of Energy | MEDIUM ENERGY SPIN PHYSICS WITH LASERS | $8.4M | FY2001 | Apr 2001 – Mar 2026 |
| Department of Health and Human Services | FUNCTIONAL ANALYSIS OF GENOME WIDE ASSOCIATIONS IN COLORECTAL CANCER | $8.4M | FY2010 | Feb 2010 – May 2022 |
| Department of Energy | HIGH ENERGY PHYSICS | $8.3M | FY1997 | Mar 1997 – Apr 2012 |
| Department of Health and Human Services | IMMUNE REGULATION OF VIRUS CLEARANCE AND TISSUE INJURY AT SITES OF INFECTION | $8.1M | FY2010 | Jul 2010 – May 2015 |
| Department of Education | PROJECT ENGAGE: THE IMPACT OF CARE FOR TEACHERS ON STUDENTS' SUCCESS | $8M | FY2024 | Jan 2024 – Dec 2028 |
| Department of Transportation | UNIVERSITY TRANSPORTATION CENTER | $7.7M | FY2014 | Jun 2014 – May 2019 |
| Department of Health and Human Services | PREDICTIVE INFORMATICS MONITORING IN THE NEONATAL INTENSIVE CARE UNIT | $7.6M | FY2014 | Jul 2014 – Apr 2027 |
| Department of Health and Human Services | COMPREHENSIVE MAGNETIC RESONANCE IN PAD | $7.6M | FY2003 | Sep 2003 – Nov 2023 |
| VA/DoDDepartment of Defense | THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY DARPA DEFENSE SCIENCES OFFICE DSO MULTIOBJECTIVE ENGINEERING AND TESTING OF ALLOY STRUCTURES METALS PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED JANUARY 30, 2024, AND IN THE RECIPIENTS REVISED PROPOSAL TITLED, OPTIMAL MULTI MATERIAL DESIGN VIA TOMOGRAPHIC CHARACTERIZATION AND DATA DRIVEN MODELS, DATED JUNE 8, 2023, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES. | $7.4M | FY2024 | Feb 2024 – Feb 2027 |
| National Science Foundation | GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) -THE NATIONAL SCIENCE FOUNDATION (NSF) GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) IS A HIGHLY COMPETITIVE, FEDERAL FELLOWSHIP PROGRAM. GRFP HELPS ENSURE THE VITALITY AND DIVERSITY OF THE SCIENTIFIC AND ENGINEERING WORKFORCE OF THE UNITED STATES. THE PROGRAM RECOGNIZES AND SUPPORTS OUTSTANDING GRADUATE STUDENTS WHO ARE PURSUING RESEARCH-BASED MASTER'S AND DOCTORAL DEGREES IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS (STEM) AND IN STEM EDUCATION. THE GRFP PROVIDES THREE YEARS OF FINANCIAL SUPPORT FOR THE GRADUATE EDUCATION OF INDIVIDUALS WHO HAVE DEMONSTRATED THEIR POTENTIAL FOR SIGNIFICANT RESEARCH ACHIEVEMENTS IN STEM AND STEM EDUCATION. THIS AWARD SUPPORTS THE NSF GRADUATE FELLOWS PURSUING GRADUATE EDUCATION AT THIS GRFP INSTITUTION. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA. | $7.3M | FY2022 | Aug 2022 – Jul 2027 |
| Department of Health and Human Services | CRYO-EM OF HELICAL PROTEIN AND NUCLEOPROTEIN POLYMERS AT NEAR ATOMIC RESOLUTION | $7.3M | FY2017 | May 2017 – Apr 2027 |
| National Science Foundation | LTER: CLIMATE DRIVERS, DYNAMICS, AND CONSEQUENCES OF ECOSYSTEM STATE CHANGE IN COASTAL BARRIER SYSTEMS | $7.2M | FY2019 | Dec 2018 – May 2025 |
| Department of Energy | RESEARCH IN THE INTENSITY FRONTIER: NOVA AND MU2E | $7.1M | FY2012 | May 2012 – Mar 2027 |
| VA/DoDDepartment of Defense | A MICRO-CELLULAR SOLIDS APPROACH TO THERMO-STRUCTURAL MATERIALS WITH CONTROLLED ARCHITECTURES | $7.1M | FY2010 | Sep 2010 – Nov 2015 |
| Department of Health and Human Services | ROLE OF TH17 IN SEVERE AND RECURRENT C. DIFFICILE INFECTION | $7.1M | FY2020 | Jul 2020 – Jun 2029 |
| VA/DoDDepartment of Defense | AN INTEGRATED CELLUAR MATERIALS APPROACH TO FORCE PROTECTION (TOPIC# 7) | $7.1M | FY2007 | Apr 2007 – Sep 2016 |
| Department of Health and Human Services | BASIC AND TRANSLATIONAL MECHANISMS OF ALLOIMMUNIZATION TO RBC TRANSFUSION - ALLOIMMUNIZATION TO TRANSFUSED RBCS REMAINS A MAJOR PROBLEM FOR THE LARGE NUMBER OF PATIENTS WHO REQUIRE TRANSFUSION (APPROXIMATELY 1 OUT OF 70 PEOPLE (~5,000,000 PATIENTS) ANNUALLY IN THE USA ALONE). ALTHOUGH A BARRIER TO TRANSFUSION IN MULTIPLE SETTINGS, ALLOIMMUNIZATION IS PARTICULARLY PROBLEMATIC FOR PATIENTS WITH SICKLE CELL DISEASE (SCD) DUE TO 1) THE INCREASED RATE OF ALLOIMMUNIZATION (UP TO 30%), 2) THE NEED FOR CHRONIC TRANSFUSION, AND 3) THE RISK OF UNDETECTED (OR NEW) ALLOANTIBODIES CAUSING POTENTIALLY CATASTROPHIC HYPERHEMOLYSIS. THERE ARE VERY FEW EFFECTIVE THERAPEUTIC INTERVENTIONS TO PREVENT RBC ALLOIMMUNIZATION (E.G., EXTENSIVE ANTIGEN MATCHING). FOR ALL TRANSFUSION INDICATIONS, PATIENTS TEND TO BE EITHER “RESPONDERS” THAT DEVELOP ALLOANTIBODIES OVER TIME WITH ONGOING TRANSFUSION OR “NON-RESPONDERS” WITH NO DETECTABLE ALLOANTIBODIES EVEN AFTER MANY TRANSFUSIONS. CURRENTLY, WE CANNOT PREDICT WHICH PATIENTS ARE LIKELY TO BE RESPONDERS AND BECOME ALLOIMMUNIZED. THIS P01 FOCUSES ON ADDRESSING THE PERSISTENT PROBLEM OF RBC ALLOIMMUNIZATION FOR THE LARGE NUMBER OF PATIENTS WHO REQUIRE TRANSFUSIONS AND ARE AT RISK FOR ALLOIMMUNIZATION. THE PROGRAM IS STRUCTURED AROUND A CENTRAL CORE (CORE A) THAT WILL COLLECT LONGITUDINAL SAMPLES FROM A COHORT OF 2000 PATIENTS WITH SCD (AT STEADY STATE, AT TIME OF TRANSFUSION, AND ONE-MONTH POST-TRANSFUSION) LINKED TO DETAILED CLINICAL INFORMATION, INCLUDING RBC ALLOIMMUNIZATION. PROJECTS 1-3 COMBINE NOVEL TRANSLATIONAL MURINE MODELS WITH CLINICAL SAMPLES FROM CORE A WHILE PROJECT 4 USES SAMPLES FROM CORE A TO TEST HYPOTHESES THROUGH AN OMICS-BASED APPROACH AND GENERATES DATA ON PATHWAYS STUDIED IN PROJECTS 1-3. IN THIS WAY, THE PROPOSED PROGRAM CREATES A SYNERGY OF APPROACHES WITH THE ABILITY TO TRANSLATE MURINE FINDINGS INTO HUMANS AND MODEL HUMAN FINDINGS IN MICE. USING THE SAMPLES FROM CORE A AS A COMMON RESOURCE, FOUR PROJECTS ARE PROPOSED. PROJECT 1 BUILDS ON A NOVEL OBSERVATION THAT A MOUSE MODEL OF SLE RECAPITULATES INCREASED RBC ALLOIMMUNIZATION OBSERVED IN HUMANS WITH SLE AND UTILIZES THE MODEL AND SAMPLES FROM CORE A TO TEST THE MECHANISTIC ROLE OF TLR7, TLR9 AND ANTI-NUCLEIC ACID ANTIBODIES IN RBC ALLOIMMUNIZATION. PROJECT 2 BUILDS ON OUR NOVEL OBSERVATION THAT MULTIPLE PURINERGIC SIGNALING PATHWAYS REGULATE RBC ALLOIMMUNIZATION IN MICE AND UTILIZES MOUSE MODELS AND SAMPLES FORM CORE A TO TEST THE MECHANISTIC ROLE OF CD73, AMP, ADORA1, ADENOSINE AND ADORA2B IN RBC ALLOIMMUNIZATION. PROJECT 3 PROPOSES MECHANISTICALLY DRIVEN STUDIES IN PRE-CLINICAL MODELS AND HUMAN STUDIES TO EXPAND UPON OUR NOVEL FINDING THAT RETICULOCYTES (IN DONOR RBC UNITS OR IN TRANSFUSION RECIPIENTS) ARE A RISK FACTOR FOR RBC ALLOIMMUNIZATION. PROJECT 4 WILL INVESTIGATE THE UNDERLYING GENETIC RISK FACTORS THAT PREDISPOSE A GIVEN PATIENT WITH SCD THROUGH ANALYSIS OF WHOLE GENOME SEQUENCING AND THE SPECIFIC MOLECULAR DRIVERS OF ALLOIMMUNIZATION TO A GIVEN TRANSFUSION THROUGH ANALYSIS OF SINGLE CELL RNASEQ DATA. THIS P01 IS DESIGNED TO HAVE NEAR-TERM BENEFITS OF GUIDING CLINICAL PRACTICE BY DISCOVERING PREDICTORS OF RESPONDER/NON-RESPONDER PATIENTS AND LONGER-TERM BENEFITS OF ELUCIDATING MECHANISMS OF RBC ALLOIMMUNIZATION TO ALLOW RATIONAL TARGETS FOR THERAPY DEVELOPMENT. | $7M | FY2023 | Sep 2023 – Jun 2028 |
| Department of Health and Human Services | AN INTERDISCIPLINARY TRAINING PROGRAM IN IMMMUNOLOGY | $7M | FY1995 | Jul 1995 – Jun 2026 |
| VA/DoDDepartment of Defense | SYSTEM-LEVEL APPROACH FOR MULTI-PHASE, NANOTECHNOLOGY-ENHANCED COOLING OF HIGH-POWER MICROELECTRONIC SYSTEMS | $6.9M | FY2007 | Apr 2007 – Aug 2013 |
| National Science Foundation | GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) | $6.8M | FY2013 | Jan 2013 – Dec 2017 |
| Department of Health and Human Services | NETWORK FOR CARDIOTHORACIC SURGICAL INVESTIGATIONS IN CARDIOVASCULAR MEDICINE | $6.8M | FY2007 | Jul 2007 – Feb 2027 |
| Department of Health and Human Services | EXPRESSION AND PROTEOMIC CHARACTERIZATION OF RISK LOCI IN TYPE 1 DIABETES | $6.6M | FY2009 | Sep 2009 – Aug 2012 |
| Department of Health and Human Services | BIOSPECIMEN PROCUREMENT AND TISSUE MICROARRAY MANUFACTURE FOR THE CHTN | $6.6M | FY2019 | Apr 2019 – Mar 2029 |
| VA/DoDDepartment of Defense | TOWARDS A MISSION CONFIGURABLE STEALTH UNDERWATER BATOID | $6.6M | FY2008 | May 2008 – Mar 2015 |
| Department of Health and Human Services | BIO-BEHAVIORAL FEEDBACK AND CONTROL OF TYPE 1 DIABETES | $6.5M | FY1996 | Jul 1996 – Jan 2031 |
| Department of Health and Human Services | THE ROLE OF COPY NUMBER VARIANTS (CNV) IN TYPE 1 DIABETES | $6.4M | FY2009 | Sep 2009 – Aug 2012 |
| Department of Health and Human Services | IGE ANTIBODIES TO THE MAMMALIAN OLIGOSACCHARIDE GALACTOSE-ALPHA-1, 3-GALACTOSE (ALPHA-GAL): IMMUNOLOGY, EPIDEMIOLOGY AND RELEVANCE TO ALLERGIC AND INFLAMMATORY DISEASE | $6.4M | FY1984 | Jul 1984 – May 2028 |
| Department of Health and Human Services | DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES | $6.4M | FY2017 | May 2017 – Apr 2027 |
| Department of Health and Human Services | URINE COLORIMETRY FOR TUBERCULOSIS PHARMACOKINETICS EVALUATION IN CHILDREN AND ADULTS | $6.3M | FY2018 | Sep 2018 – Oct 2028 |
| Department of Health and Human Services | CELLULAR AND GENETIC BASIS OF SYSTEMIC LUPUS | $6.2M | FY2001 | Sep 2001 – Mar 2022 |
| Department of Energy | STUDY OF THE NUCLEON STRUCTURE AT JEFFERSON LAB HALL A | $6.2M | FY2003 | Jun 2003 – May 2026 |
| Department of Health and Human Services | CARDIOVASCULAR SURGERY RESEARCH TRAINING GRANT | $6.1M | FY1998 | Jul 1998 – Jun 2026 |
| Department of Health and Human Services | DOPAMINERGIC AND GLUTAMATERGIC MECHANISMS OF COCAINE ADDICTION: SEX DIFFERENCES | $6.1M | FY2008 | Apr 2008 – May 2027 |
| Department of Health and Human Services | ONTOGENY OF CENTRAL NEURAL TASTE RESPONSES | $6M | FY1986 | Aug 1986 – Sep 2024 |
| National Science Foundation | LTER: DRIVERS, DYNAMICS AND CONSEQUENCES OF NON-LINEAR CHANGE IN COASTAL BARRIER SYSTEMS | $5.9M | FY2013 | Dec 2012 – Nov 2018 |
| Department of Health and Human Services | FIELD STUDIES OF HUMAN IMMUNITY TO AMEBIASIS IN BANGLADESH | $5.9M | FY1998 | Sep 1998 – Mar 2029 |
| Department of Health and Human Services | CRITICAL PERIOD PLASTICITY AND BINOCULAR MATCHING IN THE VISUAL CORTEX | $5.9M | FY2010 | Sep 2010 – Apr 2030 |
| Department of Health and Human Services | MOLECULAR MECHANISMS OF MEMBRANE TRANSPORT | $5.9M | FY1985 | Sep 1985 – Mar 2027 |
| Department of Health and Human Services | REAL-TIME MEASUREMENTS OF NEUROTRANSMISSION IN DROSOPHILA MELANOGASTER | $5.9M | FY2009 | Jul 2009 – Mar 2027 |
| Department of Health and Human Services | TARGETED CEU IMAGING OF ATHEROSCLEROSIS AND ANGIOGENESIS | $5.8M | FY2004 | Sep 2004 – Feb 2024 |
| Department of Health and Human Services | CELLULAR/MOLECULAR MECHANISMS OF RESPIRATORY NEURONAL CHEMOSENSITIVITY | $5.8M | FY2011 | May 2011 – Jun 2029 |
| Department of Health and Human Services | MINIMALLY INVASIVE CEREBRAL BLOOD FLOW AND OXYGENATION MONITORING FOR INTRACRANIAL HYPERTENSION - ABSTRACT/PROJECT SUMMARY TRAUMATIC BRAIN INJURY, ACUTE ISCHEMIC STROKE, AND INTRACEREBRAL HEMORRHAGE ARE FREQUENTLY COMPLICATED BY INTRACRANIAL HYPERTENSION LEADING TO PROGRESSIVE ISCHEMIA AND SECONDARY BRAIN INJURY. RECENT EFFORTS FOCUSED ON IMPROVING OUTCOMES HAVE THEREFORE BEEN FOCUSED UPON IMPROVING CEREBRAL OXYGENATION AND THE DEVELOPMENT OF MONITORING DEVICES TO GUIDE THERAPY. CURRENT DEVICES DESIGNED TO MEASURE TISSUE OXYGENATION ARE, HOWEVER, SEVERELY LIMITED IN THEIR SCOPE OF SURVEILLANCE AND ACCURACY. SURFACE OXIMETRY MONITORS INTERROGATE ONLY SUPERFICIAL BRAIN TISSUE, WITH CONTAMINATION FROM INTERVENING SKIN AND SKULL. INTRAPARENCHYMAL BRAIN TISSUE OXYGEN PROBES SURVEY RELATIVELY METABOLICALLY LESS ACTIVE WHITE MATTER (COMPARED TO GRAY MATTER), A VOLUME OF LESS THAN 3 MM3, AND AT A SINGLE LOCATION. LASTLY, INTRAPARENCHYMAL TISSUE OXYGEN MONITORS ARE BULKY, INCOMPATIBLE WITH MAGNETIC RESONANCE IMAGING, AND HAVE YET TO DEMONSTRATE CLINICAL EFFICACY. TO FILL THIS NEED, WE WILL FINALIZE THE DEVELOPMENT OF A BRAIN-SPECIFIC, MINIMALLY INVASIVE, OPTICAL BLOOD FLOW AND OXYGENATION MONITORING SYSTEM (FLOXBR), THEN TRANSLATE THIS DEVICE TO HUMANS. THE FLOXBR, EMPLOYING DIFFUSE OPTICAL AND CORRELATION SPECTROSCOPIES VIA A BRAIN SURFACE PROBE, MAY OFFER IMPROVED SENSITIVITY AND SPECIFICITY COMPARED TO NON-INVASIVE PROBES AND WILL PROBE LARGER VOLUMES THAN CURRENTLY AVAILABLE INVASIVE PROBES, SUCH AS THE LICOXTM TISSUE PO2 PROBE. UNLIKE INTRAPARENCHYMAL PROBES, THIS DEVICE CAN LIE ABOVE OR BELOW THE DURA AND WILL BE MORE SENSITIVE TO HIGHLY METABOLICALLY ACTIVE GRAY MATTER. ITS SMALL SIZE AND FLEXIBILITY WILL PERMIT MULTIPLE PROBES TO BE PLACED THROUGH A SINGLE BURR HOLE, THUS ALLOWING FOR THE MONITORING OF REGIONAL DIFFERENCES IN FLOW AND OXYGENATION. UNLIKE SURFACE OXIMETRY, THE FLOXBR IS NOT IMPACTED BY SUPERFICIAL TRAUMA OR EDEMA, IMPROVING RELIABILITY AND SENSITIVITY. CONTINUOUS, EASILY INTERPRETED, AND RELIABLE MINIMALLY INVASIVE MONITORING OF CEREBRAL OXYGEN DELIVERY MAY ENHANCE MANAGEMENT AND OUTCOMES IN PATIENTS SUFFERING FROM INTRACRANIAL HYPERTENSION. OUR AIMS ARE SUCCINCTLY SUMMARIZED BELOW. AIM 1) FINALIZE DEVELOPMENT & MANUFACTURE THE FLOXBR BRAIN FLOW AND OXIMETRY MONITORING DEVICE. AIM 2) PRE-CLINICAL DEVICE EVALUATION, MEASUREMENT VALIDATION, AND SAFETY TESTING OF FLOXBR. AIM 3) COMPLETE REGULATORY AND SAFETY REQUIREMENTS TO SUPPORT FLOXBR FIRST-IN-HUMANS FEASIBILITY TESTING. AIM 4) CONDUCT FIRST-IN-HUMANS FEASIBILITY TESTING. | $5.7M | FY2022 | Sep 2022 – Nov 2026 |
| National Science Foundation | LONG-TERM DRIVERS, STATE CHANGE AND DISTURBANCE ON THE VIRGINIA COAST RESERVE: LTER V | $5.6M | FY2007 | Dec 2006 – Nov 2012 |
| VA/DoDDepartment of Defense | FOCUSED ULTRASOUND INTERVENTIONS FOR NONINVASIVE PRECISION THERAPY IN PRIMARY AND METASTATIC BREAST CANCERS | $5.5M | FY2025 | Sep 2025 – Sep 2029 |
| Department of Health and Human Services | TRAINING IN CELL AND MOLECULAR BIOLOGY | $5.5M | FY1985 | Jul 1985 – Jun 2021 |
| Department of Health and Human Services | SOCIAL RELATIONSHIP QUALITIES AS PREDICTORS OF HEALTH & AGING FROM ADOLESCENCE THROUGH EARLY MIDLIFE | $5.5M | FY2008 | Jul 2008 – Jun 2028 |
| Department of Health and Human Services | AUGMENTATION OF TISSUE PERFUSION IN PAD WITH ULTRASOUND-MEDIATED CAVITATION | $5.5M | FY2016 | Apr 2016 – Mar 2025 |
| Department of Health and Human Services | THE ROLE OF ION TRANSPORT IN GLIOMA MIGRATION, PROLIFERATION, AND APOPTOSIS | $5.4M | FY1997 | Aug 1997 – Nov 2025 |
| Department of Health and Human Services | ROLE OF EOSINOPHILS IN INNATE PROTECTION FROM C. DIFFICILE | $5.4M | FY2016 | Feb 2016 – Jan 2027 |
| Department of Health and Human Services | GROWTH AND REGENERATION IN THE INNER EAR | $5.4M | FY1989 | Dec 1988 – Jul 2020 |
| Department of Health and Human Services | MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION | $5.4M | FY1991 | Sep 1991 – Dec 2024 |
| Department of Health and Human Services | MOLECULAR MECHANISMS OF RHOA-MEDIATED CA2+SENSITIZATION IN VASCULAR SMOOTH MUSCLE | $5.4M | FY2009 | Sep 2009 – Apr 2019 |
| Department of Energy | ELECTRON INTERACTIONS WITH NUCLEI | $5.3M | FY1996 | Feb 1996 – Nov 2013 |
| Department of Health and Human Services | ADOLESCENT PEER AND FAMILY PRECURSORS OF ADULT PSYCHOSOCIAL FUNCTIONING | $5.3M | FY2008 | Jul 2008 – Jun 2018 |
| Department of Health and Human Services | AN EVALUATION OF TREATMENT WITH OMALIZUMAB TO IMPROVE THE ASTHMATIC RESPONSE TO A | $5.3M | FY2012 | Aug 2012 – Jul 2017 |
| Department of Health and Human Services | NANOSCALE PROGRAMING OF CELLULAR AND PHYSIOLOGICAL PHENOTYPES | $5.2M | FY2020 | Jan 2020 – Apr 2030 |
| Department of Health and Human Services | MOLECULAR STUDY OF MOUSE VIRAL RESISTANCE MECHANISMS | $5.2M | FY2001 | Sep 2001 – Jan 2022 |
| Department of Health and Human Services | IRON DEFICIENCY: MOLECULAR AND CELLULAR CONSEQUENCES | $5.2M | FY2008 | Feb 2008 – Jun 2025 |
| Department of Health and Human Services | THE INFLUENCE OF SOCIAL NETWORKS ON DISPARITIES IN POSTNEONATAL INFANT MORTALITY | $5.1M | FY2014 | Jul 2014 – Jan 2027 |
| Department of Health and Human Services | HIGH-THROUGHPUT ASSAYS FOR IMAGING HUMAN INTRACELLULAR PATHOGEN INFECTIONS | $5.1M | FY2007 | Jun 2007 – Apr 2024 |
| Department of Agriculture | ARP ECONOMIC DEVELOPMENT GRANT FOR RURAL HEALTH CARE FACILITIES | $5.1M | FY2023 | Nov 2022 – Nov 2024 |
| Department of Health and Human Services | BFGF LOW AFFINITY RECEPTORS AND HIVAN | $5.1M | FY1994 | Sep 1994 – Jun 2027 |
| VA/DoDDepartment of Defense | NEW START GRANT | $5.1M | FY2024 | Jul 2024 – Jun 2026 |
| National Science Foundation | FOCUSED COPE: ENHANCING RESILIENCE AND EQUITY IN URBAN COASTAL COMMUNITIES THROUGH THE CO-GENERATION OF COMMUNITY CAPITALS -2209139 (GOODALL). THE OVERARCHING GOAL OF THIS PROJECT IS TO CREATE TRANSFERABLE METHODS FOR ENHANCING RESILIENCE AND EQUITY IN URBAN COASTAL COMMUNITIES. WHILE THE GOAL IS TO PRODUCE TRANSFERABLE METHODS, THE PROJECT FOCUSES ON COMMUNITIES IN HAMPTON ROADS REGION OF VIRGINIA ? ONE OF THE MOST VULNERABLE POPULATIONS TO SEA LEVEL RISE IN THE UNITED STATES ? AS COMMUNITY PARTNERS. THE HUB STRUCTURE OF THE PROJECT EMPHASIZES THE CO-GENERATION OF COMMUNITY CAPITALS AMONG A DIVERSE TEAM OF RESEARCHERS IN PARTNERSHIP WITH COMMUNITY STAKEHOLDERS. COMMUNITY CAPITALS IS A TERM INCLUSIVE OF BOTH NATURAL-BUILT CAPITALS, SUCH AS SEA WALLS, LIVING SHORELINES, AND GREEN STORMWATER INFRASTRUCTURE, AND HUMAN-SOCIAL CAPITALS, SUCH AS HEALTH, WELL-BEING, AGENCY, AND EMPOWERMENT. THE OVERARCHING HYPOTHESIS IS THAT BOTH FORMS OF COMMUNITY CAPITALS MUST BE ADVANCED IN SYNERGY IN ORDER TO HAVE RESILIENT AND EQUITABLE URBAN COASTAL COMMUNITIES. THE RESEARCH PLAN OPERATES ON TWO SPATIAL SCALES, REGIONAL AND LOCAL, BECAUSE BOTH SCALES ARE CRITICAL FOR BUILDING COMMUNITY CAPITALS. ON THE REGIONAL SCALE, THE RESEARCH TASKS ARE TO CREATE A GEOSPATIAL DATA INVENTORY, A SYSTEM-WIDE FLOOD MODEL, AND EQUITABLE POLICIES FOR REGIONAL CLIMATE RESILIENCE IN URBAN COMMUNITIES. ON THE LOCAL SCALE, THE RESEARCH TASKS ARE TO EMPOWER AND ENGAGE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED IN THE CLIMATE RESILIENCE CONVERSATION, BUILD COMMUNITY CAPITAL THROUGH WORKSHOPS THAT RESULT IN CO-DESIGNED STORMWATER INFRASTRUCTURE, AND MEASURE THE CO-BENEFITS OF GREEN STORMWATER INFRASTRUCTURE FOR MENTAL HEALTH AND WELL-BEING. WORK ACROSS THE TWO SCALES IS CONNECTED THROUGH SHARED RESOURCES AND FEEDBACK BETWEEN THE LOCAL COMMUNITY AND BROADER-SCALE REGIONAL EFFORTS. A KEY INTELLECTUAL FEATURE OF THIS RESEARCH IS THE SYNERGISTIC ADVANCEMENT OF COMMUNITY CAPITALS FOR CLIMATE RESILIENCE. MANY PROJECTS FOCUS ON ONE OF THESE COMMUNITY CAPITALS, BUT FEW SEEK TO ADVANCE BOTH IN SYNERGY WITH ONE ANOTHER. TO ADVANCE THE HUMAN-SOCIAL CAPITAL LIKE WELL-BEING, EMPOWERMENT, AND AGENCY CRITICAL TO FOSTERING EQUITABLE AND RESILIENT COMMUNITIES, THIS PROJECT ADVANCES EQUITABLE PUBLIC POLICIES THAT CAN HAVE A LASTING IMPACT ON HOW COASTAL URBAN CITIES APPROACH THE CHALLENGE OF ADDRESSING CLIMATE RESILIENCE. FOR EXAMPLE, THE CONCEPT OF CO-DESIGNED GREEN STORMWATER INTERVENTIONS THAT CAN BE IMPLEMENTED BY COMMUNITY MEMBERS CAN CONTRIBUTE TO BOTH ENHANCING NATURAL-BUILT CAPITAL AND SOCIAL-HUMAN CAPITAL. TO ENCOURAGE INCLUSION, THE PROJECT ALSO HAS A STRONG FOCUS ON REMOVING BARRIERS TO PARTICIPATION FACING UNDERREPRESENTED AND MARGINALIZED COMMUNITIES IN THE COASTAL RESILIENCE CONVERSATIONS AND ACTIVITIES. TO STRENGTHEN HOW NATURAL-BUILT CAPITALS CAN BE ASSESSED AND STRENGTHENED, THE RESEARCH ADVANCES THE STATE OF ART FOR MODELING COMPLEX URBAN STORMWATER SYSTEMS AT A REGIONAL SCALE. THE STRATEGY IS TO BUILD FROM WIDELY USED MODELS FOR ENGINEERING DESIGN, SO THAT PRODUCTS OF THE RESEARCH CAN BE MORE EASILY ADOPTED BY COASTAL COMMUNITIES, AND TO INTEGRATE THEM INTO A MORE HOLISTIC MODELING SYSTEM. LASTLY, THE HUB STRUCTURE OF THIS PROJECT PROVIDES THE OPPORTUNITY TO FOSTER CONVERGENCE ACROSS THE PROJECT TEAM?S EXPERTISE THAT RANGES FROM HYDROLOGIC ENGINEERING AND OCEAN SCIENCE, TO ARCHITECTURE AND LANDSCAPE DESIGN, TO ENVIRONMENTAL JUSTICE AND ENVIRONMENTAL PSYCHOLOGY, TO SOCIAL WORK AND COMMUNITY ENGAGEMENT. THE PROJECT HAS THREE PRIMARY BROADER IMPACT GOALS. THE FIRST IS TO BROADEN PARTICIPATION IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATH (STEM). TO ACHIEVE THIS GOAL, THE PROJECT TEAM WILL PROVIDE OPPORTUNITIES FOR EIGHT UNDERGRADUATE STUDENTS AND ONE GRADUATE STUDENT AT NORFOLK STATE UNIVERSITY (NSU) ? A HISTORICALLY BLACK UNIVERSITY LOCATED IN NORFOLK, VIRGINIA ? A PARTNER COMMUNITY FOR THE PROJECT. THE PROJECT AIMS TO CREATE A LONG-TERM PARTNERSHIP BETWEEN NSU AND THE UNIVERSITY OF VIRGINIA TO CAPITALIZE ON THEIR SHARED INTEREST IN CLIMATE RESILIENCE, AND TO CREATE AUTHENTIC AND MEANINGFUL CONNECTIONS WITH THE LOCAL COMMUNITY. THE SECOND BROADER IMPACT GOAL IS OUTREACH AND EDUCATION. THE PROJECT TEAM WILL STRENGTHEN EXISTING EFFORTS IN STEM EDUCATION TO REACH PUBLIC K-12 STUDENTS: A LEARNING BARGE CO-DEVELOPED BETWEEN UVA AND THE ELIZABETH RIVER PROJECT (ERP) AND THE SCHOOLYARD-LONG TERM ECOLOGICAL RESEARCH (SLTER), A PROJECT THAT LEVERAGES NSF SUPPORT TO TEACH STUDENTS LIVING ON VIRGINIA?S COAST ABOUT CLIMATE RESILIENCE. THE THIRD BROADER IMPACT GOAL OF THE PROJECT IS TO HAVE A POSITIVE EFFECT ON THE WELL-BEING OF THE LOCAL PARTNER COMMUNITIES. ONE WAY THIS WILL BE ASSESSED IS THROUGH STUDYING MENTAL HEALTH AND WELL-BEING CO-BENEFITS OF GREEN INFRASTRUCTURE INTERVENTIONS CO-DESIGNED AND IMPLEMENTED THROUGH THE PROJECT THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA. | $5.1M | FY2022 | Sep 2022 – Aug 2027 |
| Department of Health and Human Services | ROLE OF CREM IN AMEBIC COLITIS AND INFLAMMATORY BOWEL DISEASE | $5.1M | FY1989 | Aug 1989 – Dec 2027 |
| Department of Health and Human Services | PRORENIN RECEPTORS MEDIATE HYPERTENSION AND KIDNEY DISEASE IN DIABETES | $5M | FY2008 | Jan 2008 – Jun 2022 |
| Department of Health and Human Services | RENAL AT2 RECEPTORS IN HYPERTENSION | $5M | FY2016 | Apr 2016 – Dec 2025 |
| Department of Health and Human Services | SPHINGOLIPIDS IN ACUTE KIDNEY INJURY | $5M | FY2010 | Mar 2010 – Mar 2025 |
| National Science Foundation | VIRGINIA-NORTH CAROLINA LOUIS STOKES ALLIANCE FOR MINORITY PARTICIPATION, 2017-2022 | $5M | FY2017 | Aug 2017 – Jul 2023 |
| Department of Health and Human Services | ORGANIZATION OF CENTRAL SYMPATHETIC PATHWAYS | $5M | FY1989 | Apr 1989 – Jun 2021 |
| National Science Foundation | 2007 LSAMP: VIRGINIA-NORTH CAROLINA ALLIANCE FOR MINORITY PARTICIPATION (PHASE I) | $5M | FY2007 | May 2007 – Apr 2012 |
| Department of Health and Human Services | DUST MITE, COCKROACH AND CAT ALLERGENS IN ASTHMA | $5M | FY1984 | Jul 1984 – Jun 2018 |
| Department of Energy | SPIN TRANSITIONS, PHASE COMPETITION AND ORDERING IN PEROVSKITE OXIDES | $4.9M | FY2001 | Sep 2001 – Dec 2026 |
| Department of Education | POST-DOCTORAL RESEARCH FELLOWSHIPS | $4.9M | FY2009 | Sep 2009 – Aug 2017 |
| Department of Health and Human Services | NOVEL ROLE OF HEPATIC SEL1L-HRD1 ERAD IN FGF21 GENE TRANSCRIPTION | $4.9M | FY2018 | Sep 2018 – Jan 2028 |
| Department of Education | EVALUATION OF STATE AND DISTRICT EDUCATION PROGRAMS AND POLICIES | $4.9M | FY2009 | Jul 2009 – Jun 2016 |
| National Science Foundation | FOCUSED COPE: BUILDING CAPACITY FOR ADAPTATION IN RURAL COASTAL COMMUNITIES | $4.9M | FY2021 | Aug 2021 – Jul 2026 |
| Department of Health and Human Services | IGE ANTIBODY RESPONSES TO THE OLIGOSACCHARIDE GALACTOSE-ALPHA-1,3-GALACTOSE (ALPHA-GAL) IN MURINE AND HUMAN ATHEROSCLEROSIS - PROJECT ABSTRACT INCREASED TOTAL SERUM IGE LEVELS ARE ASSOCIATED WITH CORONARY ARTERY DISEASE (CAD). HOWEVER, THE CAUSAL ROLE OF ANTIGEN-SPECIFIC IGE IN CAD REMAINS LARGELY UNEXPLORED. RECENT WORK FROM OUR GROUP AND OTHERS PROVIDE EVIDENCE THAT HUMANS WITH IGE SENSITIZATION TO THE MAMMALIAN OLIGOSACCHARIDE ALLERGEN A-GAL HAVE LARGER CORONARY ARTERY PLAQUES AND UNSTABLE PLAQUE FEATURES SIGNIFYING INCREASED CAD COMPARED TO THOSE WITHOUT IGE TO A-GAL. YET, WHETHER IGE TO A-GAL DIRECTLY PROMOTES ATHEROSCLEROTIC PLAQUE DEVELOPMENT AND THE MOLECULAR AND CELLULAR MECHANISMS MEDIATING IGE SENSITIZATION TO A-GAL LINKED TO ATHEROSCLEROSIS FORMATION ARE UNKNOWN. BITES FROM THE LONE STAR TICK INDUCE IGE SENSITIZATION TO A-GAL AND A SUBSEQUENT SEVERE ALLERGIC RESPONSE WHEN THE SUBJECT INGESTS A-GAL-CONTAINING FOODS SUCH AS RED MEAT. HOWEVER, THE VAST MAJORITY OF INDIVIDUALS WITH IGE TO A-GAL DO NOT MANIFEST WITH DELAYED ANAPHYLAXIS AND FREQUENTLY HAVE NO OUTWARD IDENTIFYING SYMPTOMS. AS SUCH, THEY CONTINUE TO CONSUME A-GAL-CONTAINING FOOD PRODUCTS (MEAT, DAIRY, ETC.) WHICH HAVE THE CAPACITY TO CONTINUE TO STIMULATE IGE RESPONSES AND INFLAMMATION IN THE VESSEL WALL. PRELIMINARY DATA PROVIDE THE FIRST EVIDENCE THAT HUMANS WITH IGE SENSITIZATION TO A-GAL HAD A HIGHER FREQUENCY OF CCR6+ SWITCHED MEMORY (SWM) B CELLS. NOTABLY, CONSISTENT WITH THE ASSOCIATION OF THE IGE SENSITIZATION TO A-GAL AND CAD, THE AMOUNT OF CCR6 ON SWM B CELLS WAS ASSOCIATED WITH CAD SEVERITY. TRANSCRIPTOMIC ANALYSIS DEMONSTRATED THAT CCR6+ SWM B CELLS EXPRESSED HIGHER IL-4R AND STAT6 IN SUBJECTS THAT WERE IGE A-GAL+ COMPARED TO IGE A- GAL-. INTERESTINGLY, IL-4 AND STAT6 ARE IMPORTANT FOR B CELL CLASS SWITCH RECOMBINATION TO IGE, SUGGESTING THAT CELLS THAT MAKE IL-4 MAY BE IMPORTANT IN IGE A-GAL PRODUCTION. STUDYING IGE SENSITIZATION TO A-GAL IN CONVENTIONAL MURINE MODELS OF ATHEROSCLEROSIS IS NOT FEASIBLE AS MICE, LIKE ALL LOWER MAMMALS BUT UNLIKE HUMANS, EXPRESS THE ENZYME GALACTOSYLTRANSFERASE, PRODUCE A-GAL AND DO NOT DEVELOP AN IGE RESPONSE TO A- GAL. WE HAVE OBTAINED A NOVEL A-GAL-/- MOUSE THAT MIMICS THE HUMAN CONDITION TO STUDY THE ROLE OF IGE SENSITIZATION TO A-GAL IN ATHEROSCLEROSIS. COMPARING A-GAL-/- MICE TO MICE WILDTYPE (WT) FOR A-GAL, WE SHOW A SIGNIFICANT INDUCTION OF IGE TO A-GAL AFTER EXPOSURE TO LONE STAR TICK-DERIVED LIPIDS IN THE A-GAL-/- BUT NOT THE WT MOUSE. MOREOVER, PRELIMINARY DATA FROM MICE DEFICIENT IN NKT CELLS IMPLICATES INKT CELLS IN THE REGULATION OF IGE ANTIBODY PRODUCTION TO LIPIDS FROM LONE STAR TICKS. BASED ON THESE HUMAN AND MURINE DATA, THE OVERARCHING OBJECTIVE OF THIS PROPOSAL IS TO INVESTIGATE WHETHER THESE FACTORS AND CELLS PLAY A CAUSAL ROLE IN ATHEROSCLEROSIS DEVELOPMENT DUE TO IGE SENSITIZATION TO A-GAL. WE WILL USE LOSS AND GAIN OF FUNCTION STUDIES IN MURINE ATHEROSCLEROSIS MODELS TO DEFINE NOVEL MECHANISMS OF A-GAL IGE PRODUCTION AND THE IMPACT OF TICK-INDUCED A- GAL SENSITIZATION ON DIET-INDUCED ATHEROSCLEROSIS, AND TEST A LARGER COHORT OF HUMANS WITH CAD QUALITATIVELY AND QUANTITATIVELY BY INTRAVASCULAR ULTRASOUND VIRTUAL HISTOLOGY (IVUS-VH), ALLOWING FOR MORE ROBUST MULTIVARIATE ANALYSIS AND DEEPER INTERROGATION OF IMMUNE CELL PHENOTYPES THAT MARK THOSE AT GREATEST RISK. | $4.9M | FY2022 | Jul 2022 – Jun 2027 |
| Department of Health and Human Services | PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY | $4.8M | FY1999 | Sep 1999 – Nov 2018 |
| Department of Health and Human Services | COPASI: BIOCHEMICAL NETWORK MODELING AND SIMULATION SOFTWARE | $4.8M | FY2007 | Sep 2007 – Jul 2022 |
| Department of Health and Human Services | NEUROVASCUALAR REGENERATION | $4.8M | FY2014 | Jan 2014 – Jun 2020 |
| Department of Education | RESEARCH NETWORKS FOCUSED ON CRITICAL PROBLEMS OF EDUCATION POLICY AND PRACTICE (NETWORKS) | $4.8M | FY2016 | Jun 2016 – May 2025 |
| Department of Health and Human Services | FUNCTIONAL MECHANISMS OF T1D RISK VARIANTS AND THEIR TARGET GENES USING 3D EPIGENOMICS AND SINGLE CELL APPROACHES | $4.8M | FY2019 | Aug 2019 – Nov 2024 |
| VA/DoDDepartment of Defense | THE REACH INTERVENTION FOR CAREGIVERS OF VETERANS AND SERVICE MEMBERS WITH TBI: EFFICACY AND IMPLEMENTATION PLANNING ACROSS THE VA POLYTRAUMA SYSTEM OF CARE | $4.8M | FY2023 | Sep 2023 – Aug 2027 |
| Department of Health and Human Services | BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS | $4.7M | FY2020 | Feb 2020 – May 2030 |
| VA/DoDDepartment of Defense | HERCULES: HARDWARE-ENHANCED RESILIENT COMPARTMENTALIZATION AND PROGRAM ANALYSIS FOR UPGRADED LEGACY ENVIRONMENT SECURITY | $4.7M | FY2024 | Mar 2024 – Jun 2028 |
| Department of Health and Human Services | ORGANIZATION AND FUNCTION OF NEURONAL ENDOSOMES | $4.7M | FY2013 | Sep 2013 – Jul 2029 |
| VA/DoDDepartment of Defense | "(MURI-07) HELIX: A SELF-REGENERATIVE ARCHETECTURE FOR THE INCORRUPTIBLE ENTERPRISE" DATED 11/10/06 | $4.7M | FY2007 | Jul 2007 – Jun 2012 |
| National Science Foundation | GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) | $4.7M | FY2018 | Aug 2018 – Jul 2023 |
| Department of Health and Human Services | UNIVERSITY OF VIRGINIA - ICDDR,B RESEARCH UNIT FOR WOMEN'S AND CHILDREN'S HEALTH RESEARCH | $4.7M | FY2018 | Aug 2018 – Jul 2030 |
| Department of Health and Human Services | PURINERGIC REGULATION OF VEINOUS ENDOTHELIAL PERMEABILITY | $4.7M | FY2018 | Feb 2018 – May 2027 |
| Department of Health and Human Services | RETROTRAPEZOID NUCLEUS AND CENTRAL CHEMORECEPTION | $4.6M | FY2003 | Jul 2003 – Dec 2019 |
| Department of Education | THE VIRGINIA EDUCATION SCIENCES PRE-DOCTORAL TRAINING PROGRAM | $4.6M | FY2020 | Sep 2020 – Aug 2025 |
| Department of Health and Human Services | SURVIVAL OF NEISSERIA GONORRHOEAE AFTER PRIMARY HUMAN NEUTROPHIL CHALLENGE | $4.6M | FY2012 | Jul 2012 – Oct 2024 |
| VA/DoDDepartment of Defense | THIS IS A CONTINUATION OF N00014-14-1-0533 MULTI-OBJECTIVE OPTIMIZATION AND MIXED-HORIZON DECISION-MAKING FOR AUTONOMOUS VEHICLES | $4.5M | FY2016 | May 2016 – Sep 2021 |
| Department of Health and Human Services | MOLECULAR ANALYSIS OF A YEAST TRANSCRIPTIONAL REGULATOR | $4.5M | FY1997 | May 1997 – Apr 2023 |
| Department of Health and Human Services | MICROTUBULE-MEDIATED MECHANISMS UNDERLYING HAIR CELL DEVELOPMENT AND DEAFNESS | $4.5M | FY2014 | Mar 2014 – Mar 2031 |
| Department of Health and Human Services | LONG-TERM IMPACT AND INTERVENTION FOR DIARRHEA IN BRAZIL | $4.5M | FY1997 | Jun 1997 – Apr 2015 |
| Department of Energy | 50 MW SEGMENTED ULTRALIGHT MORPHING ROTORS FOR WIND ENERGY | $4.5M | FY2016 | Apr 2016 – May 2022 |
| Department of Health and Human Services | IRF4 AND IMMUNITY TO INFLUENZA INFECTION | $4.5M | FY2015 | Feb 2015 – Apr 2025 |
| Department of Health and Human Services | IDENTIFYING CELL-TYPE SPECIFIC GENETIC CONTROL OF T1D RISK VARIANTS IN TEDDY - TYPE 1 DIABETES (T1D) IS A COMPLEX DISORDER THAT ARISES FROM THE ACTION OF MULTIPLE GENETIC AND ENVIRONMENTAL RISK FACTORS WITH POPULATION CUMULATIVE RISK APPROACHING 1 IN 300 CHILDREN. THE DISEASE PROCESS FOR T1D CONSISTS OF INITIATION OF AN IMMUNE ATTACK TARGETED TO INSULIN SECRETING BETA CELLS IN THE ISLETS, MODIFYING, IMPAIRING, AND (ULTIMATELY) DESTROYING THE BETA CELLS. GENOME- WIDE ASSOCIATION STUDIES (GWAS), PERFORMED BY OURSELVES AND OTHERS, IDENTIFIED MORE THAN 100 CHROMOSOMAL LOCI WHERE THERE IS SIGNIFICANT, REPLICATED EVIDENCE OF ASSOCIATION WITH T1D. AS SHOWN BY US IN THE TYPE 1 DIABETES GENETIC CONSORTIUM IMMUNOCHIP FINE-MAPPING ANALYSIS, AND OTHER STUDIES, ~ 98-99% OF T1D CREDIBLE SET OF SNPS ARE IN THE NON-CODING REGION OF THE GENOME AND PREFERENTIALLY MAP IN ENHANCER REGIONS ACTIVE IN IMMUNE CELLS. THE PROPOSED STUDY IS AN ANCILLARY RESEARCH PROJECT OF THE ENVIRONMENTAL DETERMINANTS OF DIABETES IN THE YOUNG (TEDDY) STUDY. TEDDY WAS DESIGNED TO DISCOVER ENVIRONMENTAL TRIGGERS OF T1D IN A PROSPECTIVE COHORT OF NEWBORNS AT GENETIC RISK, FOLLOWED MULTIPLE TIMES PER YEAR WITH COLLECTION OF SAMPLES FOR DEEP PHENOTYPIC AND BIOMARKER PROFILING. THIS PROJECT WILL UTILIZE LONGITUDINAL SAMPLES AND THEIR RICH DEMOGRAPHIC, GENETIC, AND IMMUNE MARKERS COLLECTED ON TEDDY PARTICIPANTS. WE WILL USE SINGLE-CELL SEQUENCING TECHNOLOGY TO MONITOR IMMUNE MARKERS AT THE PROTEIN AND TRANSCRIPTION LEVELS TO GENERATE PROFILES FOR DIFFERENT STAGES OF ISLET AUTOIMMUNITY. TO GAIN A COMPREHENSIVE UNDERSTANDING OF THE T1D RISK GENES THAT FUNCTION IN INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY, WE PROPOSE TO APPLY SINGLE-CELL SEQUENCING TO MAP T1D RISK VARIANTS THAT ALTER GENE EXPRESSION IN CIRCULATING IMMUNE CELLS; WE WILL USE IMMUNE CELL-SURFACE MARKERS FOR CELL TYPE IDENTIFICATION AND EXAMINE IMMUNE PROFILES AT INITIATION AND PROGRESSION TO T1D. TO IDENTIFY BIOLOGICAL PATHWAYS, THAT T1D GENES FUNCTION IN, WE WILL CONSTRUCT A REFERENCE CO-EXPRESSION NETWORK AND REFINE PREDICTED GENE-GENE INTERACTIONS WITH BAYESIAN NETWORKS. | $4.4M | FY2024 | Feb 2024 – Jan 2027 |
| Department of Health and Human Services | GENOMIC ARCHITECTURE OF LGL LEUKEMIA | $4.4M | FY2016 | Dec 2015 – Jul 2029 |
| Department of Health and Human Services | BIOTECHNOLOGY TRAINING PROGRAM | $4.4M | FY2000 | Jul 2000 – Jun 2020 |
| Department of Health and Human Services | GENETIC CONTRIBUTORS TO DIABETES AND DYSLIPIDEMIA IN AFRICAN AMERICANS | $4.4M | FY2010 | Aug 2010 – Jul 2011 |
| Department of Health and Human Services | AKAP150-TRPV4 REGULATION OF ENDOTHELIAL FUNCTION IN OBESITY | $4.4M | FY2019 | Jun 2019 – May 2028 |
| Department of Agriculture | RESEARCH FOR APPROVED HATCH (HATCH ACT REGULAR RESEARCH) PROJECTS AT VIRGINIA TECH | $4.4M | FY2020 | Oct 2019 – Sep 2021 |
| Department of Health and Human Services | NEW PHARMACOTHERAPY FOR ALCOHOL AND CO-MORBID DISORDERS | $4.4M | FY2010 | Sep 2010 – Aug 2016 |
| Department of Health and Human Services | TRANSLATION OF THE UVA ADVANCED AUTOMATED INSULIN DELIVERY SYSTEMS TO CLINICAL CARE IN YOUNG CHILDREN: GLYCEMIC CONTROL, REGULATORY ACCEPTANCE AND OPTIMIZATION OF DAY TO DAY USE | $4.4M | FY2020 | Sep 2020 – Jun 2024 |
| Department of Health and Human Services | TRAINING IN THE PHARMACOLOGICAL SCIENCES | $4.3M | FY1985 | Jul 1985 – Jun 2023 |
| National Science Foundation | EXPEDITIONS: COLLABORATIVE RESEARCH: GLOBAL PERVASIVE COMPUTATIONAL EPIDEMIOLOGY | $4.3M | FY2020 | Apr 2020 – Mar 2025 |
| VA/DoDDepartment of Defense | A MEDICAL CENTER NETWORK FOR OPTIMIZED LUNG CANCER BIOSPECIMEN BANKING | $4.3M | FY2010 | Sep 2010 – Sep 2018 |
| Department of Health and Human Services | RYAN WHITE PART C OUTPATIENT EIS PROGRAM | $4.2M | FY2005 | Apr 2005 – Mar 2021 |
| Department of Health and Human Services | PAPILLOMAVIRUS E6 STRUCTURAL CONSORTIUM | $4.2M | FY2010 | Feb 2010 – Dec 2020 |
| Department of Health and Human Services | CONTROL OF SIR2 BY NUCLEAR NAD SALVAGE PATHWAYS | $4.2M | FY2005 | Aug 2005 – Jun 2025 |
| VA/DoDDepartment of Defense | THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY DARPA MICROSYSTEMS TECHNOLOGY OFFICE MTO FOR THE INTENSITY SQUEEZED PHOTONIC INTEGRATION FOR REVOLUTIONARY DETECTORS INSPIRED PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED JUNE 12, 2024, AND IN THE RECIPIENTS PROPOSAL TITLED, SQUEEZED INTEGRATED NITRIDE TECHNOLOGY SQUINT, DATED DECEMBER 17, 2023, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES. | $4.2M | FY2024 | Jun 2024 – Jul 2026 |
| Department of Health and Human Services | MECHANISMS OF MATERNAL BRAIN CHANGES WITH BIRTH INTERVENTIONS | $4.2M | FY2019 | Apr 2019 – Jun 2030 |
| Department of Health and Human Services | DETERMINANTS OF MYOGENIC AND NEURONAL MEMBRANE PHENOMENA | $4.1M | FY1988 | Jan 1988 – — |
| Department of Health and Human Services | POSTDOCTORAL TRAINING GRANT FOR MDS IN SURGICAL ONCOLOGY RESEARCH | $4.1M | FY2011 | Sep 2011 – Aug 2026 |
| Department of Health and Human Services | GAP JUNCTIONAL PATTERNING IN ARRHYTHMIC HEART | $4.1M | FY2010 | Apr 2010 – Dec 2021 |
| Department of Health and Human Services | ASTHMA AND ALLERGIC DISEASE CENTER | $4.1M | FY2006 | Jul 2006 – Jun 2011 |
| Department of Health and Human Services | HALLMARKS OF PROTECTIVE IMMUNITY IN SEQUENTIAL RHINOVIRUS INFECTIONS IN HUMANS | $4.1M | FY2016 | Jun 2016 – Nov 2022 |
| Department of Health and Human Services | LEVERAGING COMMUNITY PHARMACISTS TO OPTIMIZE SMOKING CESSATION SERVICES FOR RURAL SMOKERS IN APPALACHIA - RURAL APPALACHIAN POPULATIONS HAVE THE HIGHEST RATES OF CIGARETTE SMOKING IN THE U.S. AND ARE DISPROPORTIONATELY AFFECTED BY TOBACCO-RELATED CANCERS. PUBLICLY AVAILABLE SMOKING CESSATION RESOURCES (E.G., STATE QUITLINES, TEXT-BASED INTERVENTIONS, NICOTINE REPLACEMENT THERAPY [NRT]) ARE UNDER-UTILIZED BY RURAL APPALACHIAN SMOKERS. FURTHERMORE, RURAL APPALACHIA IS MEDICALLY UNDERSERVED; THUS, SMOKING CESSATION SERVICES WITHIN PRIMARY CARE SETTINGS FACE ADDITIONAL BARRIERS. COMMUNITY PHARMACISTS, WITH THEIR CENTRALIZED PLACEMENT IN LOCAL COMMUNITIES AND CLINICAL EXPERTISE, ARE IDEALLY SITUATED TO BUILD CAPACITY IN UNDERSERVED AREAS SUCH AS RURAL APPALACHIA TO ENHANCE EXISTING SMOKING CESSATION RESOURCES FOR SMOKERS. RESEARCH ON PHARMACIST-DELIVERED SMOKING CESSATION INTERVENTIONS IS LIMITED AND DOES NOT PROVIDE FOR DOCUMENTATION AND BILLING TO COMPENSATE PHARMACISTS FOR THEIR TIME SPENT COUNSELING PATIENTS. MEDICATION THERAPY MANAGEMENT (MTM), A PHARMACIST-DELIVERED MEDICATION ADHERENCE APPROACH THAT ALLOWS PHARMACISTS TO RECEIVE COMPENSATION FOR PROVIDING MEDICATION EXPERTISE, COULD BE LEVERAGED TO PROMOTE SMOKING CESSATION. TO ADDRESS THIS GAP, WE DEVELOPED AN MTM INTERVENTION, QUITAID, TO INCREASE SMOKING CESSATION AMONG RURAL SMOKERS. QUITAID WAS BASED ON A MEDICATION ADHERENCE INTERVENTION SHOWN TO BE EFFICACIOUS IN A QUITLINE SETTING. THE PURPOSE OF THE PROPOSED STUDY IS TO USE A PRAGMATIC APPROACH, GUIDED BY THE REACH, EFFECTIVENESS, ADOPTION, IMPLEMENTATION, AND MAINTENANCE (RE-AIM) FRAMEWORK, TO IDENTIFY THE ESSENTIAL COMPONENTS OF AN EFFECTIVE SMOKING CESSATION PROGRAM THAT CAN EASILY INTEGRATE WITHIN COMMUNITY PHARMACIES IN UNDERSERVED RURAL AREAS. SMOKERS (N=768) RECRUITED THROUGH 14 COMMUNITY PHARMACIES IN RURAL APPALACHIA WILL BE RANDOMIZED IN A 25 FULL FACTORIAL EXPERIMENT TO THE FOLLOWING FIVE TREATMENTS: (1) QUITAID (YES VS. NO), (2) TOBACCO QUITLINE (YES VS. NO), (3) SMOKEFREETXT (YES VS. NO), (4) COMBINATION NRT GUM + NRT PATCH (VS. NRT PATCH ALONE), AND/OR (5) 8 WEEKS OF NRT (VS. STANDARD 4 WEEKS). THE PRIMARY OUTCOME IS BIOCHEMICALLY- CONFIRMED POINT PREVALENCE ABSTINENCE AT THE 6-MONTH FOLLOW-UP. WE WILL ALSO ASSESS IMPLEMENTATION, INCLUDING RELATIVE COST, AS WELL AS FACILITATORS AND BARRIERS OF REACH, ADOPTION, AND MAINTENANCE OF QUITAID AND STANDARD, EVIDENCE-BASED TOBACCO TREATMENTS THROUGH AN ASK-ADVISE-CONNECT METHOD IN COMMUNITY PHARMACIES. OUR MAIN HYPOTHESIS IS THAT A SMOKING CESSATION MTM WILL INCREASE SMOKING CESSATION AND ENHANCE REACH AND ADHERENCE TO PUBLICLY AVAILABLE SMOKING CESSATION RESOURCES IN MEDICALLY UNDERSERVED RURAL AREAS. THE PROPOSED STUDY WILL: (1) PROVIDE FOUNDATIONAL EVIDENCE FOR LEVERAGING COMMUNITY PHARMACISTS IN UNDERSERVED AND RURAL AREAS TO PROMOTE UTILIZATION OF EXISTING EVIDENCE-BASED TOBACCO CESSATION RESOURCES THROUGH ENHANCED MTM SUPPORT, (2) INFORM UPDATED NATIONAL GUIDANCE ON TREATING RURAL SMOKERS, AND (3) AID STATE LEGISLATION EFFORTS RELATED TO PHARMACY SMOKING CESSATION PROGRAMS AND POLICIES. ULTIMATELY, THIS RESEARCH WILL INFORM STRATEGIES FOR SMOKING CESSATION IN RURAL AREAS, SUCH THAT CANCER RATES ACHIEVE PARITY WITH URBAN AREAS. | $4M | FY2022 | Sep 2022 – May 2028 |
| Department of Health and Human Services | MRI OF MYOCARDIAL FUNCTION IN POST-INFARCT KNOCKOUT MICE | $4M | FY2003 | Sep 2003 – Jul 2022 |
| Department of Health and Human Services | SYSTEMATIC IDENTIFICATION OF FUNCTIONAL T1D-ASSOCIATED NON-CODING SNPS USING GENETIC, TRANSCRIPTOMIC AND EPIGENETIC METHODS | $4M | FY2016 | Sep 2016 – Aug 2021 |
| Department of Health and Human Services | TUBERCULOSIS SECOND LINE DRUG SUSCEPTIBILITY CHIP | $4M | FY2011 | Apr 2011 – Mar 2017 |
| Department of Health and Human Services | EXTRINSIC MECHANISMS GOVERNING INJURY-INDUCED AXON DEGENERATION | $4M | FY2015 | Aug 2015 – Mar 2026 |
| Department of Education | PROJECT CATALYZE: THE IMPACT OF CARE + PATHS ON STUDENTS’ SUCCESS | $4M | FY2020 | Oct 2019 – Sep 2024 |
| Department of Education | ITERATIVE REPLICATION OF READ WELL IN FIRST GRADE | $4M | FY2020 | Jul 2020 – Jun 2026 |
| Department of Health and Human Services | ALANYL-GLUTAMINE SUPPLEMENTATION OF STANDARD TREATMENT FOR C. DIFFICILE INFECTION | $4M | FY2020 | Jul 2020 – Jun 2026 |
| Department of Commerce | CCAM - UNIV. OF VIRGINIA | $4M | FY2011 | Apr 2011 – Oct 2012 |
| Department of Health and Human Services | MECHANISMS OF TUMOR ESCAPE FROM ANTI-ANGIOGENIC THERAPY | $4M | FY2014 | Sep 2014 – Jun 2025 |
| Department of Health and Human Services | FORM AND FUNCTION OF OUR JANUS FACED GENOME | $4M | FY2014 | Sep 2014 – Jul 2019 |
| Department of Health and Human Services | OBSERVATION OF YOUNG CHILDREN'S COMPETENCE IN CLASSROOM | $4M | FY2005 | Sep 2005 – Dec 2022 |
| Department of Health and Human Services | EXTRACELLULAR SPACE AS MODULATOR OF GAP JUNCTION-CONDUCTION VELOCITY RELATIONSHIP | $3.9M | FY2011 | Jan 2011 – Nov 2021 |
| Department of Health and Human Services | INSTITUTIONAL CAREER DEVELOPMENT CORE | $3.9M | FY2019 | Feb 2019 – Jul 2025 |
| Department of Education | EDUCATION RESEARCH TRAINING | $3.9M | FY2014 | Sep 2014 – Aug 2021 |
| Department of Health and Human Services | HYPERPOLARIZED XENON-129 MRI: A NEW MULTI-DIMENSIONAL BIOMARKER TO DETERMINE PULMONARY PHYSIOLOGIC RESPONSES TO COPD THERAPEUTICS | $3.9M | FY2017 | Jan 2017 – Dec 2023 |
| Department of Education | RESEARCH NETWORKS FOCUSED ON CRITICAL PROBLEMS OF EDUCATION POLICY AND PRACTICE (NETWORKS) | $3.9M | FY2016 | Jan 2016 – Dec 2022 |
| Department of Health and Human Services | VISUAL SIGNAL TRANSFORMATION IN THE RETINOCOLLICULAR PATHWAY | $3.9M | FY2016 | Dec 2015 – May 2029 |
| Department of Health and Human Services | TARGETING SUCCINATE SIGNALING FOR INNOVATIVE PAIN RELIEF IN ORAL CANCER. - CURRENT PAIN MANAGEMENT STRATEGIES FOR PATIENTS WITH ORAL OR HEAD AND NECK CANCER CONDITIONS OFTEN RELY ON HIGH-DOSE OPIOID ANALGESICS, WHICH CAN BE INEFFECTIVE. SUCCINATE IS A DICARBOXYLIC ACID METABOLITE IN THE KREBS CYCLE, AND EMERGING EVIDENCE HIGHLIGHTS ITS PRO-INFLAMMATORY ROLE THROUGH THE ACTIVATION OF ITS G-PROTEIN COUPLED RECEPTOR, SUCNR1. NOTABLY, ORAL CANCER PATIENTS SHOW ELEVATED CIRCULATING SUCCINATE LEVELS AND INCREASED SUCNR1 EXPRESSION IN TUMOR TISSUES. WE HAVE BEEN AT THE FOREFRONT OF INVESTIGATING SUCCINATE/SUCNR1 SIGNALING AND HAVE DEMONSTRATED THAT SUCNR1 ACTIVATION PROMPTS PRO-INFLAMMATORY SIGNALING IN MYELOID CELLS. OUR PRELIMINARY FINDINGS INDICATE THAT PATIENTS WITH ORAL CANCER EXPERIENCING HIGHER PAIN SCORES HAVE ELEVATED PLASMA SUCCINATE LEVELS. ADDITIONALLY, SUCNR1 EXPRESSION HAS BEEN OBSERVED IN BOTH HUMAN AND MOUSE GANGLIA, WITH SUCCINATE INCREASING INFLAMMATION AND NOCICEPTION IN WILDTYPE (WT) MICE BUT NOT IN SUCNR1 KNOCKOUT (KO) MICE. IN AN MOC2 ORTHOTOPIC XENOGRAFT MODEL OF ORAL CANCER, KO MICE EXHIBITED REDUCED FACIAL NOCICEPTION AND FEWER TUMOR- INFILTRATING MYELOID CELLS. WE HYPOTHESIZE THAT INHIBITING SUCNR1 ACTIVATION COULD ALLEVIATE ORAL CANCER PAIN BY REDUCING INFLAMMATION AND NOCICEPTION. TO TEST THIS HYPOTHESIS, WE PROPOSE TWO SPECIFIC AIMS. IN AIM 1, WE WILL INVESTIGATE SUCCINATE SIGNALING AND ASSESS SUCNR1 AS A POTENTIAL TARGET FOR ALLEVIATING ORAL CANCER PAIN USING CLINICAL SAMPLES AND PRECLINICAL MODELS. THE ANALGESIC EFFECTS OF A NOVEL SUCNR1 ANTAGONIST WE HAVE DEVELOPED WILL BE EVALUATED IN 4NQO-INDUCED ORAL CANCER MICE. WE WILL MEASURE TUMOR GROWTH, ORAL FUNCTION, AND REFERRED MECHANICAL AND THERMAL HYPERSENSITIVITIES, ALONG WITH ASSOCIATED COMORBIDITIES. ADDITIONALLY, WE WILL EXPLORE THE DISTRIBUTION AND NEUROMODULATORY FUNCTION OF SUCNR1 IN HUMAN ORAL CANCER TISSUES, AND THE GANGLIA OF BOTH HUMAN AND MOUSE. IN AIM 2, WE WILL EVALUATE THE ROLE OF MYELOID SUCNR1 IN ORAL CANCER PAIN WITH GLOBAL AND MYELOID-SPECIFIC KNOCKOUT MICE, ALONGSIDE THEIR LITTERMATE CONTROLS. THREE ORAL CANCER MODELS—MOC1 AND MOC2 ORTHOTOPIC XENOGRAFTS AND 4NQO-INDUCED ORAL CANCER—WILL BE DEVELOPED IN THESE MICE. WE WILL MEASURE TUMOR GROWTH AND NOCICEPTION WHILE CHARACTERIZING VARIOUS MYELOID POPULATIONS IN TUMOR, PERIPHERAL BLOOD, AND TUMOR- DRAINING LYMPH NODES THROUGH FLOW CYTOMETRY. LASTLY, WE WILL ASSESS SUCCINATE AND CYTOKINE LEVELS IN SERUM, AND TUMOR TISSUES USING SUCCINATE ASSAYS, MESO SCALE DISCOVERY MULTIPLEX IMMUNOASSAYS, AND SEMI- QUANTITATIVE PCR. | $3.9M | FY2025 | Sep 2025 – Aug 2029 |
| VA/DoDDepartment of Defense | NEW START MURI COOPERATIVE AGREEMENT ENTITLED, "PLANETARY- AND GEOLOGICALLY-INSPIRED DISCOVERY OF REFRACTORY MATERIALS" | $3.9M | FY2023 | Jul 2023 – Jul 2028 |
| Department of Energy | MEDIUM ENERGY SPIN PHYSICS WITH LASERS | $3.8M | FY2001 | Mar 2001 – Mar 2014 |
| Department of Health and Human Services | BEHAVIORAL ROLES OF SEROTONIN | $3.8M | FY2009 | Sep 2009 – Aug 2025 |
| VA/DoDDepartment of Defense | INVESTIGATION OF INJURIES TO ARMORED VEHICLE PERSONNEL SUBJECT TO BLAST: PRELIMINARY STUDY WITH EMPHASIS ON LOWER EXTREMEITY FACTORS | $3.8M | FY2011 | Jan 2011 – Jan 2016 |
| Department of Health and Human Services | KIDS SIPSMARTER: A MULTI-LEVEL BEHAVIORAL AND HEALTH LITERACY INTERVENTION TO REDUCE SUGAR-SWEETENED BEVERAGES AMONG APPALACHIAN MIDDLE-SCHOOL STUDENTS | $3.8M | FY2018 | May 2018 – Dec 2024 |
| Department of Health and Human Services | CAV-1.TRPV4 REGULATION OF ENDOTHELIAL FUNCTION IN SMALL PULMONARY ARTERIES | $3.8M | FY2019 | Apr 2019 – Mar 2029 |
| Department of Health and Human Services | THE FUNCTIONAL ORGANIZATION OF MAMMALIAN MEMBRANES | $3.8M | FY2020 | Jan 2020 – Feb 2030 |
| Department of Health and Human Services | MIDBRAIN CIRCUITS FOR PERCEPTUAL DECISION-MAKING - ABSTRACT PERCEPTUAL DECISION-MAKING IS A FUNDAMENTAL COGNITIVE ABILITY THAT IS VITAL TO HEALTHY, DAILY FUNCTIONING AND IS IMPAIRED IN MANY DISEASES. ALTHOUGH MANY BRAIN REGIONS ARE KNOWN TO BE INVOLVED, THERE IS NO CLEAR BRAIN-WIDE MODEL OF HOW PERCEPTUAL DECISIONS ARE FORMED AND EXECUTED AND THE UNDERLYING CIRCUIT MECHANISMS ARE STILL LARGELY UNKNOWN. HERE, A TEAM OF INVESTIGATORS PROPOSE A SERIES OF EXPERIMENTS THAT WILL USE BEHAVIORAL MEASURES, IMAGING, PHYSIOLOGY, CIRCUIT DISSECTION, AND COMPUTATIONAL MODELING TO STUDY HOW THE MIDBRAIN SUPERIOR COLLICULUS (SC) PARTICIPATES IN VISUAL DECISION-MAKING. SPECIFICALLY, THIS NEW TEAM OF INVESTIGATORS WILL PROBE THE CONTRIBUTION OF TWO SC NEURONAL CELL TYPES, WIDE FIELD VERTICAL (WFV) CELLS IN THE VISUOSENSORY LAYERS AND PREDORSAL BUNDLE (PDB) CELLS IN THE MOTOR LAYERS. THESE EXPERIMENTS WILL BE DONE IN MICE AND TREE SHREWS, TO REVEAL THE UNDERLYING CIRCUITS AND COMPUTATIONAL PRINCIPLES ACROSS SPECIES AND TO LAY THE FOUNDATION FOR FUTURE EXPERIMENTS DESIGNED TO DISSECT DECISION-MAKING CIRCUITS IN PRIMATES. IN AIM 1, THE INVESTIGATORS WILL ESTABLISH AND PERFORM PSYCHOPHYSICAL EXPERIMENTS TO ASSESS PERCEPTUAL DECISION-MAKING IN BOTH SPECIES. THE BEHAVIORAL DATA WILL BE FITTED WITH COMPUTATIONAL MODELS TO ARBITRATE BETWEEN DIFFERENT THEORIES OF DECISION-MAKING. IN AIM 2, TWO PHOTON CALCIUM IMAGING AND/OR PHYSIOLOGICAL RECORDING WILL BE PERFORMED IN MICE AND TREE SHREWS TO DETERMINE THE ACTIVITY OF WFV AND PDB NEURONS DURING THE PSYCHOPHYSICAL MEASURES ESTABLISHED IN AIM 1. IN ADDITION, WFV AND PDB NEURONS WILL BE SILENCED OPTOGENETICALLY DURING THE BEHAVIORAL TASKS TO REVEAL THEIR SPECIFIC ROLES IN DECISION-MAKING. IN AIM 3, THE INVESTIGATORS WILL USE INTERSECTIONAL MONOSYNAPTIC VIRAL TRACING TECHNIQUES, MULTIPLEXED PEROXIDASE LABELING FOR CONFOCAL AND ULTRASTRUCTURAL ANALYSIS OF SYNAPTIC CONNECTIONS AND AND OPTOGENETICS-ASSISTED BRAIN SLICE RECORDING TO INVESTIGATE THE INTRINSIC AND EXTRINSIC CIRCUITS THAT LINK WFV AND PDB CELLS. TOGETHER, THESE EXPERIMENTS WILL GENERATE NOVEL KNOWLEDGE OF THE SYNAPSE TO CIRCUIT MECHANISMS UNDERLYING PERCEPTUAL DECISION-MAKING, AND PROVIDE TECHNICAL AND THEORETICAL FOUNDATIONS FOR FUTURE MECHANISTIC STUDIES OF COGNITIVE FUNCTION IN HIGHER MAMMALIAN SPECIES DIRECTLY RELEVANT TO HUMANS. | $3.8M | FY2021 | May 2021 – Apr 2024 |
| National Science Foundation | MRI: DEVELOPMENT OF ACCORD, A COMMUNITY CYBERINSTRUMENT FOR BROADENING ACCESS TO RESEARCH ON SENSITIVE DATA | $3.8M | FY2020 | Oct 2019 – Sep 2022 |
| VA/DoDDepartment of Defense | PREVENTION OF ALCOHOL RELATED INCIDENTS IN THE US AIR FORCE | $3.8M | FY2014 | Aug 2014 – Aug 2019 |
| Department of Health and Human Services | TARGETING NEUROBLASTOMA WITH ARMED T CELLS | $3.8M | FY2014 | Sep 2014 – Aug 2021 |
| Department of Health and Human Services | ROLE OF JAK2V617F IN THE PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS. | $3.8M | FY2009 | Apr 2009 – Mar 2022 |
| Department of Health and Human Services | MENINGES-TO-ASTROCYTE COMMUNICATION IN COGNITIVE FUNCTION | $3.8M | FY2010 | May 2010 – Aug 2020 |
| Department of Health and Human Services | MECHANISMS OF HETEROCELLULAR SIGNALING AT THE MYOENDOTHELIAL JUNCTION | $3.7M | FY2008 | Jan 2008 – Mar 2019 |
| Department of Health and Human Services | STRUCTURE AND FUNCTION OF E. HISTOLYTICA ADHERENCE LECTIN | $3.7M | FY1989 | Aug 1989 – Jan 2018 |
| Department of Health and Human Services | PREMATURITY-RELATED VENTILATORY CONTROL: LEADERSHIP DATA AND COORDINATION CENTER (LDCC) | $3.7M | FY2016 | Sep 2016 – Jun 2022 |
| Department of Health and Human Services | MECHANISM OF CELLULOSE SYNTHESIS AND TRANSPORT ACROSS BIOLOGICAL MEMBRANES | $3.7M | FY2012 | May 2012 – Feb 2022 |
| Department of Health and Human Services | NEURAL SUBSTRATES OF REINFORCEMENT LEARNING AND ITS TRAINING IN MAJOR DEPRESSION | $3.7M | FY2016 | Feb 2016 – Dec 2021 |
| Department of Health and Human Services | STRUCTURE AND FOLDING OF INTEGRAL MEMBRANE PROTEINS | $3.7M | FY1997 | Mar 1997 – Apr 2021 |
| Department of Health and Human Services | THE ROLES OF TUMOR MICROENVIRONMENT IN NEUROFIBROMA DEVELOPMENT AND THERAPEUTICS | $3.7M | FY2012 | May 2012 – Jul 2024 |
| Department of Energy | FUNDAMENTAL STUDIES OF CATALYTIC SITES AND CATALYST/MEMBRANE INTEGRATIONS FOR ADVANCED HYDROXIDE EXCHANGE MEMBRANE ELECTROLYZERS | $3.7M | FY2022 | Sep 2022 – Aug 2026 |
| Department of Health and Human Services | EXAMINING THE PHYSICAL TOLL OF MARGINALIZING EXPERIENCES IN EMERGING ADULTHOOD AND EXPLORING RESILIENCE POSSIBILITIES - PROJECT SUMMARY SCHOLARS HAVE CALLED FOR GREATER ATTENTION TO THE ETIOLOGIC ROLE OF SOCIAL IDENTITY-RELATED STRESSORS IN THE CREATION AND MAINTENANCE OF HEALTH DISPARITIES. IN THIS DOMAIN, A FOCUS ON EMERGING AND EARLY ADULTHOOD IS WARRANTED GIVEN THAT IDENTITY-RELATED CONCERNS PEAK DURING THIS DEVELOPMENTAL PERIOD. AMONG UNDERREPRESENTED COLLEGE STUDENTS ATTENDING ELITE PREDOMINANTLY WHITE INSTITUTIONS, THE CONFLUENCE OF HEIGHTENED NEEDS FOR IDENTITY SUPPORTS AND INFLUX OF MARGINALIZING EXPERIENCES MAY YIELD THE PERFECT STORM OF STRESSORS, RESULTING IN NEGATIVE HEALTH CONSEQUENCES, PARTICULARLY AMONG UNDERREPRESENTED STUDENTS WHO PERSIST IN THE FACE OF ADVERSE EXPOSURES. THE PROPOSED RESEARCH AIMS TO DOCUMENT 1) THE ROLE OF SPECIFIC IDENTITY-RELATED STRESSORS IN UNDERMINING THE HEALTH OF VULNERABLE GROUPS AS THEY PURSUE EDUCATIONAL AND CAREER ADVANCEMENT AND 2) THE ROLE OF SOCIAL SUPPORTS AND RESOURCES IN MITIGATING POTENTIAL HARM RESULTING FROM MARGINALIZING EXPERIENCES. THE PROPOSED RESEARCH WILL BE CONDUCTED WITH A SAMPLE OF 340 EARLY ADULTS WHO PREVIOUSLY PARTICIPATED IN A FIVE-WAVE LONGITUDINAL STUDY ACROSS FOUR YEARS (96% RETENTION RATE). ALL PARTICIPANTS WERE RECRUITED DURING THEIR FIRST YEAR OF COLLEGE AT AN ELITE PREDOMINANTLY WHITE INSTITUTION AND WERE ELIGIBLE TO PARTICIPATE IF THEY WERE A MEMBER OF AN UNDERREPRESENTED RACIAL/ETHNIC GROUP, A FIRST GENERATION COLLEGE STUDENT, OR RECEIVED THE FULL AMOUNT OF THE FEDERAL PELL GRANT (I.E., DEMONSTRATED SUBSTANTIAL FINANCIAL NEED). IN THE PROPOSED RESEARCH, ESTABLISHED INDICATORS OF PHYSICAL HEALTH AND EPIGENETIC AGING WILL BE COLLECTED FROM THIS SAMPLE OF YOUNG ADULTS (AGES 25-30) TO ASSESS HOW THEIR PREVIOUS AND CONCURRENT EXPERIENCES OF MARGINALIZATION (I.E., RISK) AND SUPPORT (I.E., PROTECTION) MAY “GET UNDER THE SKIN.” BIOMARKER MEASUREMENTS WILL BE UTILIZED IN ORDER TO IDENTIFY HEALTH RISK PRIOR TO DISEASE ONSET. DURING EARLY ADULTHOOD, MOST CHRONIC DISEASES ARE STILL ASYMPTOMATIC AND HAVE NOT YET BEEN DETECTED VIA ROUTINE HEALTH SCREENS. THUS, THE PERIOD OF EARLY ADULTHOOD ALLOWS FOR IDENTIFICATION OF PROGNOSTIC INDICATORS OF FUTURE DISEASE. NOTABLY, THE PROPOSED RESEARCH ALIGNS WELL WITH THE SCIENTIFIC VISION OF THE NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES IN THAT IT AIMS TO HELP EXPLAIN DISPARITIES IN DISEASE BY ILLUMINATING PHYSIOLOGIC PROCESSES RESULTING FROM SOCIAL INEQUITIES. ADDITIONALLY, THE PROPOSED RESEARCH SEEKS TO IDENTIFY MECHANISMS OF RESILIENCE WITH ATTENTION TO NUANCE ACROSS OUTCOMES BEING STUDIED (E.G., “SKIN-DEEP RESILIENCE”). A MORE COMPREHENSIVE UNDERSTANDING OF RISK AND RESILIENCE PROCESSES AND VARIABILITY IN HOW THEY PLAY OUT AMONG MARGINALIZED GROUPS CAN INFORM INTERVENTIONS TO FACILITATE SOCIAL MOBILITY WHILE ALSO PRESERVING AND BOLSTERING THE HEALTH OF MINORITY GROUPS. GIVEN THAT THE EMERGING AND EARLY ADULTHOOD YEARS HOLD GREAT CONSEQUENCE FOR THE LIFE COURSE, INTERVENTIONS TARGETING THIS DEVELOPMENTAL PERIOD HOLD TREMENDOUS POTENTIAL FOR REDUCING HEALTH DISPARITIES, PARTICULARLY HEALTH DISPARITIES THAT MAY BE EXACERBATED COUNTERINTUITIVELY BY SOCIAL MOBILITY. | $3.7M | FY2022 | Dec 2021 – Nov 2026 |
Department of Health and Human Services
$52.9M
CANCER CENTER SUPPORT GRANT
Department of Health and Human Services
$35.3M
MULTIMODAL DEVELOPMENTAL NEUROGENETICS OF FEMALES WITH ASD
Department of Education
$32M
CARES ACT HIGHER ED EMERGENCY RELIEF FUND PART 2 FOR THE UNIVERSITY OF VIRGINIA
Department of Education
$26.9M
CARES ACT GRANT US DEPT OF EDUCATION FOR THE UNIVERSITY OF VIRGINIA
Department of Health and Human Services
$24M
PANNEXIN CHANNELS IN VASCULAR PHYSIOLOGY & INFLAMMATION
Department of Health and Human Services
$23.9M
DOPAMINE/ANGIOSTENSIN RECEPTORS IN GENETIC HYPERTENSION
Department of Health and Human Services
$22.6M
THE STROKE HYPERGLYCEMIA INSULIN NETWORK EFFORT (SHINE) TRIAL
Department of Education
$21.3M
CARES ACT - RADFORD UNIVERSITY
Department of Health and Human Services
$20.6M
CELL MIGRATION CONSORTIUM
Department of Health and Human Services
$20.3M
PROVISION OF CLINICAL DATA TO SUPPORT A NATIONWIDE COVID-19 COHORT COLLABORATIVE
Environmental Protection Agency
$20M
DESCRIPTION:THIS AGREEMENT PROVIDES FUNDING UNDER THE INFLATION REDUCTION ACT (IRA) TO THE UNIVERSITY OF VIRGINIA. SPECIFICALLY, THE PROJECT WILL ALLOW THE UNIVERSITY OF VIRGINIA, WORKING IN UTQIAGVIK, AK, TO IMPROVE STORM- AND MELT-WATER INFRASTRUCTURE AND MANAGEMENT; PRESERVE INUPIAT TRADITIONS AND CULTURAL SITES; ENHANCE BARROW LOCAL UTILITIES' READINESS AND PREPAREDNESS, AND STRENGTHEN LOCAL CAPACITY; IMPROVE RESIDENTIAL SANITATION BY CONNECTING UNSERVICED HOMES TO MODERN WATER/SEWER SYSTEMS; AND PROTECT THE COMMUNITY'S DRINKING WATER LAGOON. ACTIVITIES:THE ACTIVITIES INCLUDE A COMPREHENSIVE DRAINAGE STUDY OF THE CITY TO INFORM INFRASTRUCTURE UPGRADES AND SUSTAINABLE WATER, SNOW AND PERMAFROST MANAGEMENT, AND IMPLEMENTING IDENTIFIED UPGRADES TO BETTER RESPOND TO INCREASED PRECIPITATION, FLOODING AND ASSOCIATED PERMAFROST DEGRADATION; INSTALLING THERMOSIPHONS IN TRADITIONAL ICE CELLARS WITH UPGRADED DRILLING EQUIPMENT, AND INSTALLING AND IMPROVING DRAINAGE AND RESTORING DISTURBED TUNDRA VEGETATION TO REDUCE FLOODING AT THE COMMUNITY'S CEMETERY; UPGRADING OR EXPANDING CRITICAL HEAVY-DUTY MAINTENANCE VEHICLES THAT ARE BETTER EQUIPPED FOR THE ARCTIC CONDITIONS TO ENHANCE THE LOCAL UTILITY'S READINESS AND PREPAREDNESS, AND STRENGTHENING LOCAL WORKFORCE CAPACITY WHILE REDUCING GREENHOUSE GAS EMISSIONS AND OCCUPATIONAL HAZARDS, AND CREATING AND EXPANDING PROGRAMS THAT BUILD KNOWLEDGE AND JOBS IN SUSTAINABLE WATER, SNOW AND PERMAFROST MANAGEMENT; CONNECTING UNSERVICED HOMES TO MODERN WATER/SEWER SYSTEMS, ELIMINATING OR REDUCING THE USE OF HONEY BUCKETS, HUMAN WASTE SPILLAGE, AND ASSOCIATED ENVIRONMENTAL AND HUMAN HEALTH RISKS; AND PROTECTING THE COMMUNITY'S DRINKING WATER LAGOON BY CONDUCTING COMPREHENSIVE FEASIBILITY STUDIES FOR PER-AND POLYFLUOROALKYL (PFAS) SUBSTANCES REMEDIATION/REMOVAL AND ALGAE BLOOM MITIGATION. SUBRECIPIENT:THE SUBAWARD WITH BARROW UTILITIES AND ELECTRIC COOPERATIVE, INC. (BUECI) WILL COVER WATER AND SEWER CONNECTIONS FOR UNSERVICED HOMES, UPGRADE OF HEAVY-DUTY VEHICLES TO IMPROVE READINESS AND REDUCE GREENHOUSE GAS EMISSIONS AND OCCUPATIONAL HAZARDS, FEASIBILITY STUDIES FOR PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND ALGAL GROWTH MITIGATION IN THE COMMUNITY DRINKING WATER LAGOON, MATERIAL COSTS TO STABILIZE SUBSIDING BUECI STRUCTURES DUE TO PERMAFROST DEGRADATION, AND CONTINUING EDUCATION FOR BUECI LEADERSHIP AND MEMBERS. THE SUBAWARD WITH NORTH SLOPE BOROUGH (NSB) WILL COVER IMPROVEMENTS TO DRAINAGE INFRASTRUCTURE AND COVER MATERIALS, AND CIVIL WORKS TO STABILIZE PERMAFROST AND REDUCE MELTWATER FLOODING, IMPROVE PUMPING OPERATION OF NEWLY ADDED SEWER TANKS, CONDUCT A COMMUNITY-WIDE DRAINAGE ASSESSMENT AND PRODUCE AN ACTION PLAN FOR STORMWATER/MELTWATER MANAGEMENT, CONTINUING EDUCATION FOR NSB LEADERSHIP AND PUBLIC WORKS OPERATORS, AND INTERNSHIPS / APPRENTICESHIPS BETWEEN DEPARTMENT OF PUBLIC WORKS AND I#7735;ISA#289;VIK COLLEGE'S WORKFORCE DEVELOPMENT PROGRAM. THE SUBAWARD WITH THE CITY OF UTQIA#289;IVK (COU) WILL ALLOW FOR IMPROVEMENTS TO THE CULTURAL SITE OF IMAIQSAUN CEMETERY AND COVER DRAINAGE DESIGN, DRAINAGE INSTALLATION AND EXPANSION, IMPROVED SNOW AND MELTWATER MANAGEMENT, GRAVESITE REVEGETATION, AND REPATRIATION OF GRAVESITES INCLUDING NEW COFFINS AND CULTURAL RE-BURIAL CEREMONY. THE SUBAWARD WITH THE INUPIAT COMMUNITY OF ARCTIC SLOPE (ICAS) WILL COVER THE PURCHASE AND SHIPPING OF THERMOSIPHONS AND AN AUGER DRILL TO BE USED FOR THEIR ICE CELLAR PRESERVATION PROJECT. THE SUBAWARD WITH THE ARCTIC INFRASTRUCTURE DEVELOPMENT CENTER AT THE UNIVERSITY OF ALASKA FAIRBANKS WILL ALLOW THE AIDC TO PROVIDE ON-SITE ASSESSMENTS, AND REVIEW AND CONSULTATION ON FEASIBILITY STUDIES AND ICE CELLAR PRESERVATION. OUTCOMES:THE ANTICIPATED DELIVERABLES INCLUDE INCLUDE A STORM(MELT)WATER INFRASTRUCTURE AND MANAGEMENT STUDY/ACTION PLAN, AND IMPLEMENTATION OF THE RECOMMENDATIONS IDENTIFIED IN THE PLAN; ACQUISITION OF THERMOSIPHON INSTALLATION EQUIPMENT AND INSTALLATION OF THERMOSIP
Department of Health and Human Services
$19.9M
TARGETED SPHINGOLIPID METABOLISM FOR TREATMENT OF AML
Environmental Protection Agency
$19.9M
DESCRIPTION:THIS AGREEMENT PROVIDES FUNDING UNDER THE INFLATION REDUCTION ACT (IRA) TO RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA (UVA). SPECIFICALLY, THE PROJECT WILL IMPLEMENT CLIMATE RESILIENCE PLANNING IN TEN COMMUNITIES THROUGH SOUTHWEST (APPALACHIAN) VIRGINIA AND ADVANCE PROJECTS THAT REDUCE POLLUTION AND CARBON EMISSIONS WHILE SIMULTANEOUSLY ADVANCING CRITICAL COMMUNITY NEEDS: CLIMATE-RESILIENT AFFORDABLE HOUSING, ENERGY-EFFICIENT AND CARBON-NEUTRAL CHILDCARE AND WORKFORCE TRAINING, AND CLIMATE-RESILIENT GATHERING SPACES THAT DOUBLE AS COMMUNITY CAPACITY BUILDING SPACES AND HEALTHCARE ACCESS POINTS. ACTIVITIES:THE ACTIVITIES INCLUDE 1) PARTNER WITH UNITED WAY OF SOUTHWEST VIRGINIA/ENDLESS OPPORTUNITIES (UW/EO), BUCHANAN COUNTY, AND DICKENSON COUNTY TO SUPPORT ELECTRIC VEHICLE TRANSPORTATION OPTIONS AS WELL AS EV CHARGING UNITS; 2) PARTNER WITH BUCHANAN COUNTY AND THE SOUTHERN GAP DEVELOPMENT AREA TO BUILD ENERGY-EFFICIENT, HEALTHY AND CLIMATE-RESILIENT WORKFORCE HOUSING; 3) PARTNER WITH UW/EO TO INCREASE THE ENERGY EFFICIENCIES OF THEIR WORKFORCE AND CHILDCARE CENTERS; 4) PARTNER WITH THE UW/EO TO SUPPORT THE INSTALLATION OF COMMUNITY SOLAR ON THEIR AFFILIATED WORKFORCE DEVELOPMENT AND CHILDCARE CENTERS; 5) PARTNER WITH DICKENSON COUNTY AND THE TOWN OF HAYSI TO DEVELOP A COMMUNITY RESILIENCE HUB THAT CAN ALSO BE A CENTER FOR COMMUNITY ENGAGEMENT AND CAPACITY; 6) PARTNER WITH HEALTHY APPALACHIA INSTITUTE TO RENOVATE 10 LOCATIONS TO DOUBLE AS COMMUNITY RESILIENCE HUBS AND HEALTHCARE OUTPOSTS; 7) CONDUCT FEASIBILITY STUDIES OF ADVANCING MIXED RENEWABLE ENERGY DEVELOPMENTS ON BROWNFIELD SITES IN BUCHANAN AND DICKENSON COUNTIES; AND 8) PARTNER WITH JAMES MADISON UNIVERSITY'S CENTER FOR THE ADVANCEMENT OF SUSTAINABLE ENERGY AND THE NETWORK OF LOCAL COMMUNITY COLLEGES TO ADVANCE CLEAN ENERGY CAREER DEVELOPMENT. SUBRECIPIENT:SUBAWARD OF $4,594,245 TO UNITED WAY (FORMERLY EO) FOR THE DECARBONIZATION AND CARBON MITIGATION OF CHILDCARE CENTERS. THIS PROJECT INCLUDES SOLAR INSTALLATION AND ENERGY EFFICIENCY UPGRADES TO CHILDCARE FACILITIES, OUTDOOR CLASSROOMS, AND BUILDING OUT PROGRAMMING FOR THE RENEWABLE ENERGY SECTOR WORKFORCE. SUBAWARD OF $1,757,708 TO DICKENSON COUNTY FOR BUILDING A CLIMATE RESILIENCE HUB IN THE TOWN OF HAYSI OUTSIDE OF THE FLOODPLAIN. THIS PROJECT INCLUDES ENGINEERING AND ARCHITECTURAL DESIGN AND PERMITS, CONSTRUCTION OF THE FACILITY, AND INSTALLATION OF EV FAST CHARGER. SUBAWARD OF $4,847,841 TO BUCHANAN COUNTY FOR THE BUILDING OF CLIMATE RESILIENT HOUSING IN SOUTHERN GAP OUTSIDE OF THE FLOODPLAIN. THIS PROJECT INCLUDES CONSTRUCTION EXTENSION OF INFRASTRUCTURE (WATER, SEWER, POWER AND TELCOM) TO SUBDIVISION LOTS, CONSTRUCTION OF INTERIOR ROADWAYS AND WALKWAYS, CONSTRUCTION OF TWO SINGLE FAMILY DWELLING UNITS, CONSTRUCTION OF MULTI-FAMILY TOWN HOUSE RENTAL UNITS, AND AN EV CHARGING STATION AT THE REGIONAL OFFICE PARK OFFICE BUILDING. SUBAWARD OF $132,000 TO VIRGINIA TECH FOR A COMMUNITY ENGAGEMENT PROJECT ON CLIMATE RESILIENCE STRATEGIC PLANNING. THIS COMMUNITY-BASED CLIMATE RESILIENCE PLANNING PROCESS INVOLVES THE RAFT (RESILIENCE ADAPTATION FEASIBILITY TOOL). SUBAWARD OF $1,973,797 TO JAMES MADISON UNIVERSITY (JMU) CENTER FOR THE ADVANCEMENT OF SUSTAINABLE ENERGY FOR DEVELOPING CLEAN ENERGY CAREERS. THIS PROJECT INCLUDES BUILDING OR EXPANDING A REGIONAL ENERGY WORKFORCE HUB IN ABINGDON IN PARTNERSHIP WITH VIRGINIA HIGHLANDS COMMUNITY COLLEGE (VHCC) AND NEW RIVER COMMUNITY COLLEGE (NRCC) TO DEVELOP GREEN JOBS PIPELINE, FROM ENTRY LEVEL INSTALLATION, TO PROJECT MANAGEMENT, TO ADVANCED MANAGERIAL AND LEADERSHIP IN RENEWABLE ENERGY CAREERS. PROGRAMS SUPPORTED AT THE REGIONAL HUB WILL ADDRESS RENEWABLE ENERGY SKILL DEVELOPMENT FOR K-12 STUDENTS, TEACHER TRAININGS FOR K-12 FACULTY, RENEWABLE ENERGY KIT AND CURRICULUM DISTRIBUTION, SUMMER CAMPS, AND SUPPORT FOR KIDWIND CHALLENGE TEAMS. OUTCOMES:THE ANTICIPATED DELIVERABLES INCLUDE SOLAR INSTALLATION, ENERGY EFFICIENCY UPGRADES,
Department of Energy
$17.6M
NEW: CENTER FOR CATALYTIC HYDROCARBON FUNCTIONALIZATION -- EFRC; PI - BRENT GUNNOE
Department of Health and Human Services
$15.4M
ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (ESETT)
Department of Health and Human Services
$14.6M
STRUCTURAL DYNAMICS OF PRESYNAPTIC MEMBRANE FUSION
Department of Health and Human Services
$14.5M
HCMR NOVEL MARKERS OF PROGNOSIS IN HYPERTROPHIC CARDIOMYOPATHY
Department of Health and Human Services
$14.3M
GENERAL CLINICAL RESEARCH CENTER
Department of Health and Human Services
$14M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANT
Department of Education
$13.8M
APPALACHIAN SUPPORT FOR SPECIALIZED EDUCATION TRAINING (ASSET)
Department of Energy
$13.3M
ELECTRON INTERACTIONS WITH NUCLEI
Department of Health and Human Services
$12.6M
CLINICAL ACCEPTANCE OF THE ARTIFICIAL PANCREAS: THE INTERNATIONAL DIABETES CLOSED LOOP (IDCL) TRIAL
Department of Health and Human Services
$12.5M
SIGNALING AND PROGRESSION IN PROSTATE CANCER
Department of Health and Human Services
$12.2M
IMMUNOBIOLOGY OF TRANSFUSION
Department of Health and Human Services
$12M
KIDNEY DEVELOPMENT CELL FATE AND PRECURSORS OF DISEASE IN THE YOUNG AND ADULT
Department of Health and Human Services
$11.6M
PROTEIN SEQUENCING BY TANDEM MASS SPECTROMETRY
Department of Health and Human Services
$10.8M
INFECTIOUS DISEASES TRAINING PROGRAM
Department of Health and Human Services
$10.6M
EPIDEMIOLOGY OF OVARIAN CANCER IN AFRICAN-AMERICAN WOMEN
National Endowment for the Humanities
$10M
CELEBRATING THE 250TH ANNIVERSARY OF THE UNITED STATES OF AMERICA: CREATING AND SUSTAINING ACCESS TO FOUNDING ERA / EARLY REP [THE COLLABORATIVE PROJECT, CELEBRATING THE 250TH ANNIVERSARY OF THE UNITED STATES OF AMERICA: CREATING AND SUSTAINING ACCESS TO FOUNDING ERA / EARLY REPUBLIC PRIMARY SOURCES, REPRESENTS A TIMELY AND TRANSFORMATIVE INVESTMENT IN RESEARCHING, EDITING, PUBLISHING, AND PROMOTING THE DOCUMENTARY HERITAGE OF THE FOUNDING ERA AND EARLY REPUBLIC. WITH SUPPORT FROM THIS GRANT, THE UNIVERSITY OF VIRGINIA AND ITS PARTNERS WILL ACHIEVE FOUR CRITICAL OUTCOMES: INCREASING OUR UNDERSTANDING OF THE FOUNDING ERA AND EARLY REPUBLIC; REFINING AND STRENGTHENING THE TECHNICAL AND INSTITUTIONAL INFRASTRUCTURE; CREATING A DYNAMIC, FREELY-ACCESSIBLE WEBSITE; AND PROVIDING HANDS-ON TRAINING AND KNOWLEDGE-SHARING OPPORTUNITIES. BY UNITING EDITORIAL EXPERTISE, TECHNOLOGICAL INNOVATION, AND PUBLIC OUTREACH, THIS INITIATIVE ENSURES THAT THE IDEAS, VOICES, AND EXPERIENCES THAT SHAPED THE FOUNDING OF THE UNITED STATES OF AMERICA REMAIN AVAILABLE, UNDERSTANDABLE, AND ENDURING FOR FUTURE GENERATIONS.]
Department of Health and Human Services
$9.8M
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES
Department of Health and Human Services
$9.8M
MEDICAL SCIENTIST TRAINING PROGRAM
Department of Health and Human Services
$9.3M
CANCER RESEARCH TRAINING IN MOLECULAR BIOLOGY
Department of Health and Human Services
$9.3M
KETAMINE ADD-ON FOR ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (KESETT) - THE KETAMINE ADD-ON THERAPY FOR ESTABLISHED STATUS EPILEPTICUS TREATMENT TRIAL (KESETT) IS A PHASE III RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL TO TEST WHETHER KETAMINE (KET) (1 OR 3 MG/KG) ADDED TO THE STANDARD THERAPY, LEVETIRACETAM (LEV), IS MORE EFFECTIVE THAN LEVETIRACETAM (60 MG/KG) ALONE IN TREATING STATUS EPILEPTICUS AFTER BENZODIAZEPINES HAVE FAILED. GENERALIZED CONVULSIVE STATUS EPILEPTICUS (SE) IS A DANGEROUS BUT COMMON NEUROLOGIC EMERGENCY; IT CAN CAUSE RESPIRATORY DEPRESSION AND PERMANENT BRAIN DAMAGE. BENZODIAZEPINES ARE AN EFFECTIVE FIRST-LINE THERAPY, BUT APPROXIMATELY ONE-THIRD OF CHILDREN AND 40% OF ADULTS DO NOT RESPOND. PATIENTS WHO FAIL BENZODIAZEPINES ARE IN ESTABLISHED STATUS EPILEPTICUS. THEY ARE TREATED WITH SECOND-LINE AGENTS SUCH AS LEVETIRACETAM, WHICH SUCCESSFULLY TERMINATES STATUS EPILEPTICUS IN ONLY 47% OF SUBJECTS. WE PROPOSE THAT ADDING KETAMINE TO LEVETIRACETAM WILL INCREASE EFFICACY TO 62%. PRECLINICAL AND CLINICAL EVIDENCE SUPPORTS THIS TRIAL. KETAMINE, AN NMDA RECEPTOR ANTAGONIST, TERMINATES BENZODIAZEPINE REFRACTORY SE IN EXPERIMENTAL ANIMALS. NMDA RECEPTOR ACTIVATION TRIGGERS SELF-REINFORCING SEIZURE MECHANISMS UNDERLYING SE. IT ABROGATES INHIBITORY PLASTICITY, PREVENTS EXCITOTOXICITY AND NEURONAL DEATH, AND PREVENTS EPILEPTOGENESIS ACCOMPANYING SE IN EXPERIMENTAL ANIMALS. RECENT CLINICAL STUDIES IN CHILDREN AND ADULTS SHOWED THAT KETAMINE TERMINATED ESTABLISHED STATUS EPILEPTICUS IN 23 OF 24 SUBJECTS. KETAMINE IS USED EXTENSIVELY IN EMERGENCY SETTINGS FOR SEDATION, INTUBATION, AGITATION, AND PAIN MANAGEMENT; IT IS ON THE WHO ESSENTIAL MEDICATIONS LIST BECAUSE IT IS SAFELY USED EXTENSIVELY. CLINICIANS USE IT EFFECTIVELY TO TREAT REFRACTORY AND SUPER-REFRACTORY SE, AND MANY EXPERTS RECOMMEND IT. ED PHYSICIANS HAVE USED IT FOR DECADES FOR PROCEDURAL SEDATION. WE PROPOSE TO TEST 1 AND 3 MG/KG KETAMINE DOSES BASED ON RECENT HUMAN STUDIES, EXTENSIVE PHARMACOKINETIC MODELING, ANIMAL-TO-HUMAN DOSE CONVERSION AS SUGGESTED BY THE FDA, AND DATA ON THE SAFETY OF KETAMINE. OUR OVERALL HYPOTHESIS IS THAT KETAMINE ADDED TO LEV WILL IMPROVE THE OUTCOME OF ESTABLISHED STATUS EPILEPTICUS COMPARED TO TREATMENT WITH LEVETIRACETAM ALONE BY CLINICALLY MEANINGFUL 15%. WE WILL TEST THIS HYPOTHESIS BY ACCOMPLISHING THE FOLLOWING SPECIFIC AIMS IN A BAYESIAN-ADAPTIVE RANDOMIZED CLINICAL TRIAL: AIM 1: DETERMINE WHETHER PARTICIPANTS RANDOMIZED TO LEVETIRACETAM +3 MG/KG KETAMINE OR LEVETIRACETAM +1 MG/KG KETAMINE WILL HAVE MORE DESIRABLE OUTCOMES THAN THOSE RECEIVING LEVETIRACETAM +PLACEBO. WE RANK THE OUTCOMES ON A SCALE RANGING FROM 1 TO 5. AIM 2: TO ENSURE THAT THE TRIAL IS INFORMATIVE FOR TREATING ESTABLISHED STATUS EPILEPTICUS IN CHILDREN BY DESCRIBING THE EFFECTIVENESS AND RATE OF ADVERSE REACTIONS OF THESE DRUGS. AIM 3: MEASURE DIFFERENCES BETWEEN TREATMENT ARMS IN SECONDARY OUTCOMES. THIS TRIAL CAN CHANGE THE TREATMENT PARADIGM FOR SE BY SUPPLEMENTING CURRENT SECOND-LINE AGENTS WITH KETAMINE TO IMPROVE THE TIMELINESS OF SEIZURE TERMINATION.
Department of Health and Human Services
$8.9M
SYSTEMS ANALYSIS OF STRESS-ADAPTED CANCER ORGANELLES (SASCO) CENTER - PROJECT SUMMARY/ABSTRACT ONCOGENE ACTIVATION IS MODULATED BY NORMAL SUBCELLULAR COMPARTMENTS THAT EXECUTE SPECIALIZED FUNCTIONS RELATED TO HALLMARK CANCER PHENOTYPES. THESE ORGANELLES MUST ADAPT TO ONCOGENIC STRESS IN ORDER FOR TUMORS TO INITIATE AND PROGRESS, BUT THERE IS LITTLE TO NO SYSTEMS-LEVEL UNDERSTANDING OF HOW SUCH ADAPTATIONS OCCUR AND WHAT VULNERABILITIES MIGHT BE CREATED. THE SYSTEMS ANALYSIS OF STRESS-ADAPTED CANCER ORGANELLES (SASCO) CENTER AT THE UNIVERSITY OF VIRGINIA WILL ADDRESS THIS CHALLENGE BY MECHANISTIC MODELING OF ORGANELLAR PROCESSES THAT ITERATES WITH QUANTITATIVE EXPERIMENTS IN DISEASE-RELEVANT CELL CULTURES AND PRIMARY TUMORS. THE WORKING SASCO CENTER HYPOTHESIS IS THAT ORGANELLE-SPECIFIC ADAPTATION TO ONCOGENIC STRESS OCCURS THROUGH A FEW CRITICAL BOTTLENECKS, WHICH BECOME IDENTIFIABLE ONCE THE RELEVANT SIGNALING, METABOLIC, AND TRANSPORT PATHWAYS HAVE BEEN PROPERLY INTEGRATED. THE CENTER BRINGS TOGETHER 14 INVESTIGATORS WITH PRIMARY AND COLLABORATIVE TRACK RECORDS IN CANCER BIOLOGY, SYSTEMS BIOLOGY, GENETICALLY ENGINEERED MOUSE MODELS OF CANCER, AND CLINICAL PRACTICE. THREE RESEARCH PROJECTS AND ONE SHARED RESEARCH CORE WILL PURSUE A COMMON RESEARCH STRATEGY, WHICH LEVERAGES MECHANISTIC MODELS TO TEST COMPETING ALTERNATIVE HYPOTHESES ABOUT HOW ORGANELLES ADAPT TO STRESSES FROM PROXIMAL ONCOGENES THAT DRIVE SPECIFIC TYPES OF CANCER. THE PROJECTS ARE ORGANIZED HIERARCHICALLY AS ORGANELLE STRESSES DOWNSTREAM OF PROLIFERATION-INDUCING ONCOGENES. PROJECT 1 WILL EXAMINE THE CHROMOSOME PASSENGER COMPLEX AND ITS REGULATED PHASE SEPARATION DURING METAPHASE AS AN ORGANELLE THAT SENSES AND REPAIRS SPINDLE DEFECTS TO SUPPRESS BREAST CANCER ANEUPLOIDY DRIVEN BY MITOTIC TRANSCRIPTION FACTORS. PROJECT 2 WILL EVALUATE THE METABOLIC CONSEQUENCES OF CHRONIC MITOCHONDRIAL FRAGMENTATION CAUSED BY MUTANT KRAS IN PRIMARY COLORECTAL CANCERS AND SECONDARY LIVER METASTASES. PROJECT 3 WILL INVESTIGATE LOCALIZED SIGNAL-TRANSDUCTION REBALANCING AS A MECHANISM FOR ALLEVIATING PLASMA-MEMBRANE STRESS CAUSED BY EGFR AMPLIFICATION IN GLIOBLASTOMA. ALL RESEARCH PROJECTS WILL RELY ON THE HIGH-CONTENT IMAGING & ANALYSIS CORE TO OBTAIN ITERATIVE MULTICHANNEL IMMUNOFLUORESCENCE DATA WITH ORGANELLE-LEVEL RESOLUTION AND QUANTIFICATION. THE SASCO OUTREACH CORE AMPLIFIES ONGOING PROGRAMS AT THE UNIVERSITY OF VIRGINIA TO PROVIDE SUMMER RESEARCH EXPERIENCES FOR UNDERGRADUATES AND FACULTY SCHOLARS FROM HISTORICALLY UNDERREPRESENTED BACKGROUNDS AS WELL AS INTRODUCTORY SYSTEMS BIOLOGY MODELING MATERIALS FOR CLINICIANS ACROSS THE COMMONWEALTH OF VIRGINIA. THE SASCO CENTER WILL THUS CREATE A NATIONAL HEADQUARTERS FOR SUBCELLULAR CANCER SYSTEMS BIOLOGY WITHIN THE BROADER CANCER SYSTEMS BIOLOGY CONSORTIUM.
Department of Energy
$8.9M
THE UNIVERSITY OF VIRGINIA EXPERIMENTAL HIGH ENERGY PHYSICS AT THE ENERGY FRONTIER
Department of Health and Human Services
$8.6M
CLINICAL AND BASIC STUDIES IN POLYCYSTIC OVARIAN SYNDROME
Department of Health and Human Services
$8.5M
CLINICAL & BASIC STUDIES IN POLYCYSTIC OVARIAN SYNDROME
Department of Defense
$8.4M
"CENTER FOR HYPERSONIC COMBINED CYCLE FLOW PHYSICS"
Department of Energy
$8.4M
MEDIUM ENERGY SPIN PHYSICS WITH LASERS
Department of Health and Human Services
$8.4M
FUNCTIONAL ANALYSIS OF GENOME WIDE ASSOCIATIONS IN COLORECTAL CANCER
Department of Energy
$8.3M
HIGH ENERGY PHYSICS
Department of Health and Human Services
$8.1M
IMMUNE REGULATION OF VIRUS CLEARANCE AND TISSUE INJURY AT SITES OF INFECTION
Department of Education
$8M
PROJECT ENGAGE: THE IMPACT OF CARE FOR TEACHERS ON STUDENTS' SUCCESS
Department of Transportation
$7.7M
UNIVERSITY TRANSPORTATION CENTER
Department of Health and Human Services
$7.6M
PREDICTIVE INFORMATICS MONITORING IN THE NEONATAL INTENSIVE CARE UNIT
Department of Health and Human Services
$7.6M
COMPREHENSIVE MAGNETIC RESONANCE IN PAD
Department of Defense
$7.4M
THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY DARPA DEFENSE SCIENCES OFFICE DSO MULTIOBJECTIVE ENGINEERING AND TESTING OF ALLOY STRUCTURES METALS PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED JANUARY 30, 2024, AND IN THE RECIPIENTS REVISED PROPOSAL TITLED, OPTIMAL MULTI MATERIAL DESIGN VIA TOMOGRAPHIC CHARACTERIZATION AND DATA DRIVEN MODELS, DATED JUNE 8, 2023, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES.
National Science Foundation
$7.3M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) -THE NATIONAL SCIENCE FOUNDATION (NSF) GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) IS A HIGHLY COMPETITIVE, FEDERAL FELLOWSHIP PROGRAM. GRFP HELPS ENSURE THE VITALITY AND DIVERSITY OF THE SCIENTIFIC AND ENGINEERING WORKFORCE OF THE UNITED STATES. THE PROGRAM RECOGNIZES AND SUPPORTS OUTSTANDING GRADUATE STUDENTS WHO ARE PURSUING RESEARCH-BASED MASTER'S AND DOCTORAL DEGREES IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS (STEM) AND IN STEM EDUCATION. THE GRFP PROVIDES THREE YEARS OF FINANCIAL SUPPORT FOR THE GRADUATE EDUCATION OF INDIVIDUALS WHO HAVE DEMONSTRATED THEIR POTENTIAL FOR SIGNIFICANT RESEARCH ACHIEVEMENTS IN STEM AND STEM EDUCATION. THIS AWARD SUPPORTS THE NSF GRADUATE FELLOWS PURSUING GRADUATE EDUCATION AT THIS GRFP INSTITUTION. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Department of Health and Human Services
$7.3M
CRYO-EM OF HELICAL PROTEIN AND NUCLEOPROTEIN POLYMERS AT NEAR ATOMIC RESOLUTION
National Science Foundation
$7.2M
LTER: CLIMATE DRIVERS, DYNAMICS, AND CONSEQUENCES OF ECOSYSTEM STATE CHANGE IN COASTAL BARRIER SYSTEMS
Department of Energy
$7.1M
RESEARCH IN THE INTENSITY FRONTIER: NOVA AND MU2E
Department of Defense
$7.1M
A MICRO-CELLULAR SOLIDS APPROACH TO THERMO-STRUCTURAL MATERIALS WITH CONTROLLED ARCHITECTURES
Department of Health and Human Services
$7.1M
ROLE OF TH17 IN SEVERE AND RECURRENT C. DIFFICILE INFECTION
Department of Defense
$7.1M
AN INTEGRATED CELLUAR MATERIALS APPROACH TO FORCE PROTECTION (TOPIC# 7)
Department of Health and Human Services
$7M
BASIC AND TRANSLATIONAL MECHANISMS OF ALLOIMMUNIZATION TO RBC TRANSFUSION - ALLOIMMUNIZATION TO TRANSFUSED RBCS REMAINS A MAJOR PROBLEM FOR THE LARGE NUMBER OF PATIENTS WHO REQUIRE TRANSFUSION (APPROXIMATELY 1 OUT OF 70 PEOPLE (~5,000,000 PATIENTS) ANNUALLY IN THE USA ALONE). ALTHOUGH A BARRIER TO TRANSFUSION IN MULTIPLE SETTINGS, ALLOIMMUNIZATION IS PARTICULARLY PROBLEMATIC FOR PATIENTS WITH SICKLE CELL DISEASE (SCD) DUE TO 1) THE INCREASED RATE OF ALLOIMMUNIZATION (UP TO 30%), 2) THE NEED FOR CHRONIC TRANSFUSION, AND 3) THE RISK OF UNDETECTED (OR NEW) ALLOANTIBODIES CAUSING POTENTIALLY CATASTROPHIC HYPERHEMOLYSIS. THERE ARE VERY FEW EFFECTIVE THERAPEUTIC INTERVENTIONS TO PREVENT RBC ALLOIMMUNIZATION (E.G., EXTENSIVE ANTIGEN MATCHING). FOR ALL TRANSFUSION INDICATIONS, PATIENTS TEND TO BE EITHER “RESPONDERS” THAT DEVELOP ALLOANTIBODIES OVER TIME WITH ONGOING TRANSFUSION OR “NON-RESPONDERS” WITH NO DETECTABLE ALLOANTIBODIES EVEN AFTER MANY TRANSFUSIONS. CURRENTLY, WE CANNOT PREDICT WHICH PATIENTS ARE LIKELY TO BE RESPONDERS AND BECOME ALLOIMMUNIZED. THIS P01 FOCUSES ON ADDRESSING THE PERSISTENT PROBLEM OF RBC ALLOIMMUNIZATION FOR THE LARGE NUMBER OF PATIENTS WHO REQUIRE TRANSFUSIONS AND ARE AT RISK FOR ALLOIMMUNIZATION. THE PROGRAM IS STRUCTURED AROUND A CENTRAL CORE (CORE A) THAT WILL COLLECT LONGITUDINAL SAMPLES FROM A COHORT OF 2000 PATIENTS WITH SCD (AT STEADY STATE, AT TIME OF TRANSFUSION, AND ONE-MONTH POST-TRANSFUSION) LINKED TO DETAILED CLINICAL INFORMATION, INCLUDING RBC ALLOIMMUNIZATION. PROJECTS 1-3 COMBINE NOVEL TRANSLATIONAL MURINE MODELS WITH CLINICAL SAMPLES FROM CORE A WHILE PROJECT 4 USES SAMPLES FROM CORE A TO TEST HYPOTHESES THROUGH AN OMICS-BASED APPROACH AND GENERATES DATA ON PATHWAYS STUDIED IN PROJECTS 1-3. IN THIS WAY, THE PROPOSED PROGRAM CREATES A SYNERGY OF APPROACHES WITH THE ABILITY TO TRANSLATE MURINE FINDINGS INTO HUMANS AND MODEL HUMAN FINDINGS IN MICE. USING THE SAMPLES FROM CORE A AS A COMMON RESOURCE, FOUR PROJECTS ARE PROPOSED. PROJECT 1 BUILDS ON A NOVEL OBSERVATION THAT A MOUSE MODEL OF SLE RECAPITULATES INCREASED RBC ALLOIMMUNIZATION OBSERVED IN HUMANS WITH SLE AND UTILIZES THE MODEL AND SAMPLES FROM CORE A TO TEST THE MECHANISTIC ROLE OF TLR7, TLR9 AND ANTI-NUCLEIC ACID ANTIBODIES IN RBC ALLOIMMUNIZATION. PROJECT 2 BUILDS ON OUR NOVEL OBSERVATION THAT MULTIPLE PURINERGIC SIGNALING PATHWAYS REGULATE RBC ALLOIMMUNIZATION IN MICE AND UTILIZES MOUSE MODELS AND SAMPLES FORM CORE A TO TEST THE MECHANISTIC ROLE OF CD73, AMP, ADORA1, ADENOSINE AND ADORA2B IN RBC ALLOIMMUNIZATION. PROJECT 3 PROPOSES MECHANISTICALLY DRIVEN STUDIES IN PRE-CLINICAL MODELS AND HUMAN STUDIES TO EXPAND UPON OUR NOVEL FINDING THAT RETICULOCYTES (IN DONOR RBC UNITS OR IN TRANSFUSION RECIPIENTS) ARE A RISK FACTOR FOR RBC ALLOIMMUNIZATION. PROJECT 4 WILL INVESTIGATE THE UNDERLYING GENETIC RISK FACTORS THAT PREDISPOSE A GIVEN PATIENT WITH SCD THROUGH ANALYSIS OF WHOLE GENOME SEQUENCING AND THE SPECIFIC MOLECULAR DRIVERS OF ALLOIMMUNIZATION TO A GIVEN TRANSFUSION THROUGH ANALYSIS OF SINGLE CELL RNASEQ DATA. THIS P01 IS DESIGNED TO HAVE NEAR-TERM BENEFITS OF GUIDING CLINICAL PRACTICE BY DISCOVERING PREDICTORS OF RESPONDER/NON-RESPONDER PATIENTS AND LONGER-TERM BENEFITS OF ELUCIDATING MECHANISMS OF RBC ALLOIMMUNIZATION TO ALLOW RATIONAL TARGETS FOR THERAPY DEVELOPMENT.
Department of Health and Human Services
$7M
AN INTERDISCIPLINARY TRAINING PROGRAM IN IMMMUNOLOGY
Department of Defense
$6.9M
SYSTEM-LEVEL APPROACH FOR MULTI-PHASE, NANOTECHNOLOGY-ENHANCED COOLING OF HIGH-POWER MICROELECTRONIC SYSTEMS
National Science Foundation
$6.8M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP)
Department of Health and Human Services
$6.8M
NETWORK FOR CARDIOTHORACIC SURGICAL INVESTIGATIONS IN CARDIOVASCULAR MEDICINE
Department of Health and Human Services
$6.6M
EXPRESSION AND PROTEOMIC CHARACTERIZATION OF RISK LOCI IN TYPE 1 DIABETES
Department of Health and Human Services
$6.6M
BIOSPECIMEN PROCUREMENT AND TISSUE MICROARRAY MANUFACTURE FOR THE CHTN
Department of Defense
$6.6M
TOWARDS A MISSION CONFIGURABLE STEALTH UNDERWATER BATOID
Department of Health and Human Services
$6.5M
BIO-BEHAVIORAL FEEDBACK AND CONTROL OF TYPE 1 DIABETES
Department of Health and Human Services
$6.4M
THE ROLE OF COPY NUMBER VARIANTS (CNV) IN TYPE 1 DIABETES
Department of Health and Human Services
$6.4M
IGE ANTIBODIES TO THE MAMMALIAN OLIGOSACCHARIDE GALACTOSE-ALPHA-1, 3-GALACTOSE (ALPHA-GAL): IMMUNOLOGY, EPIDEMIOLOGY AND RELEVANCE TO ALLERGIC AND INFLAMMATORY DISEASE
Department of Health and Human Services
$6.4M
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
Department of Health and Human Services
$6.3M
URINE COLORIMETRY FOR TUBERCULOSIS PHARMACOKINETICS EVALUATION IN CHILDREN AND ADULTS
Department of Health and Human Services
$6.2M
CELLULAR AND GENETIC BASIS OF SYSTEMIC LUPUS
Department of Energy
$6.2M
STUDY OF THE NUCLEON STRUCTURE AT JEFFERSON LAB HALL A
Department of Health and Human Services
$6.1M
CARDIOVASCULAR SURGERY RESEARCH TRAINING GRANT
Department of Health and Human Services
$6.1M
DOPAMINERGIC AND GLUTAMATERGIC MECHANISMS OF COCAINE ADDICTION: SEX DIFFERENCES
Department of Health and Human Services
$6M
ONTOGENY OF CENTRAL NEURAL TASTE RESPONSES
National Science Foundation
$5.9M
LTER: DRIVERS, DYNAMICS AND CONSEQUENCES OF NON-LINEAR CHANGE IN COASTAL BARRIER SYSTEMS
Department of Health and Human Services
$5.9M
FIELD STUDIES OF HUMAN IMMUNITY TO AMEBIASIS IN BANGLADESH
Department of Health and Human Services
$5.9M
CRITICAL PERIOD PLASTICITY AND BINOCULAR MATCHING IN THE VISUAL CORTEX
Department of Health and Human Services
$5.9M
MOLECULAR MECHANISMS OF MEMBRANE TRANSPORT
Department of Health and Human Services
$5.9M
REAL-TIME MEASUREMENTS OF NEUROTRANSMISSION IN DROSOPHILA MELANOGASTER
Department of Health and Human Services
$5.8M
TARGETED CEU IMAGING OF ATHEROSCLEROSIS AND ANGIOGENESIS
Department of Health and Human Services
$5.8M
CELLULAR/MOLECULAR MECHANISMS OF RESPIRATORY NEURONAL CHEMOSENSITIVITY
Department of Health and Human Services
$5.7M
MINIMALLY INVASIVE CEREBRAL BLOOD FLOW AND OXYGENATION MONITORING FOR INTRACRANIAL HYPERTENSION - ABSTRACT/PROJECT SUMMARY TRAUMATIC BRAIN INJURY, ACUTE ISCHEMIC STROKE, AND INTRACEREBRAL HEMORRHAGE ARE FREQUENTLY COMPLICATED BY INTRACRANIAL HYPERTENSION LEADING TO PROGRESSIVE ISCHEMIA AND SECONDARY BRAIN INJURY. RECENT EFFORTS FOCUSED ON IMPROVING OUTCOMES HAVE THEREFORE BEEN FOCUSED UPON IMPROVING CEREBRAL OXYGENATION AND THE DEVELOPMENT OF MONITORING DEVICES TO GUIDE THERAPY. CURRENT DEVICES DESIGNED TO MEASURE TISSUE OXYGENATION ARE, HOWEVER, SEVERELY LIMITED IN THEIR SCOPE OF SURVEILLANCE AND ACCURACY. SURFACE OXIMETRY MONITORS INTERROGATE ONLY SUPERFICIAL BRAIN TISSUE, WITH CONTAMINATION FROM INTERVENING SKIN AND SKULL. INTRAPARENCHYMAL BRAIN TISSUE OXYGEN PROBES SURVEY RELATIVELY METABOLICALLY LESS ACTIVE WHITE MATTER (COMPARED TO GRAY MATTER), A VOLUME OF LESS THAN 3 MM3, AND AT A SINGLE LOCATION. LASTLY, INTRAPARENCHYMAL TISSUE OXYGEN MONITORS ARE BULKY, INCOMPATIBLE WITH MAGNETIC RESONANCE IMAGING, AND HAVE YET TO DEMONSTRATE CLINICAL EFFICACY. TO FILL THIS NEED, WE WILL FINALIZE THE DEVELOPMENT OF A BRAIN-SPECIFIC, MINIMALLY INVASIVE, OPTICAL BLOOD FLOW AND OXYGENATION MONITORING SYSTEM (FLOXBR), THEN TRANSLATE THIS DEVICE TO HUMANS. THE FLOXBR, EMPLOYING DIFFUSE OPTICAL AND CORRELATION SPECTROSCOPIES VIA A BRAIN SURFACE PROBE, MAY OFFER IMPROVED SENSITIVITY AND SPECIFICITY COMPARED TO NON-INVASIVE PROBES AND WILL PROBE LARGER VOLUMES THAN CURRENTLY AVAILABLE INVASIVE PROBES, SUCH AS THE LICOXTM TISSUE PO2 PROBE. UNLIKE INTRAPARENCHYMAL PROBES, THIS DEVICE CAN LIE ABOVE OR BELOW THE DURA AND WILL BE MORE SENSITIVE TO HIGHLY METABOLICALLY ACTIVE GRAY MATTER. ITS SMALL SIZE AND FLEXIBILITY WILL PERMIT MULTIPLE PROBES TO BE PLACED THROUGH A SINGLE BURR HOLE, THUS ALLOWING FOR THE MONITORING OF REGIONAL DIFFERENCES IN FLOW AND OXYGENATION. UNLIKE SURFACE OXIMETRY, THE FLOXBR IS NOT IMPACTED BY SUPERFICIAL TRAUMA OR EDEMA, IMPROVING RELIABILITY AND SENSITIVITY. CONTINUOUS, EASILY INTERPRETED, AND RELIABLE MINIMALLY INVASIVE MONITORING OF CEREBRAL OXYGEN DELIVERY MAY ENHANCE MANAGEMENT AND OUTCOMES IN PATIENTS SUFFERING FROM INTRACRANIAL HYPERTENSION. OUR AIMS ARE SUCCINCTLY SUMMARIZED BELOW. AIM 1) FINALIZE DEVELOPMENT & MANUFACTURE THE FLOXBR BRAIN FLOW AND OXIMETRY MONITORING DEVICE. AIM 2) PRE-CLINICAL DEVICE EVALUATION, MEASUREMENT VALIDATION, AND SAFETY TESTING OF FLOXBR. AIM 3) COMPLETE REGULATORY AND SAFETY REQUIREMENTS TO SUPPORT FLOXBR FIRST-IN-HUMANS FEASIBILITY TESTING. AIM 4) CONDUCT FIRST-IN-HUMANS FEASIBILITY TESTING.
National Science Foundation
$5.6M
LONG-TERM DRIVERS, STATE CHANGE AND DISTURBANCE ON THE VIRGINIA COAST RESERVE: LTER V
Department of Defense
$5.5M
FOCUSED ULTRASOUND INTERVENTIONS FOR NONINVASIVE PRECISION THERAPY IN PRIMARY AND METASTATIC BREAST CANCERS
Department of Health and Human Services
$5.5M
TRAINING IN CELL AND MOLECULAR BIOLOGY
Department of Health and Human Services
$5.5M
SOCIAL RELATIONSHIP QUALITIES AS PREDICTORS OF HEALTH & AGING FROM ADOLESCENCE THROUGH EARLY MIDLIFE
Department of Health and Human Services
$5.5M
AUGMENTATION OF TISSUE PERFUSION IN PAD WITH ULTRASOUND-MEDIATED CAVITATION
Department of Health and Human Services
$5.4M
THE ROLE OF ION TRANSPORT IN GLIOMA MIGRATION, PROLIFERATION, AND APOPTOSIS
Department of Health and Human Services
$5.4M
ROLE OF EOSINOPHILS IN INNATE PROTECTION FROM C. DIFFICILE
Department of Health and Human Services
$5.4M
GROWTH AND REGENERATION IN THE INNER EAR
Department of Health and Human Services
$5.4M
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION
Department of Health and Human Services
$5.4M
MOLECULAR MECHANISMS OF RHOA-MEDIATED CA2+SENSITIZATION IN VASCULAR SMOOTH MUSCLE
Department of Energy
$5.3M
ELECTRON INTERACTIONS WITH NUCLEI
Department of Health and Human Services
$5.3M
ADOLESCENT PEER AND FAMILY PRECURSORS OF ADULT PSYCHOSOCIAL FUNCTIONING
Department of Health and Human Services
$5.3M
AN EVALUATION OF TREATMENT WITH OMALIZUMAB TO IMPROVE THE ASTHMATIC RESPONSE TO A
Department of Health and Human Services
$5.2M
NANOSCALE PROGRAMING OF CELLULAR AND PHYSIOLOGICAL PHENOTYPES
Department of Health and Human Services
$5.2M
MOLECULAR STUDY OF MOUSE VIRAL RESISTANCE MECHANISMS
Department of Health and Human Services
$5.2M
IRON DEFICIENCY: MOLECULAR AND CELLULAR CONSEQUENCES
Department of Health and Human Services
$5.1M
THE INFLUENCE OF SOCIAL NETWORKS ON DISPARITIES IN POSTNEONATAL INFANT MORTALITY
Department of Health and Human Services
$5.1M
HIGH-THROUGHPUT ASSAYS FOR IMAGING HUMAN INTRACELLULAR PATHOGEN INFECTIONS
Department of Agriculture
$5.1M
ARP ECONOMIC DEVELOPMENT GRANT FOR RURAL HEALTH CARE FACILITIES
Department of Health and Human Services
$5.1M
BFGF LOW AFFINITY RECEPTORS AND HIVAN
Department of Defense
$5.1M
NEW START GRANT
National Science Foundation
$5.1M
FOCUSED COPE: ENHANCING RESILIENCE AND EQUITY IN URBAN COASTAL COMMUNITIES THROUGH THE CO-GENERATION OF COMMUNITY CAPITALS -2209139 (GOODALL). THE OVERARCHING GOAL OF THIS PROJECT IS TO CREATE TRANSFERABLE METHODS FOR ENHANCING RESILIENCE AND EQUITY IN URBAN COASTAL COMMUNITIES. WHILE THE GOAL IS TO PRODUCE TRANSFERABLE METHODS, THE PROJECT FOCUSES ON COMMUNITIES IN HAMPTON ROADS REGION OF VIRGINIA ? ONE OF THE MOST VULNERABLE POPULATIONS TO SEA LEVEL RISE IN THE UNITED STATES ? AS COMMUNITY PARTNERS. THE HUB STRUCTURE OF THE PROJECT EMPHASIZES THE CO-GENERATION OF COMMUNITY CAPITALS AMONG A DIVERSE TEAM OF RESEARCHERS IN PARTNERSHIP WITH COMMUNITY STAKEHOLDERS. COMMUNITY CAPITALS IS A TERM INCLUSIVE OF BOTH NATURAL-BUILT CAPITALS, SUCH AS SEA WALLS, LIVING SHORELINES, AND GREEN STORMWATER INFRASTRUCTURE, AND HUMAN-SOCIAL CAPITALS, SUCH AS HEALTH, WELL-BEING, AGENCY, AND EMPOWERMENT. THE OVERARCHING HYPOTHESIS IS THAT BOTH FORMS OF COMMUNITY CAPITALS MUST BE ADVANCED IN SYNERGY IN ORDER TO HAVE RESILIENT AND EQUITABLE URBAN COASTAL COMMUNITIES. THE RESEARCH PLAN OPERATES ON TWO SPATIAL SCALES, REGIONAL AND LOCAL, BECAUSE BOTH SCALES ARE CRITICAL FOR BUILDING COMMUNITY CAPITALS. ON THE REGIONAL SCALE, THE RESEARCH TASKS ARE TO CREATE A GEOSPATIAL DATA INVENTORY, A SYSTEM-WIDE FLOOD MODEL, AND EQUITABLE POLICIES FOR REGIONAL CLIMATE RESILIENCE IN URBAN COMMUNITIES. ON THE LOCAL SCALE, THE RESEARCH TASKS ARE TO EMPOWER AND ENGAGE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED IN THE CLIMATE RESILIENCE CONVERSATION, BUILD COMMUNITY CAPITAL THROUGH WORKSHOPS THAT RESULT IN CO-DESIGNED STORMWATER INFRASTRUCTURE, AND MEASURE THE CO-BENEFITS OF GREEN STORMWATER INFRASTRUCTURE FOR MENTAL HEALTH AND WELL-BEING. WORK ACROSS THE TWO SCALES IS CONNECTED THROUGH SHARED RESOURCES AND FEEDBACK BETWEEN THE LOCAL COMMUNITY AND BROADER-SCALE REGIONAL EFFORTS. A KEY INTELLECTUAL FEATURE OF THIS RESEARCH IS THE SYNERGISTIC ADVANCEMENT OF COMMUNITY CAPITALS FOR CLIMATE RESILIENCE. MANY PROJECTS FOCUS ON ONE OF THESE COMMUNITY CAPITALS, BUT FEW SEEK TO ADVANCE BOTH IN SYNERGY WITH ONE ANOTHER. TO ADVANCE THE HUMAN-SOCIAL CAPITAL LIKE WELL-BEING, EMPOWERMENT, AND AGENCY CRITICAL TO FOSTERING EQUITABLE AND RESILIENT COMMUNITIES, THIS PROJECT ADVANCES EQUITABLE PUBLIC POLICIES THAT CAN HAVE A LASTING IMPACT ON HOW COASTAL URBAN CITIES APPROACH THE CHALLENGE OF ADDRESSING CLIMATE RESILIENCE. FOR EXAMPLE, THE CONCEPT OF CO-DESIGNED GREEN STORMWATER INTERVENTIONS THAT CAN BE IMPLEMENTED BY COMMUNITY MEMBERS CAN CONTRIBUTE TO BOTH ENHANCING NATURAL-BUILT CAPITAL AND SOCIAL-HUMAN CAPITAL. TO ENCOURAGE INCLUSION, THE PROJECT ALSO HAS A STRONG FOCUS ON REMOVING BARRIERS TO PARTICIPATION FACING UNDERREPRESENTED AND MARGINALIZED COMMUNITIES IN THE COASTAL RESILIENCE CONVERSATIONS AND ACTIVITIES. TO STRENGTHEN HOW NATURAL-BUILT CAPITALS CAN BE ASSESSED AND STRENGTHENED, THE RESEARCH ADVANCES THE STATE OF ART FOR MODELING COMPLEX URBAN STORMWATER SYSTEMS AT A REGIONAL SCALE. THE STRATEGY IS TO BUILD FROM WIDELY USED MODELS FOR ENGINEERING DESIGN, SO THAT PRODUCTS OF THE RESEARCH CAN BE MORE EASILY ADOPTED BY COASTAL COMMUNITIES, AND TO INTEGRATE THEM INTO A MORE HOLISTIC MODELING SYSTEM. LASTLY, THE HUB STRUCTURE OF THIS PROJECT PROVIDES THE OPPORTUNITY TO FOSTER CONVERGENCE ACROSS THE PROJECT TEAM?S EXPERTISE THAT RANGES FROM HYDROLOGIC ENGINEERING AND OCEAN SCIENCE, TO ARCHITECTURE AND LANDSCAPE DESIGN, TO ENVIRONMENTAL JUSTICE AND ENVIRONMENTAL PSYCHOLOGY, TO SOCIAL WORK AND COMMUNITY ENGAGEMENT. THE PROJECT HAS THREE PRIMARY BROADER IMPACT GOALS. THE FIRST IS TO BROADEN PARTICIPATION IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATH (STEM). TO ACHIEVE THIS GOAL, THE PROJECT TEAM WILL PROVIDE OPPORTUNITIES FOR EIGHT UNDERGRADUATE STUDENTS AND ONE GRADUATE STUDENT AT NORFOLK STATE UNIVERSITY (NSU) ? A HISTORICALLY BLACK UNIVERSITY LOCATED IN NORFOLK, VIRGINIA ? A PARTNER COMMUNITY FOR THE PROJECT. THE PROJECT AIMS TO CREATE A LONG-TERM PARTNERSHIP BETWEEN NSU AND THE UNIVERSITY OF VIRGINIA TO CAPITALIZE ON THEIR SHARED INTEREST IN CLIMATE RESILIENCE, AND TO CREATE AUTHENTIC AND MEANINGFUL CONNECTIONS WITH THE LOCAL COMMUNITY. THE SECOND BROADER IMPACT GOAL IS OUTREACH AND EDUCATION. THE PROJECT TEAM WILL STRENGTHEN EXISTING EFFORTS IN STEM EDUCATION TO REACH PUBLIC K-12 STUDENTS: A LEARNING BARGE CO-DEVELOPED BETWEEN UVA AND THE ELIZABETH RIVER PROJECT (ERP) AND THE SCHOOLYARD-LONG TERM ECOLOGICAL RESEARCH (SLTER), A PROJECT THAT LEVERAGES NSF SUPPORT TO TEACH STUDENTS LIVING ON VIRGINIA?S COAST ABOUT CLIMATE RESILIENCE. THE THIRD BROADER IMPACT GOAL OF THE PROJECT IS TO HAVE A POSITIVE EFFECT ON THE WELL-BEING OF THE LOCAL PARTNER COMMUNITIES. ONE WAY THIS WILL BE ASSESSED IS THROUGH STUDYING MENTAL HEALTH AND WELL-BEING CO-BENEFITS OF GREEN INFRASTRUCTURE INTERVENTIONS CO-DESIGNED AND IMPLEMENTED THROUGH THE PROJECT THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Department of Health and Human Services
$5.1M
ROLE OF CREM IN AMEBIC COLITIS AND INFLAMMATORY BOWEL DISEASE
Department of Health and Human Services
$5M
PRORENIN RECEPTORS MEDIATE HYPERTENSION AND KIDNEY DISEASE IN DIABETES
Department of Health and Human Services
$5M
RENAL AT2 RECEPTORS IN HYPERTENSION
Department of Health and Human Services
$5M
SPHINGOLIPIDS IN ACUTE KIDNEY INJURY
National Science Foundation
$5M
VIRGINIA-NORTH CAROLINA LOUIS STOKES ALLIANCE FOR MINORITY PARTICIPATION, 2017-2022
Department of Health and Human Services
$5M
ORGANIZATION OF CENTRAL SYMPATHETIC PATHWAYS
National Science Foundation
$5M
2007 LSAMP: VIRGINIA-NORTH CAROLINA ALLIANCE FOR MINORITY PARTICIPATION (PHASE I)
Department of Health and Human Services
$5M
DUST MITE, COCKROACH AND CAT ALLERGENS IN ASTHMA
Department of Energy
$4.9M
SPIN TRANSITIONS, PHASE COMPETITION AND ORDERING IN PEROVSKITE OXIDES
Department of Education
$4.9M
POST-DOCTORAL RESEARCH FELLOWSHIPS
Department of Health and Human Services
$4.9M
NOVEL ROLE OF HEPATIC SEL1L-HRD1 ERAD IN FGF21 GENE TRANSCRIPTION
Department of Education
$4.9M
EVALUATION OF STATE AND DISTRICT EDUCATION PROGRAMS AND POLICIES
National Science Foundation
$4.9M
FOCUSED COPE: BUILDING CAPACITY FOR ADAPTATION IN RURAL COASTAL COMMUNITIES
Department of Health and Human Services
$4.9M
IGE ANTIBODY RESPONSES TO THE OLIGOSACCHARIDE GALACTOSE-ALPHA-1,3-GALACTOSE (ALPHA-GAL) IN MURINE AND HUMAN ATHEROSCLEROSIS - PROJECT ABSTRACT INCREASED TOTAL SERUM IGE LEVELS ARE ASSOCIATED WITH CORONARY ARTERY DISEASE (CAD). HOWEVER, THE CAUSAL ROLE OF ANTIGEN-SPECIFIC IGE IN CAD REMAINS LARGELY UNEXPLORED. RECENT WORK FROM OUR GROUP AND OTHERS PROVIDE EVIDENCE THAT HUMANS WITH IGE SENSITIZATION TO THE MAMMALIAN OLIGOSACCHARIDE ALLERGEN A-GAL HAVE LARGER CORONARY ARTERY PLAQUES AND UNSTABLE PLAQUE FEATURES SIGNIFYING INCREASED CAD COMPARED TO THOSE WITHOUT IGE TO A-GAL. YET, WHETHER IGE TO A-GAL DIRECTLY PROMOTES ATHEROSCLEROTIC PLAQUE DEVELOPMENT AND THE MOLECULAR AND CELLULAR MECHANISMS MEDIATING IGE SENSITIZATION TO A-GAL LINKED TO ATHEROSCLEROSIS FORMATION ARE UNKNOWN. BITES FROM THE LONE STAR TICK INDUCE IGE SENSITIZATION TO A-GAL AND A SUBSEQUENT SEVERE ALLERGIC RESPONSE WHEN THE SUBJECT INGESTS A-GAL-CONTAINING FOODS SUCH AS RED MEAT. HOWEVER, THE VAST MAJORITY OF INDIVIDUALS WITH IGE TO A-GAL DO NOT MANIFEST WITH DELAYED ANAPHYLAXIS AND FREQUENTLY HAVE NO OUTWARD IDENTIFYING SYMPTOMS. AS SUCH, THEY CONTINUE TO CONSUME A-GAL-CONTAINING FOOD PRODUCTS (MEAT, DAIRY, ETC.) WHICH HAVE THE CAPACITY TO CONTINUE TO STIMULATE IGE RESPONSES AND INFLAMMATION IN THE VESSEL WALL. PRELIMINARY DATA PROVIDE THE FIRST EVIDENCE THAT HUMANS WITH IGE SENSITIZATION TO A-GAL HAD A HIGHER FREQUENCY OF CCR6+ SWITCHED MEMORY (SWM) B CELLS. NOTABLY, CONSISTENT WITH THE ASSOCIATION OF THE IGE SENSITIZATION TO A-GAL AND CAD, THE AMOUNT OF CCR6 ON SWM B CELLS WAS ASSOCIATED WITH CAD SEVERITY. TRANSCRIPTOMIC ANALYSIS DEMONSTRATED THAT CCR6+ SWM B CELLS EXPRESSED HIGHER IL-4R AND STAT6 IN SUBJECTS THAT WERE IGE A-GAL+ COMPARED TO IGE A- GAL-. INTERESTINGLY, IL-4 AND STAT6 ARE IMPORTANT FOR B CELL CLASS SWITCH RECOMBINATION TO IGE, SUGGESTING THAT CELLS THAT MAKE IL-4 MAY BE IMPORTANT IN IGE A-GAL PRODUCTION. STUDYING IGE SENSITIZATION TO A-GAL IN CONVENTIONAL MURINE MODELS OF ATHEROSCLEROSIS IS NOT FEASIBLE AS MICE, LIKE ALL LOWER MAMMALS BUT UNLIKE HUMANS, EXPRESS THE ENZYME GALACTOSYLTRANSFERASE, PRODUCE A-GAL AND DO NOT DEVELOP AN IGE RESPONSE TO A- GAL. WE HAVE OBTAINED A NOVEL A-GAL-/- MOUSE THAT MIMICS THE HUMAN CONDITION TO STUDY THE ROLE OF IGE SENSITIZATION TO A-GAL IN ATHEROSCLEROSIS. COMPARING A-GAL-/- MICE TO MICE WILDTYPE (WT) FOR A-GAL, WE SHOW A SIGNIFICANT INDUCTION OF IGE TO A-GAL AFTER EXPOSURE TO LONE STAR TICK-DERIVED LIPIDS IN THE A-GAL-/- BUT NOT THE WT MOUSE. MOREOVER, PRELIMINARY DATA FROM MICE DEFICIENT IN NKT CELLS IMPLICATES INKT CELLS IN THE REGULATION OF IGE ANTIBODY PRODUCTION TO LIPIDS FROM LONE STAR TICKS. BASED ON THESE HUMAN AND MURINE DATA, THE OVERARCHING OBJECTIVE OF THIS PROPOSAL IS TO INVESTIGATE WHETHER THESE FACTORS AND CELLS PLAY A CAUSAL ROLE IN ATHEROSCLEROSIS DEVELOPMENT DUE TO IGE SENSITIZATION TO A-GAL. WE WILL USE LOSS AND GAIN OF FUNCTION STUDIES IN MURINE ATHEROSCLEROSIS MODELS TO DEFINE NOVEL MECHANISMS OF A-GAL IGE PRODUCTION AND THE IMPACT OF TICK-INDUCED A- GAL SENSITIZATION ON DIET-INDUCED ATHEROSCLEROSIS, AND TEST A LARGER COHORT OF HUMANS WITH CAD QUALITATIVELY AND QUANTITATIVELY BY INTRAVASCULAR ULTRASOUND VIRTUAL HISTOLOGY (IVUS-VH), ALLOWING FOR MORE ROBUST MULTIVARIATE ANALYSIS AND DEEPER INTERROGATION OF IMMUNE CELL PHENOTYPES THAT MARK THOSE AT GREATEST RISK.
Department of Health and Human Services
$4.8M
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
Department of Health and Human Services
$4.8M
COPASI: BIOCHEMICAL NETWORK MODELING AND SIMULATION SOFTWARE
Department of Health and Human Services
$4.8M
NEUROVASCUALAR REGENERATION
Department of Education
$4.8M
RESEARCH NETWORKS FOCUSED ON CRITICAL PROBLEMS OF EDUCATION POLICY AND PRACTICE (NETWORKS)
Department of Health and Human Services
$4.8M
FUNCTIONAL MECHANISMS OF T1D RISK VARIANTS AND THEIR TARGET GENES USING 3D EPIGENOMICS AND SINGLE CELL APPROACHES
Department of Defense
$4.8M
THE REACH INTERVENTION FOR CAREGIVERS OF VETERANS AND SERVICE MEMBERS WITH TBI: EFFICACY AND IMPLEMENTATION PLANNING ACROSS THE VA POLYTRAUMA SYSTEM OF CARE
Department of Health and Human Services
$4.7M
BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS
Department of Defense
$4.7M
HERCULES: HARDWARE-ENHANCED RESILIENT COMPARTMENTALIZATION AND PROGRAM ANALYSIS FOR UPGRADED LEGACY ENVIRONMENT SECURITY
Department of Health and Human Services
$4.7M
ORGANIZATION AND FUNCTION OF NEURONAL ENDOSOMES
Department of Defense
$4.7M
"(MURI-07) HELIX: A SELF-REGENERATIVE ARCHETECTURE FOR THE INCORRUPTIBLE ENTERPRISE" DATED 11/10/06
National Science Foundation
$4.7M
GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP)
Department of Health and Human Services
$4.7M
UNIVERSITY OF VIRGINIA - ICDDR,B RESEARCH UNIT FOR WOMEN'S AND CHILDREN'S HEALTH RESEARCH
Department of Health and Human Services
$4.7M
PURINERGIC REGULATION OF VEINOUS ENDOTHELIAL PERMEABILITY
Department of Health and Human Services
$4.6M
RETROTRAPEZOID NUCLEUS AND CENTRAL CHEMORECEPTION
Department of Education
$4.6M
THE VIRGINIA EDUCATION SCIENCES PRE-DOCTORAL TRAINING PROGRAM
Department of Health and Human Services
$4.6M
SURVIVAL OF NEISSERIA GONORRHOEAE AFTER PRIMARY HUMAN NEUTROPHIL CHALLENGE
Department of Defense
$4.5M
THIS IS A CONTINUATION OF N00014-14-1-0533 MULTI-OBJECTIVE OPTIMIZATION AND MIXED-HORIZON DECISION-MAKING FOR AUTONOMOUS VEHICLES
Department of Health and Human Services
$4.5M
MOLECULAR ANALYSIS OF A YEAST TRANSCRIPTIONAL REGULATOR
Department of Health and Human Services
$4.5M
MICROTUBULE-MEDIATED MECHANISMS UNDERLYING HAIR CELL DEVELOPMENT AND DEAFNESS
Department of Health and Human Services
$4.5M
LONG-TERM IMPACT AND INTERVENTION FOR DIARRHEA IN BRAZIL
Department of Energy
$4.5M
50 MW SEGMENTED ULTRALIGHT MORPHING ROTORS FOR WIND ENERGY
Department of Health and Human Services
$4.5M
IRF4 AND IMMUNITY TO INFLUENZA INFECTION
Department of Health and Human Services
$4.4M
IDENTIFYING CELL-TYPE SPECIFIC GENETIC CONTROL OF T1D RISK VARIANTS IN TEDDY - TYPE 1 DIABETES (T1D) IS A COMPLEX DISORDER THAT ARISES FROM THE ACTION OF MULTIPLE GENETIC AND ENVIRONMENTAL RISK FACTORS WITH POPULATION CUMULATIVE RISK APPROACHING 1 IN 300 CHILDREN. THE DISEASE PROCESS FOR T1D CONSISTS OF INITIATION OF AN IMMUNE ATTACK TARGETED TO INSULIN SECRETING BETA CELLS IN THE ISLETS, MODIFYING, IMPAIRING, AND (ULTIMATELY) DESTROYING THE BETA CELLS. GENOME- WIDE ASSOCIATION STUDIES (GWAS), PERFORMED BY OURSELVES AND OTHERS, IDENTIFIED MORE THAN 100 CHROMOSOMAL LOCI WHERE THERE IS SIGNIFICANT, REPLICATED EVIDENCE OF ASSOCIATION WITH T1D. AS SHOWN BY US IN THE TYPE 1 DIABETES GENETIC CONSORTIUM IMMUNOCHIP FINE-MAPPING ANALYSIS, AND OTHER STUDIES, ~ 98-99% OF T1D CREDIBLE SET OF SNPS ARE IN THE NON-CODING REGION OF THE GENOME AND PREFERENTIALLY MAP IN ENHANCER REGIONS ACTIVE IN IMMUNE CELLS. THE PROPOSED STUDY IS AN ANCILLARY RESEARCH PROJECT OF THE ENVIRONMENTAL DETERMINANTS OF DIABETES IN THE YOUNG (TEDDY) STUDY. TEDDY WAS DESIGNED TO DISCOVER ENVIRONMENTAL TRIGGERS OF T1D IN A PROSPECTIVE COHORT OF NEWBORNS AT GENETIC RISK, FOLLOWED MULTIPLE TIMES PER YEAR WITH COLLECTION OF SAMPLES FOR DEEP PHENOTYPIC AND BIOMARKER PROFILING. THIS PROJECT WILL UTILIZE LONGITUDINAL SAMPLES AND THEIR RICH DEMOGRAPHIC, GENETIC, AND IMMUNE MARKERS COLLECTED ON TEDDY PARTICIPANTS. WE WILL USE SINGLE-CELL SEQUENCING TECHNOLOGY TO MONITOR IMMUNE MARKERS AT THE PROTEIN AND TRANSCRIPTION LEVELS TO GENERATE PROFILES FOR DIFFERENT STAGES OF ISLET AUTOIMMUNITY. TO GAIN A COMPREHENSIVE UNDERSTANDING OF THE T1D RISK GENES THAT FUNCTION IN INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY, WE PROPOSE TO APPLY SINGLE-CELL SEQUENCING TO MAP T1D RISK VARIANTS THAT ALTER GENE EXPRESSION IN CIRCULATING IMMUNE CELLS; WE WILL USE IMMUNE CELL-SURFACE MARKERS FOR CELL TYPE IDENTIFICATION AND EXAMINE IMMUNE PROFILES AT INITIATION AND PROGRESSION TO T1D. TO IDENTIFY BIOLOGICAL PATHWAYS, THAT T1D GENES FUNCTION IN, WE WILL CONSTRUCT A REFERENCE CO-EXPRESSION NETWORK AND REFINE PREDICTED GENE-GENE INTERACTIONS WITH BAYESIAN NETWORKS.
Department of Health and Human Services
$4.4M
GENOMIC ARCHITECTURE OF LGL LEUKEMIA
Department of Health and Human Services
$4.4M
BIOTECHNOLOGY TRAINING PROGRAM
Department of Health and Human Services
$4.4M
GENETIC CONTRIBUTORS TO DIABETES AND DYSLIPIDEMIA IN AFRICAN AMERICANS
Department of Health and Human Services
$4.4M
AKAP150-TRPV4 REGULATION OF ENDOTHELIAL FUNCTION IN OBESITY
Department of Agriculture
$4.4M
RESEARCH FOR APPROVED HATCH (HATCH ACT REGULAR RESEARCH) PROJECTS AT VIRGINIA TECH
Department of Health and Human Services
$4.4M
NEW PHARMACOTHERAPY FOR ALCOHOL AND CO-MORBID DISORDERS
Department of Health and Human Services
$4.4M
TRANSLATION OF THE UVA ADVANCED AUTOMATED INSULIN DELIVERY SYSTEMS TO CLINICAL CARE IN YOUNG CHILDREN: GLYCEMIC CONTROL, REGULATORY ACCEPTANCE AND OPTIMIZATION OF DAY TO DAY USE
Department of Health and Human Services
$4.3M
TRAINING IN THE PHARMACOLOGICAL SCIENCES
National Science Foundation
$4.3M
EXPEDITIONS: COLLABORATIVE RESEARCH: GLOBAL PERVASIVE COMPUTATIONAL EPIDEMIOLOGY
Department of Defense
$4.3M
A MEDICAL CENTER NETWORK FOR OPTIMIZED LUNG CANCER BIOSPECIMEN BANKING
Department of Health and Human Services
$4.2M
RYAN WHITE PART C OUTPATIENT EIS PROGRAM
Department of Health and Human Services
$4.2M
PAPILLOMAVIRUS E6 STRUCTURAL CONSORTIUM
Department of Health and Human Services
$4.2M
CONTROL OF SIR2 BY NUCLEAR NAD SALVAGE PATHWAYS
Department of Defense
$4.2M
THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY DARPA MICROSYSTEMS TECHNOLOGY OFFICE MTO FOR THE INTENSITY SQUEEZED PHOTONIC INTEGRATION FOR REVOLUTIONARY DETECTORS INSPIRED PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED JUNE 12, 2024, AND IN THE RECIPIENTS PROPOSAL TITLED, SQUEEZED INTEGRATED NITRIDE TECHNOLOGY SQUINT, DATED DECEMBER 17, 2023, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES.
Department of Health and Human Services
$4.2M
MECHANISMS OF MATERNAL BRAIN CHANGES WITH BIRTH INTERVENTIONS
Department of Health and Human Services
$4.1M
DETERMINANTS OF MYOGENIC AND NEURONAL MEMBRANE PHENOMENA
Department of Health and Human Services
$4.1M
POSTDOCTORAL TRAINING GRANT FOR MDS IN SURGICAL ONCOLOGY RESEARCH
Department of Health and Human Services
$4.1M
GAP JUNCTIONAL PATTERNING IN ARRHYTHMIC HEART
Department of Health and Human Services
$4.1M
ASTHMA AND ALLERGIC DISEASE CENTER
Department of Health and Human Services
$4.1M
HALLMARKS OF PROTECTIVE IMMUNITY IN SEQUENTIAL RHINOVIRUS INFECTIONS IN HUMANS
Department of Health and Human Services
$4M
LEVERAGING COMMUNITY PHARMACISTS TO OPTIMIZE SMOKING CESSATION SERVICES FOR RURAL SMOKERS IN APPALACHIA - RURAL APPALACHIAN POPULATIONS HAVE THE HIGHEST RATES OF CIGARETTE SMOKING IN THE U.S. AND ARE DISPROPORTIONATELY AFFECTED BY TOBACCO-RELATED CANCERS. PUBLICLY AVAILABLE SMOKING CESSATION RESOURCES (E.G., STATE QUITLINES, TEXT-BASED INTERVENTIONS, NICOTINE REPLACEMENT THERAPY [NRT]) ARE UNDER-UTILIZED BY RURAL APPALACHIAN SMOKERS. FURTHERMORE, RURAL APPALACHIA IS MEDICALLY UNDERSERVED; THUS, SMOKING CESSATION SERVICES WITHIN PRIMARY CARE SETTINGS FACE ADDITIONAL BARRIERS. COMMUNITY PHARMACISTS, WITH THEIR CENTRALIZED PLACEMENT IN LOCAL COMMUNITIES AND CLINICAL EXPERTISE, ARE IDEALLY SITUATED TO BUILD CAPACITY IN UNDERSERVED AREAS SUCH AS RURAL APPALACHIA TO ENHANCE EXISTING SMOKING CESSATION RESOURCES FOR SMOKERS. RESEARCH ON PHARMACIST-DELIVERED SMOKING CESSATION INTERVENTIONS IS LIMITED AND DOES NOT PROVIDE FOR DOCUMENTATION AND BILLING TO COMPENSATE PHARMACISTS FOR THEIR TIME SPENT COUNSELING PATIENTS. MEDICATION THERAPY MANAGEMENT (MTM), A PHARMACIST-DELIVERED MEDICATION ADHERENCE APPROACH THAT ALLOWS PHARMACISTS TO RECEIVE COMPENSATION FOR PROVIDING MEDICATION EXPERTISE, COULD BE LEVERAGED TO PROMOTE SMOKING CESSATION. TO ADDRESS THIS GAP, WE DEVELOPED AN MTM INTERVENTION, QUITAID, TO INCREASE SMOKING CESSATION AMONG RURAL SMOKERS. QUITAID WAS BASED ON A MEDICATION ADHERENCE INTERVENTION SHOWN TO BE EFFICACIOUS IN A QUITLINE SETTING. THE PURPOSE OF THE PROPOSED STUDY IS TO USE A PRAGMATIC APPROACH, GUIDED BY THE REACH, EFFECTIVENESS, ADOPTION, IMPLEMENTATION, AND MAINTENANCE (RE-AIM) FRAMEWORK, TO IDENTIFY THE ESSENTIAL COMPONENTS OF AN EFFECTIVE SMOKING CESSATION PROGRAM THAT CAN EASILY INTEGRATE WITHIN COMMUNITY PHARMACIES IN UNDERSERVED RURAL AREAS. SMOKERS (N=768) RECRUITED THROUGH 14 COMMUNITY PHARMACIES IN RURAL APPALACHIA WILL BE RANDOMIZED IN A 25 FULL FACTORIAL EXPERIMENT TO THE FOLLOWING FIVE TREATMENTS: (1) QUITAID (YES VS. NO), (2) TOBACCO QUITLINE (YES VS. NO), (3) SMOKEFREETXT (YES VS. NO), (4) COMBINATION NRT GUM + NRT PATCH (VS. NRT PATCH ALONE), AND/OR (5) 8 WEEKS OF NRT (VS. STANDARD 4 WEEKS). THE PRIMARY OUTCOME IS BIOCHEMICALLY- CONFIRMED POINT PREVALENCE ABSTINENCE AT THE 6-MONTH FOLLOW-UP. WE WILL ALSO ASSESS IMPLEMENTATION, INCLUDING RELATIVE COST, AS WELL AS FACILITATORS AND BARRIERS OF REACH, ADOPTION, AND MAINTENANCE OF QUITAID AND STANDARD, EVIDENCE-BASED TOBACCO TREATMENTS THROUGH AN ASK-ADVISE-CONNECT METHOD IN COMMUNITY PHARMACIES. OUR MAIN HYPOTHESIS IS THAT A SMOKING CESSATION MTM WILL INCREASE SMOKING CESSATION AND ENHANCE REACH AND ADHERENCE TO PUBLICLY AVAILABLE SMOKING CESSATION RESOURCES IN MEDICALLY UNDERSERVED RURAL AREAS. THE PROPOSED STUDY WILL: (1) PROVIDE FOUNDATIONAL EVIDENCE FOR LEVERAGING COMMUNITY PHARMACISTS IN UNDERSERVED AND RURAL AREAS TO PROMOTE UTILIZATION OF EXISTING EVIDENCE-BASED TOBACCO CESSATION RESOURCES THROUGH ENHANCED MTM SUPPORT, (2) INFORM UPDATED NATIONAL GUIDANCE ON TREATING RURAL SMOKERS, AND (3) AID STATE LEGISLATION EFFORTS RELATED TO PHARMACY SMOKING CESSATION PROGRAMS AND POLICIES. ULTIMATELY, THIS RESEARCH WILL INFORM STRATEGIES FOR SMOKING CESSATION IN RURAL AREAS, SUCH THAT CANCER RATES ACHIEVE PARITY WITH URBAN AREAS.
Department of Health and Human Services
$4M
MRI OF MYOCARDIAL FUNCTION IN POST-INFARCT KNOCKOUT MICE
Department of Health and Human Services
$4M
SYSTEMATIC IDENTIFICATION OF FUNCTIONAL T1D-ASSOCIATED NON-CODING SNPS USING GENETIC, TRANSCRIPTOMIC AND EPIGENETIC METHODS
Department of Health and Human Services
$4M
TUBERCULOSIS SECOND LINE DRUG SUSCEPTIBILITY CHIP
Department of Health and Human Services
$4M
EXTRINSIC MECHANISMS GOVERNING INJURY-INDUCED AXON DEGENERATION
Department of Education
$4M
PROJECT CATALYZE: THE IMPACT OF CARE + PATHS ON STUDENTS’ SUCCESS
Department of Education
$4M
ITERATIVE REPLICATION OF READ WELL IN FIRST GRADE
Department of Health and Human Services
$4M
ALANYL-GLUTAMINE SUPPLEMENTATION OF STANDARD TREATMENT FOR C. DIFFICILE INFECTION
Department of Commerce
$4M
CCAM - UNIV. OF VIRGINIA
Department of Health and Human Services
$4M
MECHANISMS OF TUMOR ESCAPE FROM ANTI-ANGIOGENIC THERAPY
Department of Health and Human Services
$4M
FORM AND FUNCTION OF OUR JANUS FACED GENOME
Department of Health and Human Services
$4M
OBSERVATION OF YOUNG CHILDREN'S COMPETENCE IN CLASSROOM
Department of Health and Human Services
$3.9M
EXTRACELLULAR SPACE AS MODULATOR OF GAP JUNCTION-CONDUCTION VELOCITY RELATIONSHIP
Department of Health and Human Services
$3.9M
INSTITUTIONAL CAREER DEVELOPMENT CORE
Department of Education
$3.9M
EDUCATION RESEARCH TRAINING
Department of Health and Human Services
$3.9M
HYPERPOLARIZED XENON-129 MRI: A NEW MULTI-DIMENSIONAL BIOMARKER TO DETERMINE PULMONARY PHYSIOLOGIC RESPONSES TO COPD THERAPEUTICS
Department of Education
$3.9M
RESEARCH NETWORKS FOCUSED ON CRITICAL PROBLEMS OF EDUCATION POLICY AND PRACTICE (NETWORKS)
Department of Health and Human Services
$3.9M
VISUAL SIGNAL TRANSFORMATION IN THE RETINOCOLLICULAR PATHWAY
Department of Health and Human Services
$3.9M
TARGETING SUCCINATE SIGNALING FOR INNOVATIVE PAIN RELIEF IN ORAL CANCER. - CURRENT PAIN MANAGEMENT STRATEGIES FOR PATIENTS WITH ORAL OR HEAD AND NECK CANCER CONDITIONS OFTEN RELY ON HIGH-DOSE OPIOID ANALGESICS, WHICH CAN BE INEFFECTIVE. SUCCINATE IS A DICARBOXYLIC ACID METABOLITE IN THE KREBS CYCLE, AND EMERGING EVIDENCE HIGHLIGHTS ITS PRO-INFLAMMATORY ROLE THROUGH THE ACTIVATION OF ITS G-PROTEIN COUPLED RECEPTOR, SUCNR1. NOTABLY, ORAL CANCER PATIENTS SHOW ELEVATED CIRCULATING SUCCINATE LEVELS AND INCREASED SUCNR1 EXPRESSION IN TUMOR TISSUES. WE HAVE BEEN AT THE FOREFRONT OF INVESTIGATING SUCCINATE/SUCNR1 SIGNALING AND HAVE DEMONSTRATED THAT SUCNR1 ACTIVATION PROMPTS PRO-INFLAMMATORY SIGNALING IN MYELOID CELLS. OUR PRELIMINARY FINDINGS INDICATE THAT PATIENTS WITH ORAL CANCER EXPERIENCING HIGHER PAIN SCORES HAVE ELEVATED PLASMA SUCCINATE LEVELS. ADDITIONALLY, SUCNR1 EXPRESSION HAS BEEN OBSERVED IN BOTH HUMAN AND MOUSE GANGLIA, WITH SUCCINATE INCREASING INFLAMMATION AND NOCICEPTION IN WILDTYPE (WT) MICE BUT NOT IN SUCNR1 KNOCKOUT (KO) MICE. IN AN MOC2 ORTHOTOPIC XENOGRAFT MODEL OF ORAL CANCER, KO MICE EXHIBITED REDUCED FACIAL NOCICEPTION AND FEWER TUMOR- INFILTRATING MYELOID CELLS. WE HYPOTHESIZE THAT INHIBITING SUCNR1 ACTIVATION COULD ALLEVIATE ORAL CANCER PAIN BY REDUCING INFLAMMATION AND NOCICEPTION. TO TEST THIS HYPOTHESIS, WE PROPOSE TWO SPECIFIC AIMS. IN AIM 1, WE WILL INVESTIGATE SUCCINATE SIGNALING AND ASSESS SUCNR1 AS A POTENTIAL TARGET FOR ALLEVIATING ORAL CANCER PAIN USING CLINICAL SAMPLES AND PRECLINICAL MODELS. THE ANALGESIC EFFECTS OF A NOVEL SUCNR1 ANTAGONIST WE HAVE DEVELOPED WILL BE EVALUATED IN 4NQO-INDUCED ORAL CANCER MICE. WE WILL MEASURE TUMOR GROWTH, ORAL FUNCTION, AND REFERRED MECHANICAL AND THERMAL HYPERSENSITIVITIES, ALONG WITH ASSOCIATED COMORBIDITIES. ADDITIONALLY, WE WILL EXPLORE THE DISTRIBUTION AND NEUROMODULATORY FUNCTION OF SUCNR1 IN HUMAN ORAL CANCER TISSUES, AND THE GANGLIA OF BOTH HUMAN AND MOUSE. IN AIM 2, WE WILL EVALUATE THE ROLE OF MYELOID SUCNR1 IN ORAL CANCER PAIN WITH GLOBAL AND MYELOID-SPECIFIC KNOCKOUT MICE, ALONGSIDE THEIR LITTERMATE CONTROLS. THREE ORAL CANCER MODELS—MOC1 AND MOC2 ORTHOTOPIC XENOGRAFTS AND 4NQO-INDUCED ORAL CANCER—WILL BE DEVELOPED IN THESE MICE. WE WILL MEASURE TUMOR GROWTH AND NOCICEPTION WHILE CHARACTERIZING VARIOUS MYELOID POPULATIONS IN TUMOR, PERIPHERAL BLOOD, AND TUMOR- DRAINING LYMPH NODES THROUGH FLOW CYTOMETRY. LASTLY, WE WILL ASSESS SUCCINATE AND CYTOKINE LEVELS IN SERUM, AND TUMOR TISSUES USING SUCCINATE ASSAYS, MESO SCALE DISCOVERY MULTIPLEX IMMUNOASSAYS, AND SEMI- QUANTITATIVE PCR.
Department of Defense
$3.9M
NEW START MURI COOPERATIVE AGREEMENT ENTITLED, "PLANETARY- AND GEOLOGICALLY-INSPIRED DISCOVERY OF REFRACTORY MATERIALS"
Department of Energy
$3.8M
MEDIUM ENERGY SPIN PHYSICS WITH LASERS
Department of Health and Human Services
$3.8M
BEHAVIORAL ROLES OF SEROTONIN
Department of Defense
$3.8M
INVESTIGATION OF INJURIES TO ARMORED VEHICLE PERSONNEL SUBJECT TO BLAST: PRELIMINARY STUDY WITH EMPHASIS ON LOWER EXTREMEITY FACTORS
Department of Health and Human Services
$3.8M
KIDS SIPSMARTER: A MULTI-LEVEL BEHAVIORAL AND HEALTH LITERACY INTERVENTION TO REDUCE SUGAR-SWEETENED BEVERAGES AMONG APPALACHIAN MIDDLE-SCHOOL STUDENTS
Department of Health and Human Services
$3.8M
CAV-1.TRPV4 REGULATION OF ENDOTHELIAL FUNCTION IN SMALL PULMONARY ARTERIES
Department of Health and Human Services
$3.8M
THE FUNCTIONAL ORGANIZATION OF MAMMALIAN MEMBRANES
Department of Health and Human Services
$3.8M
MIDBRAIN CIRCUITS FOR PERCEPTUAL DECISION-MAKING - ABSTRACT PERCEPTUAL DECISION-MAKING IS A FUNDAMENTAL COGNITIVE ABILITY THAT IS VITAL TO HEALTHY, DAILY FUNCTIONING AND IS IMPAIRED IN MANY DISEASES. ALTHOUGH MANY BRAIN REGIONS ARE KNOWN TO BE INVOLVED, THERE IS NO CLEAR BRAIN-WIDE MODEL OF HOW PERCEPTUAL DECISIONS ARE FORMED AND EXECUTED AND THE UNDERLYING CIRCUIT MECHANISMS ARE STILL LARGELY UNKNOWN. HERE, A TEAM OF INVESTIGATORS PROPOSE A SERIES OF EXPERIMENTS THAT WILL USE BEHAVIORAL MEASURES, IMAGING, PHYSIOLOGY, CIRCUIT DISSECTION, AND COMPUTATIONAL MODELING TO STUDY HOW THE MIDBRAIN SUPERIOR COLLICULUS (SC) PARTICIPATES IN VISUAL DECISION-MAKING. SPECIFICALLY, THIS NEW TEAM OF INVESTIGATORS WILL PROBE THE CONTRIBUTION OF TWO SC NEURONAL CELL TYPES, WIDE FIELD VERTICAL (WFV) CELLS IN THE VISUOSENSORY LAYERS AND PREDORSAL BUNDLE (PDB) CELLS IN THE MOTOR LAYERS. THESE EXPERIMENTS WILL BE DONE IN MICE AND TREE SHREWS, TO REVEAL THE UNDERLYING CIRCUITS AND COMPUTATIONAL PRINCIPLES ACROSS SPECIES AND TO LAY THE FOUNDATION FOR FUTURE EXPERIMENTS DESIGNED TO DISSECT DECISION-MAKING CIRCUITS IN PRIMATES. IN AIM 1, THE INVESTIGATORS WILL ESTABLISH AND PERFORM PSYCHOPHYSICAL EXPERIMENTS TO ASSESS PERCEPTUAL DECISION-MAKING IN BOTH SPECIES. THE BEHAVIORAL DATA WILL BE FITTED WITH COMPUTATIONAL MODELS TO ARBITRATE BETWEEN DIFFERENT THEORIES OF DECISION-MAKING. IN AIM 2, TWO PHOTON CALCIUM IMAGING AND/OR PHYSIOLOGICAL RECORDING WILL BE PERFORMED IN MICE AND TREE SHREWS TO DETERMINE THE ACTIVITY OF WFV AND PDB NEURONS DURING THE PSYCHOPHYSICAL MEASURES ESTABLISHED IN AIM 1. IN ADDITION, WFV AND PDB NEURONS WILL BE SILENCED OPTOGENETICALLY DURING THE BEHAVIORAL TASKS TO REVEAL THEIR SPECIFIC ROLES IN DECISION-MAKING. IN AIM 3, THE INVESTIGATORS WILL USE INTERSECTIONAL MONOSYNAPTIC VIRAL TRACING TECHNIQUES, MULTIPLEXED PEROXIDASE LABELING FOR CONFOCAL AND ULTRASTRUCTURAL ANALYSIS OF SYNAPTIC CONNECTIONS AND AND OPTOGENETICS-ASSISTED BRAIN SLICE RECORDING TO INVESTIGATE THE INTRINSIC AND EXTRINSIC CIRCUITS THAT LINK WFV AND PDB CELLS. TOGETHER, THESE EXPERIMENTS WILL GENERATE NOVEL KNOWLEDGE OF THE SYNAPSE TO CIRCUIT MECHANISMS UNDERLYING PERCEPTUAL DECISION-MAKING, AND PROVIDE TECHNICAL AND THEORETICAL FOUNDATIONS FOR FUTURE MECHANISTIC STUDIES OF COGNITIVE FUNCTION IN HIGHER MAMMALIAN SPECIES DIRECTLY RELEVANT TO HUMANS.
National Science Foundation
$3.8M
MRI: DEVELOPMENT OF ACCORD, A COMMUNITY CYBERINSTRUMENT FOR BROADENING ACCESS TO RESEARCH ON SENSITIVE DATA
Department of Defense
$3.8M
PREVENTION OF ALCOHOL RELATED INCIDENTS IN THE US AIR FORCE
Department of Health and Human Services
$3.8M
TARGETING NEUROBLASTOMA WITH ARMED T CELLS
Department of Health and Human Services
$3.8M
ROLE OF JAK2V617F IN THE PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS.
Department of Health and Human Services
$3.8M
MENINGES-TO-ASTROCYTE COMMUNICATION IN COGNITIVE FUNCTION
Department of Health and Human Services
$3.7M
MECHANISMS OF HETEROCELLULAR SIGNALING AT THE MYOENDOTHELIAL JUNCTION
Department of Health and Human Services
$3.7M
STRUCTURE AND FUNCTION OF E. HISTOLYTICA ADHERENCE LECTIN
Department of Health and Human Services
$3.7M
PREMATURITY-RELATED VENTILATORY CONTROL: LEADERSHIP DATA AND COORDINATION CENTER (LDCC)
Department of Health and Human Services
$3.7M
MECHANISM OF CELLULOSE SYNTHESIS AND TRANSPORT ACROSS BIOLOGICAL MEMBRANES
Department of Health and Human Services
$3.7M
NEURAL SUBSTRATES OF REINFORCEMENT LEARNING AND ITS TRAINING IN MAJOR DEPRESSION
Department of Health and Human Services
$3.7M
STRUCTURE AND FOLDING OF INTEGRAL MEMBRANE PROTEINS
Department of Health and Human Services
$3.7M
THE ROLES OF TUMOR MICROENVIRONMENT IN NEUROFIBROMA DEVELOPMENT AND THERAPEUTICS
Department of Energy
$3.7M
FUNDAMENTAL STUDIES OF CATALYTIC SITES AND CATALYST/MEMBRANE INTEGRATIONS FOR ADVANCED HYDROXIDE EXCHANGE MEMBRANE ELECTROLYZERS
Department of Health and Human Services
$3.7M
EXAMINING THE PHYSICAL TOLL OF MARGINALIZING EXPERIENCES IN EMERGING ADULTHOOD AND EXPLORING RESILIENCE POSSIBILITIES - PROJECT SUMMARY SCHOLARS HAVE CALLED FOR GREATER ATTENTION TO THE ETIOLOGIC ROLE OF SOCIAL IDENTITY-RELATED STRESSORS IN THE CREATION AND MAINTENANCE OF HEALTH DISPARITIES. IN THIS DOMAIN, A FOCUS ON EMERGING AND EARLY ADULTHOOD IS WARRANTED GIVEN THAT IDENTITY-RELATED CONCERNS PEAK DURING THIS DEVELOPMENTAL PERIOD. AMONG UNDERREPRESENTED COLLEGE STUDENTS ATTENDING ELITE PREDOMINANTLY WHITE INSTITUTIONS, THE CONFLUENCE OF HEIGHTENED NEEDS FOR IDENTITY SUPPORTS AND INFLUX OF MARGINALIZING EXPERIENCES MAY YIELD THE PERFECT STORM OF STRESSORS, RESULTING IN NEGATIVE HEALTH CONSEQUENCES, PARTICULARLY AMONG UNDERREPRESENTED STUDENTS WHO PERSIST IN THE FACE OF ADVERSE EXPOSURES. THE PROPOSED RESEARCH AIMS TO DOCUMENT 1) THE ROLE OF SPECIFIC IDENTITY-RELATED STRESSORS IN UNDERMINING THE HEALTH OF VULNERABLE GROUPS AS THEY PURSUE EDUCATIONAL AND CAREER ADVANCEMENT AND 2) THE ROLE OF SOCIAL SUPPORTS AND RESOURCES IN MITIGATING POTENTIAL HARM RESULTING FROM MARGINALIZING EXPERIENCES. THE PROPOSED RESEARCH WILL BE CONDUCTED WITH A SAMPLE OF 340 EARLY ADULTS WHO PREVIOUSLY PARTICIPATED IN A FIVE-WAVE LONGITUDINAL STUDY ACROSS FOUR YEARS (96% RETENTION RATE). ALL PARTICIPANTS WERE RECRUITED DURING THEIR FIRST YEAR OF COLLEGE AT AN ELITE PREDOMINANTLY WHITE INSTITUTION AND WERE ELIGIBLE TO PARTICIPATE IF THEY WERE A MEMBER OF AN UNDERREPRESENTED RACIAL/ETHNIC GROUP, A FIRST GENERATION COLLEGE STUDENT, OR RECEIVED THE FULL AMOUNT OF THE FEDERAL PELL GRANT (I.E., DEMONSTRATED SUBSTANTIAL FINANCIAL NEED). IN THE PROPOSED RESEARCH, ESTABLISHED INDICATORS OF PHYSICAL HEALTH AND EPIGENETIC AGING WILL BE COLLECTED FROM THIS SAMPLE OF YOUNG ADULTS (AGES 25-30) TO ASSESS HOW THEIR PREVIOUS AND CONCURRENT EXPERIENCES OF MARGINALIZATION (I.E., RISK) AND SUPPORT (I.E., PROTECTION) MAY “GET UNDER THE SKIN.” BIOMARKER MEASUREMENTS WILL BE UTILIZED IN ORDER TO IDENTIFY HEALTH RISK PRIOR TO DISEASE ONSET. DURING EARLY ADULTHOOD, MOST CHRONIC DISEASES ARE STILL ASYMPTOMATIC AND HAVE NOT YET BEEN DETECTED VIA ROUTINE HEALTH SCREENS. THUS, THE PERIOD OF EARLY ADULTHOOD ALLOWS FOR IDENTIFICATION OF PROGNOSTIC INDICATORS OF FUTURE DISEASE. NOTABLY, THE PROPOSED RESEARCH ALIGNS WELL WITH THE SCIENTIFIC VISION OF THE NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES IN THAT IT AIMS TO HELP EXPLAIN DISPARITIES IN DISEASE BY ILLUMINATING PHYSIOLOGIC PROCESSES RESULTING FROM SOCIAL INEQUITIES. ADDITIONALLY, THE PROPOSED RESEARCH SEEKS TO IDENTIFY MECHANISMS OF RESILIENCE WITH ATTENTION TO NUANCE ACROSS OUTCOMES BEING STUDIED (E.G., “SKIN-DEEP RESILIENCE”). A MORE COMPREHENSIVE UNDERSTANDING OF RISK AND RESILIENCE PROCESSES AND VARIABILITY IN HOW THEY PLAY OUT AMONG MARGINALIZED GROUPS CAN INFORM INTERVENTIONS TO FACILITATE SOCIAL MOBILITY WHILE ALSO PRESERVING AND BOLSTERING THE HEALTH OF MINORITY GROUPS. GIVEN THAT THE EMERGING AND EARLY ADULTHOOD YEARS HOLD GREAT CONSEQUENCE FOR THE LIFE COURSE, INTERVENTIONS TARGETING THIS DEVELOPMENTAL PERIOD HOLD TREMENDOUS POTENTIAL FOR REDUCING HEALTH DISPARITIES, PARTICULARLY HEALTH DISPARITIES THAT MAY BE EXACERBATED COUNTERINTUITIVELY BY SOCIAL MOBILITY.
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Source: IRS e-Filed Form 990
No officer or director compensation data available for this organization.
This data is sourced from IRS Form 990, Part VII. It may not be available if the organization files Form 990-N (e-Postcard) or has not yet been enriched.
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Organizations with annual gross receipts of $50,000 or less file the simplified Form 990-N instead of a full Form 990. These filings contain minimal financial data and are not included in ProPublica's database.
View on ProPublica Nonprofit Explorer →Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Tax-deductibility: IRS Publication 78